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Abstract
Healthcare-associated infections (HAIs) are a significant source of morbidity and mortality in U.S.
hospitals. Policy makers have responded with a variety of state and federal policies to reduce infections
by increasing the visibility and accountability of hospital performance. One policy initiative that has
gained momentum is state-level legislative mandates requiring hospitals to report HAI-related
performance data, which often includes public release of this data. These reporting mandates have
produced mixed results, however, regarding their impact on healthcare organizational processes, patient
outcomes or consumer decision-making.
This dissertation comprises three papers that explore the relationship between HAI public reporting,
organizational climate and HAI infection rates. The first paper presents a conceptual framework derived
from an integrative review of the HAI reporting literature that proposes new pathways for testing these
relationships. The second paper uses data from the Prevention of Nosocomial Infections and CostEffectiveness Refined (P-NICER) survey, specifically the Leading a Culture of Quality for Infection
Prevention (LCQ-IP) instrument, to examine differences in infection prevention organizational climate
between hospitals in states with and without HAI reporting mandates. Bivariate and multivariate analysis
revealed no statistically significant associations between key climate domains supporting infection
prevention and state reporting mandates, despite finding noted associations with other hospital
characteristics. The final paper uses National Healthcare Safety Network (NHSN) surveillance data, from
the P-NICER survey, to conduct a quasi-experimental longitudinal analysis examining the impacts of
reporting mandates on Clostridium difficile (C. difficile) infections in U.S. hospitals. Poisson regression
models yielded no statistically significant differences in incidence rate ratios for C. difficile at varying time
intervals before and after implementation of reporting mandates. Sensitivity analysis showed similar
findings, with no differences in rates of infections over time between hospitals in reporting and nonreporting states. This dissertation provides a well-circumscribed analysis of varying organizational
factors and patient outcomes thought to be impacted by mandatory HAI reporting. Findings are used to
propose new directions for nursing research and public policy.
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ABSTRACT
PUBLIC REPORTING OF HEALTHCARE-ASSOCIATED INFECTIONS: THE
IMPACT OF PUBLIC POLICY ON HEALTHCARE ORGANIZATIONS AND
PATIENT OUTCOMES
Stephen Perez
Julie Sochalski, PhD, RN, FAAN
Healthcare-associated infections (HAIs) are a significant source of morbidity and
mortality in U.S. hospitals. Policy makers have responded with a variety of state and
federal policies to reduce infections by increasing the visibility and accountability of
hospital performance. One policy initiative that has gained momentum is state-level
legislative mandates requiring hospitals to report HAI-related performance data, which
often includes public release of this data. These reporting mandates have produced
mixed results, however, regarding their impact on healthcare organizational processes,
patient outcomes or consumer decision-making.
This dissertation comprises three papers that explore the relationship between
HAI public reporting, organizational climate and HAI infection rates. The first paper
presents a conceptual framework derived from an integrative review of the HAI reporting
literature that proposes new pathways for testing these relationships. The second paper
uses data from the Prevention of Nosocomial Infections and Cost-Effectiveness Refined
(P-NICER) survey, specifically the Leading a Culture of Quality for Infection Prevention
(LCQ-IP) instrument, to examine differences in infection prevention organizational
vi

climate between hospitals in states with and without HAI reporting mandates. Bivariate
and multivariate analysis revealed no statistically significant associations between key
climate domains supporting infection prevention and state reporting mandates, despite
finding noted associations with other hospital characteristics. The final paper uses
National Healthcare Safety Network (NHSN) surveillance data, from the P-NICER
survey, to conduct a quasi-experimental longitudinal analysis examining the impacts of
reporting mandates on Clostridium difficile (C. difficile) infections in U.S. hospitals.
Poisson regression models yielded no statistically significant differences in incidence rate
ratios for C. difficile at varying time intervals before and after implementation of
reporting mandates. Sensitivity analysis showed similar findings, with no differences in
rates of infections over time between hospitals in reporting and non-reporting states. This
dissertation provides a well-circumscribed analysis of varying organizational factors and
patient outcomes thought to be impacted by mandatory HAI reporting. Findings are used
to propose new directions for nursing research and public policy.
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1.1 Introduction
Healthcare-associated infections (HAIs) are a significant source of morbidity and
mortality within the United States (U.S.) healthcare system. The Centers for Disease
Control and Prevention (CDC) defines HAIs as those infections which are acquired
during the course of treatment and care at a healthcare facility, oftentimes causing some
adverse reaction or outcome for the patient. 1 Although certain infections contracted or
incubating outside of the healthcare setting can be transmitted through hospitals and other
institutions, these are not considered HAIs and excluded from surveillance definitions.1
HAIs can range in severity, from relatively mild cases of upper respiratory infections to
life-threatening bloodstream infections, but all place a significant burden on patients,
caregivers, and the larger health system. Data from 2011 suggest approximately 722,000
HAIs occurred in U.S. hospitals that year alone, resulting in 75,000 deaths2. Estimated
direct costs to the health system range from $28.4 to $33 billion dollars.3 Most recent
surveillance data available from the CDC showed a national reduction in overall rates of
HAIs since baseline data was collected in 2008, likely reflecting national efforts to
implement evidence-based prevention efforts across healthcare settings.4 While this trend
is encouraging for all concerned with patient safety, closer examination of state-level
HAI data yield a slower decline and less consistent trends within specific states. 4
HAIs can have multiple microbial etiologies and range from localized to more
systemic or disseminated infections. While all HAIs are of clinical importance to patients
and caregivers within the health system, certain infections have long been targeted for
reduction based both on their detrimental impact and their preventability when using
2

evidence-based interventions. Infections of particular interest encompass: those that are
related to surgical or other medical/procedural interventions; those that are caused by
multidrug-resistant organisms (MDROs); and, infections that, at their initial emergence,
were epidemiologically linked to healthcare settings. Specifically, these infections
include surgical site infections (SSIs), central line-associated bloodstream infections
(CLABSIs), catheter-associated urinary tract infections (CAUTIs), ventilator-associated
pneumonias (VAPs), blood stream infections (BSIs) caused by Methicillin-resistant
Staphylococcus aureus (MRSA), and gastrointestinal infections caused by Clostridium
difficile (C. difficile) .1,5 In a 2014 point-prevalence study by Magill and colleagues5,
these infections were noted as collectively responsible for over 50% of HAI infections in
2011, with the remaining half consisting of infections considered to be more varied in
etiology, pathogenicity and cost.
The financial impact of HAIs on healthcare settings is significant. A recent study
by Zimlichman et. al6 found per-case costs for infections are highest in CLABSIs at
approximately $46,000 per patient; costs associated with CLABSIs in which MRSA was
causative pathogen rose even higher. The same study found SSI costs contributing the
most to overall HAI annual costs, responsible for nearly $3.3 billion dollars annually.6
Although other etiologies and types of HAIs permeate the healthcare environment, these
infections have specific surveillance definitions, continue to be costly to patients and
health systems and have been deemed preventable through evidence-based
intervention.1,6 A 2011 systematic review found nearly 65-70% of CLABSIs and
CAUTIs were highly preventable within the healthcare setting.7
3

In addition to the costly outcomes from device-associated infections and surgical
site infections, invasive MRSA and C. difficile HAIs have garnered increased attention
and targeted prevention strategies over the past few years. These infections are prevalent
in healthcare setting, can be difficult to treat, cause significant complications in
compromised individuals, and can be transmitted back and forth between the community
and healthcare environments. The burdens of these two infections in hospitalized
patients can be immense with regard to complexity of treatment and prolonging the
course of hospitalization, particularly in critically ill individuals and those with multiple
co-morbid conditions. Despite the availability of evidence-based guidance for prevention
of these infections, transmission and healthcare-associated cases continue to persist in
healthcare settings.5,8–11
The past two decades have yielded growing concern over preventable HAIs
among the public and policymakers. HAIs have played an increasing role in U.S. federal
patient safety policy and have been a national target for improvement since 2013, with a
goal of total elimination by 2020.12 Federal and state-level lawmakers have used these
infections as a means of monitoring performance and, in some cases, promoting
improved performance among healthcare institutions.13
One policy intervention that has been widely used to promote improvements in
the reduction of HAIs has been public reporting of hospital and statewide HAI-related
data. Beginning in the mid-2000s, state-level policy began to mandate the public release
of HAI data in a variety of formats and for varying infections. Originally CLABSIs were
the most prominent infections to fall under reporting mandates, but data from additional
4

device-associated infections soon followed.14 More recent mandates have expanded to
include the public reporting of MRSA and C. difficile data in addition to deviceassociated HAIs. These data are also used for newer federal initiatives that promote
improvements through incentives for healthcare systems if they are able to reduce their
incident infections on an annual basis.12,13,15 Healthcare-associated MRSA and C.
difficile infections were recently added to these incentive programs as measures of patient
safety and system improvement, reflecting state-level public reporting initiatives and the
need to reduce morbidity and mortality resulting from these infections. However, little is
known about the efficacy of these incentive programs and whether the public reporting of
MRSA and C-difficile HAI data decreases infection rates and improves patient outcomes.
Studies evaluating the impact of publicly reporting HAI data have shown mostly
mixed findings, consistent with broader research on the effects of releasing non-HAI
healthcare data.16–21 Both qualitative and quantitative methodologies have been used to
analyze the effects of public reporting mandates and the mechanisms by which these laws
may stimulate improvements. Yet while previous work has shown effects of the laws on
healthcare organizations and infection rates, these effects have not been uniform across
healthcare settings or outcomes. This suggests the need for further research on the
impacts of these laws and the mechanisms by which these laws promote improvement or
change in organizations.
The purpose of this dissertation is to explore the impact of HAI public reporting
laws on patient outcomes and organizations. This work will examine these impacts from
multiple perspectives. A revised conceptual framework detailing how the laws affect
5

patient outcomes, consumers and organizations will be presented using evidence from
current HAI public reporting literature. This revision will build on previously proposed
frameworks and examine their relevance to the current literature. This revised
framework will provide new guidance for inquiry supported by what is currently known
and where there is paucity in the available evidence. Public reporting mandates and their
effects on patient outcomes, specifically MRSA blood stream infections (BSIs) and C.
difficile infections, will be examined in the first of two studies. No previous U.S. studies
have looked at these infections in relation to these laws, despite their prevalence in
healthcare institutions and their prominence in public reporting mandates. While this
study focuses on patient outcomes, the third study will center on the impact of these laws
on organizations. The relationship of public reporting laws to infection prevention
specific organizational climate measures will be examined by exploring responses to
survey data designed to measure organizational climate specific to infection prevention.
These responses will be examined in hospitals in states with and without public reporting
to determine what, if any effects these laws may have on organizational climate.
Findings from these inquiries will guide future research and provide new directions for
policy evaluation and formative analysis.

1.2 HAIs as Policy Priorities in the United States
In 1999, the Institute of Medicine (IOM) released what would become a sentinel
work examining the issue of patient safety and preventable errors in the modern
healthcare system. To Err is Human: Building a Safer Health System quickly became a
major impetus of advocacy and policy intervention to address the national growing
6

concern about patient safety issues within healthcare institutions. The report detailed the
complex issues of errors committed within the healthcare system that often resulted in
grave outcomes for patients, and avoidable financial burdens on systems22. Types of
errors discussed in this report ranged from preventable medication errors to errors
associated with the provision of medical care, including HAIs. While IOM didn’t detail
strategies for preventing HAIs specifically, they did propose several broader policy level
recommendations to tackle the problem of HAIs and other preventable conditions within
health systems. Part of those policy recommendations included a stronger research
infrastructure to understand why these issues exist. Additionally a system of mandatory
public reporting of these events inclusive of HAIs was proposed to foster accountability
and provide incentives for strengthening quality of care.22
Shortly after the release of this report, issues of patient safety and HAIs gained
more substantial standing in the policy priority environment. Data from the early 2000s
suggested a trend toward rising HAIs and a need for improved accountability and
transparency23. These needs were coupled with a new push for consumer empowerment
and an ongoing national push toward improvement programs tied to financial
incentives.24 Public reporting of these infections began in some states as early as 2002
with a strong uptake among state legislative bodies and administrative agencies toward
the end of the decade.14,25 Yet this increase outpaced the available evidence that these
mandates improved care; a fact that did not go unnoticed by industry and infectious
disease experts.24 Despite apprehensions from experts and health systems, the policies
moved forward.
7

The U.S. Department of Health and Human Services (HHS) HAI Action Plan was
launched in 2009 to highlight and combat the growing issue of HAIs across the country.
This initiative originally focused on HAIs in the acute care setting but has since expanded
to include community and outpatient settings and long-term care facilities. Components
of this initiative span research, outreach, incentivizing health systems, and technology.12
All aspects are focused on collaborative efforts between the federal government, payors,
and health systems to reduce the incidence of HAIs in the U.S. while identifying best
practices and evidence-based innovation. Federal involvement in HAI reduction and
mandated reporting increased with the passage of the Patient Protection and Affordable
Care Act (ACA) .15 This legislation centered on reporting hospital-acquired conditions
(HACs) and mandating a subsequent reduction in payment to lower performing hospitals
in hopes of motivating them to improve care by leveraging these financial penalties.15
The total HAC score used to determine penalty payments involved several patient safety
and quality measures; by fiscal year 2017 (FY17), five measures included incident
HAIs.15 Evidence from Lee et. al26, shows that HACs were ineffective in stimulating a
reduction in HAIs. Utilizing a different approach, a policy intervention called Value
Based Purchasing (VBP), also stipulated in the ACA, emphasized payment rather than
non-payment for improved quality of care. VBP purchasing focuses on incentivizing
hospitals by evaluating performance and providing additional payments based on baseline
measures and ongoing improvements.13 Early on in VBP implementation measures for
incentive payments included some infection-related performance measures, but did not
include C. difficile or MRSA. In FY17, incident hospital-onset C. difficile and MRSA
infections were added to the list of critical performance measures central to the VBP
8

program. Even as other measures are slated for removal, all HAI-related measures
appear to remain, signifying their importance as a policy priority.13
As public reporting and associated policies continue to expand and become
ingrained in the larger healthcare system, HAIs remain a key component. However, as
specific policies concerning public reporting of these infections continue to evolve, they
remain diverse in their structure and implementation.

1.3 Public Reporting of Healthcare Performance Data
Public reporting of healthcare and health system performance measures has been
a part of federal policy and guidelines since the mid-1980s.27 While data collection and
dissemination varies by disease process, outcome, and reporting body, certain tenets of
public reporting policy remain constant. In a 2012 evidence report for the Agency for
Healthcare Research and Quality (AHRQ), Totten and colleagues27 describe public
reporting as “data, publicly available or available to a broad audience free of charge or at
a nominal cost, about a health care structure, process, or outcome at any provider level
(individual clinician, group, or organizations [e.g., hospitals, nursing facilities]) or at the
health plan level” (p.3).

The same report speculates that the abilty of public reporting tp

guide behavior lies in its capacity to influence the actions of both providers and
consumers within the same healthcare system. At best, evidence that public reporting is
effective in this capacity appears to be mixed in the current literature..20,27–29 As
Romano and colleagues30 note, stimulating change from public reporting of quality
measures is a complex endeavor that relies on the ability of an organization to assimilate
and use data to improve their own processes and the ability of society and consumers to
9

use reported data for effective decision-making.30 Yet, despite the rise in publicly
reporting healthcare performance measures over the past three decades, empirical
findings from examination of its impact on organizational processes, clinical outcomes
and effectiveness in different types of health systems remains mixed. Public reporting of
HAI data, newer still to the policy landscape, was largely crafted without this empirical
evidence and has faced challenges in implementation.24 Current research evaluating
HAI reporting laws is subject to these same challenges since states may vary in their
policy implementation and behaviors within health systems in ways that are not
completely understood.

1.4 Public Reporting of HAI-related Performance Data
Public reporting of HAIs, like those measures previously discussed, has gained
momentum over the past decade. While hospitals have tracked HAI related data for
many years, mandated reporting of data through state-level legislative initiatives has only
recently gained policy traction.25 This primarily involves requiring hospitals to report
their data to state government bodies. While public reporting of HAI data can be
mandated or voluntary, most states in the U.S. (37 states as of 2013) now have some type
of HAI-related public reporting legislation, with a significant amount of that data now
available at the federal level as well.14
HAI data collection in the U.S. is facilitated by the National Healthcare Safety
Network (NHSN), a national HAI surveillance system managed by the CDC. NSHN
receives reported HAIs from healthcare institutions around the country who follow
specific surveillance criteria for the identification and reporting of certain HAIs.
10

Aggregate data from this system is available to the public through federal channels (i.e.,
Hospital Compare Website), and allows for uniform definitions for infection surveillance
as well as some risk-adjusted comparison.1,31 NHSN often uses the standardized
infection ratio (SIR) as a measure of performance and progress around HAI
prevention.4,32,33 Centers for Medicare and Medicaid Services (CMS) uses the same HAIrelated data published on their Hospital Compare Website in a variety of payment
reduction plans including the HAC Reduction Program and incentive programs including
VBP.13,15
Since its inception, the public reporting of HAI data has been met with
controversy related to the perceived increased burden on healthcare systems,
inconsistencies in data used for reporting, and the paucity of evidence concerning the
effectiveness of publicly reporting data with regard to HAIs.24,34,35 Since that time, some
of these issues, primarily data inconsistencies, have been addressed with the use of the
NHSN surveillance and reporting system. However, questions persist around the
accuracy and validity of publicly reported HAI data.35,36
In preparation for compliance with state-mandated public reporting of HAI data,
the CDC’s Healthcare Infection Control Practices Advisory Committee (HICPAC)
published a systematic review of evidence evaluating public reporting in the literature in
2006.24 The review included recommendations for evaluation of public reporting of
HAIs, yet no studies to date had evaluated outcomes related to these mandates.24
HICPAC recommended both process improvements and clinical outcomes be included as
measures for evaluating the efficacy of publicly reporting HAI data.37 Recommendations
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for clinical outcome measures centered on infections that cause significant morbidity and
mortality and are known to be preventable when employing evidence based prevention
efforts. Specific considerations were given to the importance of selecting patient
populations considered at-risk for these infections as well a means of validating reported
data. These recommendations were emphasized and clarified in updated guidance from
HICPAC in 2013.38 Due to the increasing utility of publicly reported HAI surveillance
data, HICPAC released new guidance to ensure that valid surveillance data is used
properly. Along with HICPAC’s praise for policymakers’ shift toward using surveillance
data for public reporting (vs. administrative data or some combination of both), the
guidance recommended strict adherence to NHSN surveillance definition with supported
documentation, methods for data validation, and support from hospital administration
emphasizing the authority of the hospital epidemiology or infection prevention staff.38
A 2014 study by Reagan and colleagues14, showed that mandatory public
reporting of C. difficile and MRSA varied across states. While one state, Missouri, began
mandatory public reporting of MRSA infections in 2005, most states began reporting of
C. difficile and MRSA after 2008. Many did not implement mandatory reporting of these
infections until 2013.14 By 2013, 20 states had passed laws mandating the reporting of
MRSA HAI data, with nearly half of these states passing laws in 2012 or later. This
paper also detailed 19 states that had mandatory reporting of C. difficile HAIs.14 An
additional study by Reagan and colleagues39 in 2015 examined specific public reporting
laws pertaining to C. difficile. While the study showed a gradual increase in mandated
reporting of these infections since 2008, yet less than half of U.S. states were noted to
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have C. difficile reporting laws. Reporting requirements were both by state statute and
administrative ruling, such as the incorporation of healthcare quality reporting into state
law.39 Public reporting of these infections and others has gained momentum in states
across the U.S. The value of these laws in their impact of health systems and patient
outcomes continues to be studied in the literature. Yet, to the knowledge of this author,
few studies have evaluated the effect of MRSA and C. difficile public reporting mandates
on on infection rates in acute care settings. Evaluation of these laws’ effects on
preventable infections such as C. difficile and MRSA are key to understanding the impact
of these public policies on patient safety.

1.5 Conceptual Framework for the Public Reporting of Healthcare Outcomes
Evaluating the impact public reporting has on healthcare organizations and
outcomes, relies first on understanding how these policies may impact these health
systems and their consumers. In 2003, Berwick and colleagues40 proposed the most
widely used framework for understanding the effects of public reporting on the healthcare
system. The authors illustrate two distinct pathways by which the measurement of
quality in healthcare can stimulate improvement (Figure 1). Pathway One, the
improvement through Selection pathway, describes the mechanism by which consumer
choice drives the need for change and improvement. If publicly reported data alters the
way consumers select their healthcare providers, this may stimulate improvement within
that organization to prevent loss of market share.40 Pathway Two, improvement through
Change in care, describes systems’ propensities toward internal drivers of change to
improve outcomes, regardless of consumer choices and market.40 Intrinsic motivations
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stimulate change in health systems when performance data is reported internally or
externally. However, Berwick et. al, contend that often these motivations are not enough
to overcome the status quo performance-level in a health system.40 In these instances, the
Selection pathway may act on the Change pathway to drive the motivation of
organizations and individuals through the change process. While this may contribute to
changes in health systems, any measured improvements may be vulnerable to the
variability in reporting policies and the ability of stakeholders to interpret data for
decision-making .40

Figure 1.1 Conceptual Framework Linking Quality Measurement and Improvement

Figure 1. Conceptual Framework Linking Quality Measurement and Improvement: Pathways proposed by Berwick and
colleagues40 linking performance measurement and improvement. These pathways have been used in subsequent
literature to describe the pathways by which public reporting of healthcare performance data could stimulate
improvement and promote better patient outcomes.
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Building off those pathways described by Berwick and colleagues40, Hibbard et
al41 discerns a third pathway which centralizes the role of a health system’s reputation as
pertinent to stimulating change from performance data. The authors gave health systems
data regarding their own performance and assigned each health system to either public,
private (in-house), or no reporting groups. Hibbard and colleagues41 determined that
low-scoring hospitals also had more negative associations with public reporting, and
found that reported data would detract more from their reputation than their market share.
Findings also showed more quality improvement processes in the hospitals that publicly
report than in the other two groups.41 The authors contented that since public reporting
hospitals showed increases in quality improvement efforts in response to their
performance data, intrinsic motivation and the previously described change pathway may
be relatively weak.29 Thus they proposed the Reputation pathway be added to the
framework proposed by Berwick and colleagues29 yielding to concerns about public
reputation.
Although these frameworks hypothesize that publicly reporting hospital
performance data stimulates improvements in care and better outcomes, findings in the
scientific literature have left some of these pathways untested. Furthermore, these
conceptual frameworks have not been examined considering more recent literature that
explores the public reporting of performance data. Studies evaluating how HAI public
reporting laws impact health system stakeholders and patient outcomes have been
published since these conceptual frameworks have been proposed. Yet many of these
studies do not specifically test these pathways. A revised conceptual framework, based
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on a synthesis of the current HAI public reporting literature is needed to examine and
update these complex pathways, and provide new directions for empirical testing. This is
particularly true for HAIs, given their priority throughout state and federal policy
initiatives. The first paper in this dissertation will propose this revised conceptual
framework to describe the pathways by which publicly reporting HAI may impact
consumers, health systems, and outcomes. This framework will draw on the current HAI
public reporting literature to guide the development of revised pathways and delineate
opportunities for empirical testing.

1.6 The Effectiveness of Public Reporting on Improving Performance and Patient
Outcomes
Empirical findings on the effectiveness of public reporting to impact patient
outcomes, health system improvement, or consumer decision-making, remain mixed.
Two large reviews showed mixed results when evaluating impact of public reporting on
healthcare outcomes. In 2000, Marshall and colleagues28 reviewed 21 studies, three of
which examined direct clinical outcomes, all cardiovascular mortality measures.
Findings in each of the three reviewed studies confirmed reductions in mortality after
public reporting. The authors believed that advocates for public reporting may see this as
a small but valid justification in its use to drive improvements, despite possible
alternative explanations that may have contributed to these findings.28 Also, the authors
note that little evidence supports consumer use of publicly reported data in decisionmaking, and the exact mechanism of system or organizational behavior change and
improvement remains unknown. A systematic review published in 2008 found more
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conflicting evidence around public reporting’s effects on clinical outcomes than that
which was presented in Marshall and colleagues’ work.20,28 Eleven studies examining
hospital outcome data showed that while initial findings suggested improvements related
to publicly reported data, additional studies showed similar declines in mortality data in
states or systems without public reporting, particularly when mortality rates were
adjusted for risk.20 This review found some effect of public reporting on the stimulation
of quality improvement in hospital settings with more inconsistent effects on the selection
of hospitals or providers.20 Both reviews show similar findings that suggest public
reporting does stimulate process improvement yet may have a somewhat less appreciable
effect on clinical outcomes.20,28 While these reviews found some associations between
the reporting of outcomes and effects on systems processes, mechanisms by which public
reporting serves as a driver for change remains poorly understood.
A closer examination of public reporting literature regarding HAIs reveals similar
mixed results. An initial systematic review published in 2006 found very little evidence
supporting organizational or patient impact as a result of the public reporting of HAI
performance data.24 Since then, some studies have attempted to examine clinical
outcomes and organizational change related to publicly reported HAI data. In 2014,
Black and Kim42 examined the changes in CLABSI rates in Pennsylvania before and after
the implementation of public reporting laws. They found that rates of CLABSI fell in
both administrative and reported data sets (19% and 40% respectively). Yet the authors
noted there may have been evidence of gaming as a result of reporting that may have
clouded the validity of the finidngs.42 A retrospective cohort study evaluating public
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reporting requirements and CLABSI SIRs showed no difference among facility level
SIRs across states with varying strata and reporting requirements.16 Like research from
Black and Kim (2014), Marsteller and colleagues (2014) evaluated the effect of public
reporting on CLABSI rates and participation in a performance improvement program.
Results showed greater reduction in CLABSI rates after mandatory reporting within the
first year of reporting and higher rates of participation in the CUSP: Stop BSI program, a
national collaborative aimed at reducing CLABSIs among participating institutions.43
CLABSI SIRs and prevention practices in neonatal intensive care units (NICUs) were
evaluated in a 2014 study by Zachariah and colleagues. While this study showed greater
than 95% compliance with prevention activities in mandatory reporting states compared
to control states (p=.0002), no statistically significant relationship was found in CLABSI
SIRs between the two groups.17 Rinke et. al (2015), evaluated effects of mandated
reporting on CLABSI rates in critically ill pediatric patients using administrative data and
found that regardless of reporting status all states experienced a decrease in CLABSI
rates during the study period regardless of reporting mandates.44 A recent study by Liu
and colleagues (2016) used longitudinal data to evaluate the impact of HAI reporting
laws on CLABSI rates and found ongoing reduction in CLABSI rates due to
implementation of the laws after controlling for secular trends in infection data and
facility characteristics. Additionally, the authors note decreasing trends in CLABSI rates,
particularly in the 6 months leading up to the implementation of the laws when compared
to the 25 months or more prior (incidence rate ratio [IRR] = 0.66 [p<.001] .19 The
authors contend that this finding indicates that public reporting mandates stimulate
changes in potential improvement processes even prior to their implementation19.
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The only study to examine the relationship between public reporting of infection
data and C. difficile infection was done in Canada by Daneman and colleagues and
published in 2012. Their study compared observed rates to predicted rates used to
simulate C. difficile rates in the absence of public reporting. Findings showed a rate of
8.92 cases per 10,000 patient days in Ontario in the calendar year after public reporting,
which was lower than the predicted rate of 12.16 (p<.001, 95% CI 11.35 – 13.04) cases
per 10,000 patient days45. Overall 26.7% (95% CI 21.4% - 31.6%) reduction in C.
difficile cases was associated with public reporting45.
As of 2014, 23 states have implemented MRSA public reporting mandates, and 22
have implemented C. difficile mandates.4 While findings from Canada support the
positive impact public reporting may have on C. difficile infections, no studies evaluating
reporting policy have been conducted to determine if similar effects are seen domestically
regarding C. difficile rates. Additionally, MRSA-related outcomes remain unexamined in
the context of state-level public reporting laws. As previously discussed these infections
are increasingly important in federal HAI-related policy and hospital quality initiatives.
Yet, no studies have evaluated these effects longitudinally on MRSA and C. difficile
infections in U.S. hospitals.

The second paper in this dissertation will use longitudinal

data to evaluate the impact of state public reporting laws specifically on MRSA
bloodstream infections (BSIs) and C. difficile infections. Given their associated
morbidity and mortality, and financial impact, additional study is needed to evaluate the
role of reporting mandates in improving patient outcomes related to these diseases.
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1.7 Pathogenesis and Clinical Outcomes of MRSA Bloodstream and C.difficile
Infections
C. difficile and MRSA BSIs are a preventable source of morbidity and mortality
in hospitalized patients. This has led to ongoing concern among patients, policy-makers,
clinicians and healthcare administrators. Policy mandates that require hospitals to report
these infections aim at preventing their associated complications and improving
outcomes.
MRSA is the most common cause of skin and soft tissue infections in the
community setting and is well-documented as a cause of invasive infection in the
hospitalized patient9,46–48. A Gram-positive, anaerobe, Staphylococcus aureus (S.
aureus) is a frequent colonizer of the nares, pharynx, and skin of humans47,49. Individuals
with known colonization who progress to infection with S. aureus, invasive or otherwise,
often do so with their colonizing strain of the bacteria47. Persons with frequent exposure
to the healthcare system, uncontrolled chronic disease, immune compromise, presence of
invasive devices, and exposure to broad-spectrum antibiotics are most at risk for
colonization and/or infection. Methicillin resistance was noted in S. aureus nearly
immediately after the introduction of the antibiotic in the early 1960s49. S. aureus has
multiple virulence factors which contribute to it pathogenesis and propensity for
progression to invasive disease in compromised individuals11,47,50. Some virulence
factors precipitate development of sepsis through toxin-mediated disease, while others
assist with binding and evasion of host defenses47,49. Binding factors also contribute the
development of biofilms which can adhere to implanted devices in hospitalized patients
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and may be significantly resistant to antibiotic treatments47. Studies of whether added
virulence is propagated by methicillin resistance continue to yield mixed results11,47–49.
The increased prevalence of MRSA infections within the healthcare setting is
mediated by inpatient use of antibiotics47. Methicillin resistance confers a decreased
affinity to β-lactam antibiotics and broad spectrum antibiotic use can provide a selective
advantage for MRSA in the hospital setting11. MRSA can be transmitted from healthcare
provider to patient, or patient to patient, via normal contact associated with standard
provision of care11. Infection within the healthcare setting can affect multiple systems,
but invasive disease often occurs as a BSI, commonly referred to as MRSA bacteremia.
The sequelae of MRSA bacteremia are significant. This manifestation of invasive
disease is often associated with increased risk of death and prolonged hospitalization,
particularly in older and critically ill adults50. Disseminated MRSA infection in the blood
precipitates hematogenous spread of the bacteria to other organs, often resulting in organ
dysfunction, sepsis and death50.
Like MRSA, C. difficile is an anaerobic, Gram-positive, bacteria. This sporeforming bacillus is transmissible in humans via the fecal-oral route. Spores are extremely
resilient in the hospital environment and are not killed by conventional alcohol-based
hand rubs; these are common products used for hand hygiene in healthcare settings51.
Production of two exotoxins, toxin A (ToxA) and B (ToxB), is associated with its
primary virulence factors and its resultant pathogenesis in the gastrointestinal system.
These toxins’ direct effects and their associated immunologic responses can cause
diarrheal disease ranging from mild, self-limiting infection to severe colitis requiring
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surgical intervention, systemic decompensation, and death52. Over the past decade a
novel emergence of a more virulent strain of C. difficile, 027/BI/NAP1, has predominated
in healthcare settings and been associated with more severe disease and worse clinical
outcomes of C. difficile infection (CDI)52,53. Although some data suggests a decline in
the 027 strain, additional lineages of C. difficile have arisen and are causing disease,
including NAP07, PCR-Ribotype 078. This particular strain has been associated with the
production of a binary toxin, which may amplify the effects of ToxA and ToxB and lead
to enhanced pathogenicity8,51,53. The most significant risk factors for CDI are recent
antibiotic exposure, older age (> 65 yrs) and contact with a healthcare setting52,54,55.
While asymptomatic colonization of susceptible patients in the healthcare settings can
occur, the majority of testing and eradication efforts are centered on confirming CDI in
those with symptomatic disease as they are most likely to spread the infection to other
patients and contaminate their surroundings. Both infections have experienced
fluctuations in rates and prevalence both in the community and healthcare systems over
the past two decades. Despite an encouraging trend downward in infections, their
presence in healthcare settings continues to be of significant concern.

1.8 The Epidemiology of MRSA and C. difficile within the Healthcare Setting
MRSA and C. difficile infections in U.S. healthcare institutions continue to be of
concern for both providers and policy makers, despite national decreases in their rates
since 2008. 4 This is likely because these infections have been deemed preventable
within healthcare systems and yet still cause significant morbidity and mortality in
hospitalized patient.
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Since its discovery in the early 1960s, rates of MRSA-associated disease rose
within healthcare settings and the community through the mid-2000s.48,49 As HAIs
became a focal point of clinical and policy intervention, invasive healthcare-associated
MRSA was targeted for enhanced prevention strategies. From 2005 to 2008 a decline in
invasive healthcare associated MRSA has been noted.56,57 A study from Kallen and
colleagues in 2010 showed this decline was most prominent, -11.2% (95% CI -15.9 to 6.3%) in MRSA (BSIs) .56 An additional study using the same data set but examining
rates through 2011 showed similar improvements, yielding an overall reduction in
hospital onset invasive MRSA of approximately 54% during the study period.57
Similar findings are noted in a recently released HAI progress report from the
CDC. This report analyzed data from 2014 and compared it to their national baseline data
from 2008. SIRs are computed using risk adjusted models to compare both national and
state-specific trends.

In the most recent comparison data, SIRs for MRSA BSIs in

reporting hospitals decreased by 13% nationally from 2011 to 2014.4 Despite this
national trend, state level SIRs have not uniformly seen a decrease. Closer examination
of state level data yields an increase in some state-specific SIRs when comparing 2014
data to baseline SIRs calculated in 2011, suggesting that reductions are not ubiquitous
across states and institutions4

Additionally data from the CDC’s Active Bacterial Core

Surveillance program notes that the death rate from health-care associated MRSA
infections remain nearly 5 times higher that of community acquired cases.58 The same
data show that MRSA BSIs continue to account for more than two-thirds of all invasive
MRSA infections deemed healthcare-associated. These data show that despite overall
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some overall reductions nationally MRSA BSIs continue to be a significant contributor to
morbidity and mortality in the hospitalized patient.
Like MRSA, C. difficile infections are a significant concern in the hospital setting.
C. difficile is the most common healthcare-associated gastrointestinal infection and the
most common cause of antibiotic-associated diarrhea in the U.S.5,55 Recent studies have
indicated that C. difficile was responsible for more than 450,000 infections and 29,300
deaths in the U.S. in 2011, increasing excess healthcare expenditures by $1.5 billion.6,8
One modeling study by Desai and colleagues (2016) suggests that in 2014, an estimated
439,237 incident C. difficile infections occurred in the U.S with roughly two-thirds
originating in hospital or long-term care settings. This same study yielded that roughly
one-third of severe infections and deaths from C. difficile occurred in hospitalized
patients.54 Additional findings from this study confirmed that adults over 65 continue to
suffer from the largest burden of C. difficile infections, and higher proportions on total
deaths from C. difficile in hospitalized patients occurs in those with immune compromise
and chronic kidney disease.54
Similar to data reported on incident MRSA infections, the CDC compiles reported
data on hospital-onset C. difficile. SIRs are used to compare hospital performance to
national and state baselines and year-to-year performance. As of 2014, C. difficile
infections were down by 8% among reporting hospitals when compared to the 2011
baseline. 4 However, between 2013 and 2014, an increase in these infections were noted
suggesting a recent upswing in infections. In fact, C. difficile infections were only one of
two HAIs in this report to see an increase over the 2013 comparison; surgical site
24

infections related to colon surgeries were the other4. Some state-specific trends in SIRs
also showed increases when compared to 2013 data, emphasizing that the issue of
healthcare-associated C. difficile infection, is still a significant one.4
Decreasing rates of these infections and curbing thier transmission within
hospitals are a focal point of U.S. federal and state HAI-related policy. A wide range of
evidence-based interventions are described in current guidelines that aim to achieve these
outcomes. Yet while eliminating transmission of these infections within hospitals remains
a prominent policy goal12, the implementation and response to these policies have led to
inconsistencies in patient outcomes and infection rates. As previously discussed, a
national decrease in MRSA and C. difficile infections has been observed, but within
states and likely within hospitals, rates do not always echo the national trend.
One potential reason for these discrepancies is that healthcare organizations are
unique entities and respond to policy initiatives in the context of their internal and
external environments.40 As policies become more widespread, organizations must adapt
and implement these policies within their own unique environment. One framework for
specific characteristics of healthcare organizations may contribute to patient outcomes is
that of organizational climate. While organizational climate has been examined in
healthcare literature, little is known about its relationship to public reporting policy and
whether these policies act to strengthen infection prevention climate in health systems.
The third paper in this dissertation will use survey data to explore how a climate infection
prevention may be impacted by these policies. This pathway is important for
understanding the true nature of how these public reporting laws impact organizations
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and allows for new research on the relationship between policy, organizations and patient
outcomes.

1.9 Public Reporting, Organizational Climate, and Outcomes
As some experts have noted, public reporting does not exist apart from larger
structural components of organizations.30,40,59,60 Organizations respond to publicly
reported health outcomes, yet these outcomes are impacted by a considerable
organizational characteristics, processes and structures. Thus, the effectiveness of public
reporting to improve outcomes can potentially be mediated by these critical
organizational factors. One concept related to organizational functioning which could be
impacted by public reporting is the organizational climate.
Organizational climate is described in the literature as the perceptions regarding
specific organizational attributes including leadership, accountability, communication
and social norms, reported by persons within the organization.61,62 Stone and
colleagues61describe organizational climate as a set of core structural domains and
process domains that impact outcomes and processes of care. They propose the
Integrative Model of Organizational Climate as a means of describing the relationships
between structural domains, processes and outcomes (Figure 2). In this model that is not
specific to HAIs, structural domains, including leadership and organizational
characteristics encompass inputs such as communication processes and values of the
organization.61 Process domains include quality emphasis, group dynamics, work design
and supervision. These processes mediate the relationship between larger structural
domains and healthcare worker-related outcomes (i.e., satisfaction) and patient outcomes
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(i.e. clinical outcomes or patient satisfaction) .61 The model was developed from surveys
and data used in previous studies63 to describe key structures and characteristics of
organizations. Themes were analyzed and grouped into the domains and processes and
the resultant model was tested with empirical evidence showing statistically significant
associations between structural domains and healthcare worker outcomes, specifically
intention to leave. While clinical outcomes were not evaluated in this study, the authors
note the value of this model lies in its capacity to support further investigations
concerning organizational climate in healthcare.61 A later systematic review examined
the relationship of organizational climate on both clinical outcomes and employee related
outcomes using an adapted form of this model.62 In this review, MacDavitt and
colleagues62 discuss conflicting findings regarding certain aspects of organizational
climate and outcomes of care. The authors propose that this may be due to varying
measures of climate and clinical outcomes.
Like the findings noted by MacDavitt et. al62, organizational climate literature
related to HAIs has shown mixed findings. Stone et. al, (2007) studied the impact of
nurse working conditions on various patient safety outcomes including CLABSI and
CAUTI. Analyses showed slightly higher risk of CLABSI in units where nurses
perceived a more positive organizational climate (adjusted OR 1.19; 95% CI, 1.05-1.36),
but a lower risk of CAUTI (adjusted OR 0.61; 95% CI, 0.44-0.83) .64 A 2013 study from
Salge and colleagues examining organizational context and longitudinal MRSA rates,
found climates that encouraged the reporting of errors were associated with reductions in
MRSA blood stream infections over time.
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Figure 1.2 The Integrative Model of Organizational Climate

Published by Stone et. al in 2004, this model describes the relationship between core structural and process domains related to
organizational climate. This model provides a framework for how organizational climate, can impact patient care related outcomes.

Other factors from this study that were associated with decreased MRSA
infections dealt more with infection control procedures and training than with
organizational climate.65 A more recent study from nurse researchers in Colorado
examined organizational context and used secondary data from the Leading a Culture of
Quality Instrument for Infection Prevention (LCQ-IP) from the Prevention of Nosocomial
Infections and Cost-Effectiveness Refined Survey (P-NICER) .66 Using the Quality
Health Outcomes Model, the authors conducted latent variable modeling within a
structural equation modeling framework (SEM) to examine the relationships between
constructs within the model, organizational climate variables, a CLABSI-related
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intervention (Central Line Bundles), and outcome (CLABSI events). The final latent
variable model suggested a relationship between high levels of adherence to the
intervention and organizational context, but this did not extend to CLABSI outcomes.66
Broader climate-related conceptual relationships have been proposed to explain
why organizations respond differently to policy initiatives and attain varying results in
improving patient outcomes. Berwick et. al40contend that improving performance
through the measurement and reporting of data relies heavily on an organization’s ability
to improve processes and promote an environment conducive to change. Core processes
identified by Berwick include leadership, investment in time and change management,
communication, and ongoing evaluation.40 Marshall, Romano, and Davies30discuss the
impact public reporting can have on organizational culture by empowering changemakers, strengthening the value of quality improvement, and improving accountability.
They discuss how public reporting’s impact on social norms within organizations can
have long-lasting effects, but only with the understanding of the unique role internal
structures and processes play in impacting behavior and outcomes.30 Yet despite these
proposals, few studies target the effect of public reporting on these organizational-level
processes. These complexities require additional study to understand the relationship
between public reporting, organizational climate and the impact on HAI-related patient
outcomes.

1.10 Significance of this Research
The public reporting of HAI related data is now mandated in most states in the
U.S. Yet despite widespread adoption and implementation, mixed empirical evidence
29

exists that supports its influence on HAI infection rates. Less still is known about which
organizational characteristics may aid or hinder these laws in being effective. This
research fills existing gaps by providing a comprehensive approach to examining these
concepts in the context of HAI-related performance data. Paper one provides an updated
framework for examining the pathways by which public reporting of HAI may impact
organizations and, in turn, outcomes for patients and health systems. The associated
literature review offers a thorough analysis about what is known regarding HAI public
reporting using an existing public reporting framework to organize the findings.
The first study and second paper in this dissertation, examines the longitudinal
relationship between public reporting and outcomes associated with C. difficile and
MRSA blood stream infections. While similar methodologies to previous studies was
used, this is the first study to use longitudinal surveillance data to evaluate the effect of
these laws on a healthcare-associated MDRO and C. difficile, one of the most
burdensome HAIs in the United States. Recent policy initiatives, including federal VBP,
have included MRSA and C. difficile infections as prime measures for incentive
programs during fiscal year 2017. Results of this retrospective study provides needed
insight into the effects of these laws on infection rates within hospitals as well as lay the
groundwork for policy evaluation and ongoing evaluation of these outcomes.
Organizational contexts and climate may potentially play a significant role in how
HAI public reporting impacts outcomes. The second study and third paper in this
dissertation examined variables related to organizational climate as reported by health
systems and their relationship to public reporting. This exploratory study evaluated
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associations between key domains of organizational climate and public reporting by
examining comprehensive organizational climate data and specific climate-related factors
associated with infection prevention and control within healthcare institutions. This
study is the first to examine these relationships. The findings lay the foundation for
understanding if and how these reporting mandates are associated with organizational
climate and provide a baseline for additional studies including those examining
outcomes.
These studies serve as an exploration into whether public reporting policies work
to improve outcomes related to C. difficile and MRSA and begin to explore examine what
factors contribute to these effects within the context of organizations. They shed light on
an important policy initiative and guide new thinking about how to evaluate these laws
given their continued evolution and growing complexity.

1.11 Specific Aims
This dissertation aims to illuminate the relationship between public reporting of HAIrelated data and HAI outcomes, while exploring the relationship of specific organizational
factors which may enhance or attenuate the impact of public reporting.
Aim One: To develop a revised conceptual framework that describes the relational pathways by
which the public reporting of HAI data impacts health system organizational variables,
subsequent impacts on HAI rates, and consumer decision-making. Innovation: In the existing
literature, no conceptual frameworks for public reporting of HAI data have been developed for
the purposes of guiding inquiry and policy evaluation. Impact: Development of a conceptual
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framework specific to the public reporting of HAI data will help to guide evaluation of public
reporting policy and new inquiry in public reporting and HAI research.
Aim Two: Using data from the National Healthcare Safety Network (NHSN), conduct a
longitudinal secondary data analysis quasi-experimental study to determine the effect of
mandatory HAI public reporting laws on Laboratory Identified MRSA blood stream infections
and C. difficile infection (CDI) while controlling for other variables. Hypothesis: Implementing
state-based mandatory public reporting of healthcare-associated CDI and MRSA is associated
with a decrease in rates of these MDROs within hospitals from those states. Innovation: In the
existing literature, no studies have evaluated the impact of state-mandated public reporting laws
in Healthcare-associated CDI and MRSA rates in the United States using NHSN surveillance
data. Impact: Understanding the impacts of state-based public reporting policy on healthcareassociated MDRO infection rates will help determine the efficacy of these broad policy-related
interventions.
Aim Three: Using cross-sectional data from the P-NICER Survey, conduct an exploratory data
analysis examining the relationship between the presence of HAI public reporting mandates and
organizational climate in U.S. hospitals. Innovation: There is a gap in the present literature
regarding the relationship between HAI public reporting mandates and concepts central to
organizational climate. Impact: Examining this relationship will provide baseline data for future
research to investigate the intricate relationship between reporting mandates, organizational
climate and HAI related outcomes.
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2.1 Abstract:
Background: Healthcare-associated infections (HAIs) are a significant burden in the
U.S. healthcare system. These infections are often considered preventable and multiple
evidence-based guidelines that provide prevention strategies are widely available.
However, despite the adoption and implementation of prevention practices, these
infections continue to persist. Policy makers have responded to the problem with
national and state-level mandatory reporting legislation or statutes that require hospitals
to report their data to an oversight body, often times for public dissemination. Although
there is some mixed evidence in the literature as to whether these mandates have any
impact on hospitals and patient outcomes, less is known about the mechanisms by which
these policies make their impact. Previous conceptual frameworks have attempted to
broadly describe specific pathways (Change, Selection and Reputation) by which
mandated reporting of healthcare performance data affects outcomes and organizations,
but no framework exists specific to HAIs. Purpose: The aim of this paper is to propose a
revised conceptual framework describing how mandated HAI reporting impacts
outcomes and organizations, based on an integrative review of available literature that
has specifically explored these relationships. Research Design: An integrative review
was conducted to determine the existing evidence in the literature that supports or refutes
previously described HAI reporting pathways from pior conceptual frameworks.
Methods: Inclusion and exclusion criteria were developed and a search of SCOPUS,
PubMed, and CINHAL data bases using targeted search terms was conducted. Abstracts
were reviewed and final selections were made for inclusion in the review. Findings from
qualitative, quantitative and mixed methodological studies were grouped by previously
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proposed mandated reporting pathways and findings were integrated to support or
challenge previously proposed pathways. New pathways were also proposed based on
available evidence from the literature. Results: Nineteen publications were selected for
inclusion in this review, spanning 18 empirical studies and 1 systematic review. Impacts
of mandatory reporting largely support the Change and Selection Pathways but also
suggest new relationships and variables which should be included in the revised
framework. Additionally, the impact of the Reputation Pathway on consumer selection
and organizations is significantly revised. Conclusion: This revised conceptual
framework is the first to incorporate HAI-specific evidence regarding the impacts of
public reporting on health systems, patient outcomes and consumers decision-making.
The existing pathways supported or challenged by current evidence and the new
pathways presented in this framework allow researchers to test the intricate effects public
reporting policy may have on stakeholders and organizations within the healthcare
system.
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2.2 Introduction
Healthcare-associated infections (HAIs) are a significant cause of morbidity and
mortality in the United States (U.S.) healthcare system. The U.S. Centers for Disease
Control and Prevention (CDC) estimates that on any given day, approximately 1 in 25
hospitalized patients in the U.S. experiences an HAI.1 Each year, these infections result
in roughly 75,000 deaths. Of the multitude of HAIs that can occur in a clinical setting,
many of the costliest and most dangerous are those associated with medical devices,
surgical procedures, multi-drug resistant organism (MDROs), and Clostridium difficile
(C. difficile).1–3 Central-line associated bloodstream infections (CLABSIs), catheterassociated urinary tract infections (CAUTIs), surgical-site infections (SSIs), and
ventilator-associated pneumonias (VAPs), are device and procedure associated infections
that continue to be a preventable source of complications leading to higher healthcare
costs, prolonged length of stay, increased complexity of care, and excess mortality in
acute care settings.3,4
In response to the growing concern surrounding patient safety and preventable
adverse patient outcomes including HAIs, policymakers have implemented multiple
strategies to push healthcare institutions towards improving quality of care.5–7 One of
the most-widely propagated interventions is the mandated reporting of healthcare facility
performance data.6,8–10 These mandates typically have three components: the reporting
of HAI-related performance data to an oversight body (often state health departments),
the public release of that performance data, and the linkage of these performance data to
facility identifiers, allowing the public to see which data belongs to which facilities.11
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The linkage of facility identifier for release of information to the public is often a key
component of these state mandates and driver of change in health systems.12,13 Public
reporting has gained ground in the past two decades as a potential means of holding
health systems accountable for outcomes, improving quality of care, and empowering
consumers and payors to make informed decisions about where to obtain services.6,8,10
Most states as of 2013 do include a public reporting component to their HAI reporting
mandates.14 Evaluation of patient outcomes resulting from these polices has shown
mixed results; nevertheless, they continue to be implemented throughout the U.S. and
serve as a benchmark for federal incentive programs aimed at improving quality.5,7,8,15
The aim of this paper is to develop a revised conceptual framework that
characterizes the impact of HAI public reporting on healthcare systems, patient
outcomes, and consumers based on existing evidence in the available HAI public
reporting literature. An integrative review of existing literature was used to examine
these impacts and identify potential gaps in knowledge regarding specific pathways
included in this revised framework. This framework will serve as a foundation for
further inquiries regarding the public reporting of HAIs and identify new directions for
HAI public reporting research

2.3 Public Reporting of HAI-related Performance Data
HAIs have been a focus of public reporting for over a decade.14 McKibben and
colleagues (2006) describe public reporting relevant to HAIs as “information provided to
the public about the quality of health services” (p.143). Since 2003, policies to mandate
the public reporting of HAIs have been implemented in a majority of states.14,15 Over a
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decade later, public reporting of HAI-related data continues to be a policy priority for
legislators, federal administrators and patient advocates alike. However, effects on
various stakeholders within healthcare systems, including consumers, infection
prevention departments and personnel, and administrators is not fully understood.
Additionally, impacts on organizational processes and improvements as well as specific
HAI outcomes, particularly infection rates, has been explored in the literature but
continues to remain somewhat ambiguous.
Public reporting of HAI data in the United States focuses primarily on infectionrelated data at the level of the healthcare system; these data are often used to make
meaningful comparisons and observations regarding trends in patient outcomes or quality
of care.1,14,16 These policies can be legislatively enacted, implemented as part of an
administrative statute, or mandated through participation in other public reporting
programs.11,16 A study from Herzig and colleagues in 2014 found that as of the prior
year, 37 states had implemented mandatory HAI public reporting, with significant
variability in types events reported.14 Most state laws mandate that case-based
surveillance data are reported by healthcare institutions to the National Healthcare Safety
Network (NHSN), a national HAI surveillance system with oversight from the CDC. As
of 2014 however, all states have hospitals that report HAI data to NHSN in some capacity
whether in fulfillment of state mandates or federal requirements1,14 These data are then
made publicly available via federal channels, allowing for some risk-adjusted comparison
of HAI-related outcomes.17 These risk-adjustments allow for comparison among
institutions with varying characteristics that may impact HAI outcomes such as size,
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geography, or case-mix. The standardized infection ratio (SIR) is the main reported
statistic used by the Centers for Medicare and Medicaid Services (CMS) and the CDC to
publicly report HAIs. 18 This ratio examines the relationship between the number of
observed infections to the number of expected infections based on a risk-adjusted model
for device-associated HAIs, surgical site infections, MRSA bloodstream infections, and
C. difficile gastrointestinal infections.1 Specific criteria are used to meet surveillance
definitions required for consistent case-reporting across states and facilities in an attempt
to circumvent issues of variation in data reported and noted issues with validation of true
HAI cases.16,19 In addition to being publicly reported these data are also used for various
incentive programs including the Hospital Value-Based Purchasing program (VBP).7
Although these laws have now been implemented in some states for over a
decade, at the time of their original inception little evidence was available support their
effect on reducing HAI events and improving patient care. In many cases policy
mandates were outpacing evidence and HAI experts were left concerned that little
empirical foundation existed with which the challenges of implementing these laws could
be justified.15 However the impacts of non-HAI public reporting mandates had been
explored in the literature.9 In addition, conceptual frameworks had been developed to
hypotheses the unique pathways and relationships by which reporting performance
improvement data may impact outcomes and stimulate change hospitals. Berwick et.al20
developed a conceptual framework describing the impact of performance measurement
and data reporting on health system performance, consumer engagement, and quality of
care.20–22 While this framework does not specifically address the public reporting of
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infection data, it identifies proposed pathways by which publicly reported performance
data may stimulate change in healthcare systems.

2.4 Conceptual Framework for Quality Measurement and Improvement
In 2003, Berwick and colleagues20 published one of the most highly referenced
frameworks for how quality measurement might stimulate improvement in providers and
organizations (Figure 1). The paper describes the varying pathways by which measuring
performance might affect the actions and decisions of consumers, clinicians, payors and
other various actors within the larger healthcare system.
The Selection Pathway described in this framework involves choice in the hands
of consumers, payors and referring clinicians.20 Decisions to select services are based on
measurement of and access to performance data of the institution or provider in question.
The threat of avoidance of lower performing institutions by informed payors and
consumers motivates those organizations to improve practices. Not surprisingly, this
pathway relies on the presentation of understandable, valid data as well as the ability of
healthcare consumers to correctly interpret and use this data for decision-making.20
A second pathway identified by Berwick et. al20, the Change Pathway, describes a
more intrinsically motivated health system. This pathway relies on the ability of health
systems and providers to receive performance measurement feedback and implement
change based on those data.
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Figure 2.1 Conceptual Framework Linking Quality Measurement and Improvement:
Change and Selection

Pathways proposed by Berwick and colleagues20 linking performance measurement and
improvement. This pathway has been used in subsequent literature to describe the
pathways by which public reporting of healthcare performance data could stimulate
improvement and promote better patient outcomes.

Significant investment on the part of these systems to collect and report data, promote the
use of performance improvement techniques, and incentivize improvements in care is
needed to ensure this pathway works optimally in the healthcare system environment.
Berwick and colleagues20contend that individual intrinsic drivers such as pride, caring,
and desire-to-achieve can help stimulate the change pathway. However, without an
environment that supports and drives improvement initiatives, intrinsic drivers may fail to
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move the dial on quality of care.20 The Selection Pathway is also a recognized source of
motivation for the Change Pathway, although in Berwick, et.al’s work it remains an
untested driver.20 The authors hypothesize that provider and administrator aversion to
loss of market share, community criticism, and other negative motivators can portend a
shift toward improvement through the Change Pathway.20
The notion that selection could serve as a motivator for change was explored by
Hibbard and colleagues which led to the proposal of a third pathway for public reporting
to stimulate change within healthcare systems.21–23 Their study contrasted the effect of
issuing public versus private reports to health systems on performance improvement
practices.22 Findings from this work showed that those low-performing hospitals
receiving publicized performance reports undertook more quality improvement activities
than those hospitals receiving non-publicized reports.22 Hibbard and colleagues argued
that these findings indicated a concern for reputation served as a motivator for change.
Findings from a subsequent paper indicated that this motivation is even greater than
concern for loss of market share.23 Hibbard contended that these findings support the
relative weakness of the aforementioned Change Pathway to improve care through public
reporting and that a Reputation Pathway may be have a stronger propensity to stimulate
improvement practices.21
In 2008, Fung and colleagues8 published a systematic review of studies that
examine how public reporting of performance data improves quality of care. They
addressed the Berwick20 framework in their review of the literature. Their findings
showed that consumer selection of physicians and hospitals was affected by the
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publishing of performance data, particularly in the specialty area of cardiac surgery.
Health plan selection was also affected by reported performance, with several studies,
both experimental and observational, showing a preference for selecting plans with
higher performance ratings even though these plans may be higher cost and involve more
restrictions.8 The effects of public reporting on the consumer selection of hospitals and
individual providers was more mixed. Fung et. al8 reviewed 9 studies examining the
effects of public reporting on hospitals and market share; overall studies showed that
releasing hospital performance data had little or no effect on hospital utilization or market
share. In studies examining provider selection after publicly reporting performance data,
some effect was noted, particularly with regard to cardiac surgeons and the New York
State Cardiac Surgery Reporting System.8 Five studies examining this data found that
physicians with better outcomes were more likely to see increases in growth for surgical
charges, while those surgeons with higher mortality scores were less likely to be selected
by Medicare enrollees.8
In addition to selection, Fung et. al8 also examined the effects of reporting on
clinical outcomes and process improvements. While a minority of studies in the review
showed an improvement on mortality indicators after public reporting, most had
inconclusive findings or could not account for secular trends in decreasing mortality in
non-reporting environments.8 Underlying trends in these outcomes, including regression
to the mean, may be a key limitation in analyzing these data and isolating the effect of
reporting mandates. This suggests the presence of additional complexity in the pathways
between reporting and impact, highlighting the need for further review of the literature
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and empirical investigation. Quality improvement activity was the outcome most widely
affected by public reporting. Studies of hospital settings found that most healthcare
systems responded to the publication of their performance data by initiating quality
improvement efforts, including efforts in domains noted in the various reports.8
To date the most widely examined public reporting conceptual framework and its
pathways have not been revised to account for the breadth of available evidence
regarding the effect of public reporting and HAIs. The aim of this paper is to develop a
revised public reporting framework that incorporates available literature concerning the
effect of public reporting on HAI-related outcomes. This framework will allow
researchers and policy-makers to target inquiries and develop relevant evaluation
methods that address the impact of these public reporting laws on HAIs.

2.5 Methodology
An integrative review of the literature was conducted to examine the relationship
between public reporting and HAIs.24

The integrative review methodology is well-

suited for the aim of this review.24,25 Whittemore and Knafl (2005) discuss the
integrative review as uniquely inclusive of diverse research methodologies and allowing
for results aimed at a wide array of purposes, including the development of concepts and
the review of evidence. Ganong25 underscores the utility of the integrative review for
examining theoretical issues and posing new directions for needed research. These
reviews often are guided by the use of a previously determined conceptual framework
related to the phenomenon of interest, guiding the sampling of publications and
development of inclusion/exclusion criteria. The methodology put forward by
55

Whittemore and Knafl24 was used to conduct all steps of this review.
Since the aim of this review is to develop a revised conceptual framework from
current evidence, prior work from Berwick20, Hibbard21, and their colleagues was used to
guide the development of inclusion and exclusion criteria for the final selected studies
(Table 1). These previously discussed pathways and frameworks focus primarily on the
impact of publicly reported performance data on various stakeholder groups within health
systems. Thus, empirical studies and published work were reviewed with the intent of
evaluating the impact of public reporting on stakeholder groups as a primary outcome.
Similar to those outlined by previous frameworks, stakeholder groups are defined for this
review as consumers or patients (inclusive of broad patient outcomes), health systems or
organizations, payers and provider groups.20,21 This strategy also reflects previous work
published by the Agency for Health Research and Quality (AHRQ) in attempts to
evaluate similar relationships.13 A 2012 review was conducted by Totten et. al13 for
AHRQ, resulted in findings similar to those reported by Fung and colleagues8. However,
Totten et. al13 used a structured guide for reporting that specifies the Population
(healthcare providers or consumers), Intervention (public reporting of data), Comparators
(examining groups with different data reporting or no reporting), Outcomes
(improvements in care or changes in processes), Timing (trajectory of reporting and
outcome evaluation), and Setting (hospitals or other healthcare organizations). This
guide is useful in identifying studies that are structured to evaluate the impact of public
reporting on key stakeholders in the healthcare system.
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Table 2.1 Inclusion and Exclusion Criteria for Integrative Review of the HAI and
Public Reporting Literature
Inclusion Criteria
•
•
•

Exclusion Criteria
•

Published between 2006 and 2016
Published in a peer-reviewed
journal
English language publication

Studies with the following
characteristics:
o Editorials, commentaries and
papers describing the policy
landscape
o Studies examining long-term
care and outpatient setting
o Primary outcome is data
validation
o Primary outcome is not
evaluation of stakeholder
impact

Searches were conducted in Scopus, PubMed and the Cumulative Index of
Nursing and Allied Health Literature (CINAHL) querying for publications in peerreviewed journals published between 2006 and 2016 and using specific search
terminology (Table 2). This timeframe was selected since official guidance for the public
reporting of HAIs was published in 200526. Initial search was completed in Scopus and a
subsequent review of titles and abstracts (where available) was conducted to exclude
those studies or publications that met the exclusion criteria (figure 2). Relevance to
exclusion criteria was ascertained by using abstracts to determine the purpose of the
study, identify the outcome of interest, and identify the methodology used by the
researchers. After this initial review, a full text review was done of the remaining
publications to ensure relevance to the conceptual framework sampling and pathways
previously described. This same process was completed with additional search terms
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and strategies in Scopus, while also reviewing titles for duplicates from previous
searches. The total publication yield from the full text review in Scopus indicated the
potential need for expanded search terms to include “HAI”, “healthcare-acquired” and
“mandated”. This was ascertained by a review of the references of selected papers from
the Scopus review. These terms were subsequently applied to the additional searches.
Once results from the Scopus search were finalized, PubMed and CINHAL were
queried using the same criteria and expanded search terms, with attention to duplicative
results from the Scopus findings (figure 2). The final articles selected for inclusion were
then reviewed, grouped and analyzed by where they fit within the various public
reporting pathways. Again, references of the final selected studies were screened.
Publications were analyzed for study design, relevance to previous frameworks, outcome
of interest, strengths and limitations (appendix A).
Special attention and analysis was given to each study’s contribution to what is
known about the impact of public reporting on specific stakeholder groups and cohesion
with previously proposed pathways. Proposed pathways from prior conceptual
frameworks were used to group the selected studies for analysis. Those studies which
examined potential relationships or variables most fitting of the Change Pathway were
analyzed to determine if findings supported, challenged or posed new relationships or
variables along that pathway.20 Similar methods were used for articles related to the
Selection and Reputation Pathways. 20,21
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Table 2.2 Search terms and initial yield for Integrative Review of the HAI and Public
Reporting Literature (2006-2016)
Database/Search Engine

Boolean/Search Terms

Total
Retrieved

Scopus

Public reporting (all text) *AND infections (all text)

189

Scopus

Public reporting (all text) *AND healthcare-associated
(all text) *AND infections (all text)

43

Scopus

Mandatory reporting (all text) *AND healthcareassociated (all text) *AND infections (all text)

42

PubMed

Public (title/abstract) *OR Mandatory (title/abstract)
*AND Reporting (title/abstract) *AND Infections
(title/abstract)

571

PubMed

Public (title/abstract) *AND Reporting (title/abstract)
*AND Healthcare-associated (title/abstract) *AND
Infections (title/abstract)

45

PubMed

Mandatory (title/abstract) *AND Reporting
(title/abstract) *AND Healthcare-associated
(title/abstract) *AND Infections (title/abstract)

24

PubMed

Mandatory (title/abstract) *AND Reporting
(title/abstract) *AND HAI (title/abstract)

29

PubMed

Mandatory (title/abstract) *AND Reporting
(title/abstract) *AND Healthcare-acquired
(title/abstract) *AND Infections (title/abstract)

2

CINAHL

Public (title/abstract) *AND Reporting (title/abstract)
*AND Healthcare-associated (title/abstract) *AND
Infections (title/abstract)

72

CINAHL

Mandatory (title/abstract) *AND Reporting
(title/abstract) *AND Healthcare-associated
(title/abstract) *AND Infections (title/abstract)

46

CINAHL

Mandatory (title/abstract) *AND Reporting
(title/abstract) *AND HAI (title/abstract)

53

CINHAL

Public (title/abstract) *AND Reporting (title/abstract)
*AND HAI (title/abstract)

80
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Results were organized and synthesized with regard to specific pathways examined by
each article.20,21 Evidence from the review was then used to update existing pathways
and propose a revised conceptual framework specific to public reporting in the context of
HAIs and its impact on specific stakeholder groups.

2.6 Results
Nineteen studies were identified for inclusion in this review.15,27–44 Fifteen empirical
publications and 1 systematic review of prior HAI public reporting literature were
identified in the initial Scopus search. This review was deemed suitable for inclusion
because its primary aim was to determine the impact of public reporting on HAI
outcomes.15 Subsequent PubMed searchers identified 3 additional studies after removal
of duplicates and reviews of abstracts and full text where applicable. Review of
references of included publications was conducted, and one additional study was
identified which was published as a research paper in the Northwestern University
Pritzker School of Law, Law and Economics Research Paper Series.40 It was noted that
this paper served as the source of data for a narrative case-study paper identified in the
Scopus search and already included in the review.
In consultation with the study team and after reviewing both texts, it was decided
that the source paper from Black and Kim (2014) would be used as it contained data and
results from the empirical study rather than a case description of challenges and findings.
Studies were then grouped an analyzed in relevance to conceptual framework pathways
and methodology.
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Figure 2.2 Literature Search Framework and Inclusion of Studies for Review
Phase 1: Scopus

Phase 2. PubMed and CINHAL
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In total 13 studies described their methodologies as quantitative, four as
qualitative, one as mixed-methods, and one as a systematic review. Key characteristics
of studies were collected and evaluated using a template described in the integrative
review literature (Appendix A).45 Five studies described a conceptual framework in their
background or methods, including two that describe the specific pathways previously
discussed. However, only one of these studies attempted to carry these pathways through
to the analysis and discussion portion of the publication.29
The Change Pathway: Patient Outcomes, Providers, and Organizations
Berwick and colleagues describes the process of change within organizations and
individuals as guided and stimulated by performance measurement, yet the specific
sources of motivation for change remain highly variable.20 In many of the studies that
examine patient outcomes, the change pathway is invoked with some noted associations
between public reporting mandates and patient outcomes.
Studies using quantitative methods to evaluate public reporting’s impact on HAI
outcomes showed conflicting results in that some showed decreases in HAI infection
rates and others did not. These effects on C. difficile in Canada were noted when
Daneman and colleagues conducted a longitudinal retrospective cohort study, comparing
modeled rates of C.difficile without the presence of a mandate to observed rates of the
infection after the implementation of a mandate.39 Results showed a 26.7% reduction
(p<0.001) from the expected outcome in C.difficile one year after implementation of
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public reporting. This trend was seen across multiple institutions included in the study
sample of administrative data.39
A study from Black and Kim (2014) described CLABSI rates before and after
public reporting mandates in Pennsylvania.40 Researchers used a difference-indifference study design, to assess the change in CLABSI rates in Pennsylvania and
control states, before and after public reporting implementation.40 Comparing
administrative inpatient CLABSI rates in Pennsylvania to that of control states, the
authors noted that CLABSI rates fell by 24% in Pennsylvania during the reporting period
compared to 3% drop in those states without reporting.40 Hospitals with the highest rates
in Pennsylvania had more significant decreases during the reporting period. Similar work
from Pakyz and colleagues38 evaluated the effect of public reporting on CLABSI SIRs
through a cross-sectional retrospective cohort study. One-hundred and fifty hospitals
were divided into three groups: those in states with public reporting meeting three legal
requirements (data submission, reporting of data to the public and inclusion of facility
identifiers), those in states with public reporting not meeting the three requirements, and
those in states without public reporting.38 Findings showed no differences in SIRs among
all three groups.38 Marsteller and colleagues36 used a similar study design to Black and
Kim40 to examine the impact of public reporting on CLABSI rates with an additional
outcome of participation in a national program aimed at reducing the rates of CLABSI in
the inpatient setting (On the CUSP: Stop BSI program). Findings indicated that program
participation was higher in states where reporting mandates were enacted at the time of
On the CUSP: Stop BSI program implementation, potentially suggesting that pending or
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new mandates may be associated with participation in process improvement intitiatives.36
Facilities in states with the voluntary or long-standing reporting requirements had higher
rates at baseline and greater reduction in CLABSIs during the first 6 months of the
program with incidence rate ratios (IRR) of 1.48 and 1.14 respectively (p=.002,
p=.033).36 All groups initiating the process improvement intervention saw decreases in
CLABSI rates.36 A more recent study by Liu and colleagues (2016) used a difference-indifference design to examine CLABSI rates in ICUs and associations with mandatory
reporting. With a longitudinal national sample of CLABSI data (n=244 hospitals, with
1,902 ICU years) from NHSN, the study team concluded that when compared to 25
months or more prior to the law’s implementation, notable decreases in CLABSIs were
seen both in anticipation of the law (IRR = 0.66 , p<.001) and long after the laws went
into effect (IRR=0.343, p=.009) .41
Three studies involving data from the pediatric population contribute similar
findings to previous literature.37,42 In a study evaluating clinical outcomes from public
reporting in critically ill pediatric patients, Rinke and colleagues (2015) used data from
the Kid’s Inpatient Database (KID) to determine the extent of public reporting’s impact
on CLABSI rates. Analysis yielded statistically significant reductions in CLABSIs in all
3 reporting groups regardless of when or if reporting was initiated (never reporting vs.
reporting began in 2006 vs. reporting began in 2009) .37 Differences in CLABSI
reduction between groups were not statistically significant, except in the never reporting
group which showed a greater reduction when compared to the group that began
reporting in 2009 (OR=2.1, p<0.001) .37 Flett and colleagues (2015) examined CLABSI
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public reporting and its impact on point-of-care indicators, specifically blood culture and
antibiotic use in pediatric populations. Despite anticipating lower blood culture rates and
antibiotic utilization multivariable linear regression showed no difference in adjusted rate
ratios (ARRs) before and after public reporting implementation for either indicator.42 A
third study in the pediatric population by Zachariah and colleagues (2014) explored the
relationship between mandated CLABSI reporting, process improvements and outcomes
in the neonatal intensive care unit (NICU). The authors found that when compared to
control states, NICUs in states with mandates more often reported greater than 95%
compliance with all prevention practices (p=.002) .43 However this did not translate into
a difference in clinical outcomes as no statistical significance was found in CLABSI SIR
differences between both groups (mandated reporting vs. no mandates).43 These findings
were also unable to significantly link NICUs that reported greater than 95% compliance
with prevention activities and an SIR less than 1.43 Finally, a 2006 systematic review by
Mckibben and colleagues15 was conducted to evaluate existing evidence for support
newly enacted public reporting mandates. While the published report did include
recommendations for implementing a public reporting program centered on HAI
performance data, finding from the review showed little empirical evidence suggesting
the effectiveness of public reporting to improve outcomes.15
Significant associations between public reporting and lower infection rates are
noted in some studies, but in general remain inconsistent across the body of literature.
Studies that showed statistically significant effects were those that used quasiexperimental methodologies for analysis.36,39–41 . However, even studies that show a
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decline in infection rates do not illuminate the pathways by which these laws impact
these outcomes.
A diverse sampling of methodologies was used in studies that describe the
organizational impact of public reporting. In the first study, Pegues34 described the
University of California, Los Angeles (UCLA) Health System’s response to the 2009
Health and Human Services Federal and state HAI Action plan.34 Pegues used the
Context-Input-Process-Product model, to evaluate the state of HAI prevention prior,
during, and after process improvements related to state and federal HAI policy, including
public reporting. Specifically, he described the inputs of public reporting mandates for
HAIs as main driver for a host of HAI prevention strategies and process improvements. 34
Specific needs around reporting prompted additional methods for data validation, unit
and hospital-specific HAI data reporting strategies (dashboards), and stronger
surveillance. These changes improved practice by highlighting trends in HAI rates in
specific hospital units, allowing for improved infection prevention with targeted
evidence-based interventions predetermined by the hospital.34 A more expansive
qualitative study by Uchida and colleagues33used semi-structured interviews of infection
prevention personnel conducted in six hospitals throughout California. Thematic
analysis of responses yielded both positive realizations and specific concerns generated
by public reporting. Specifically, respondents believed that mandated reporting
emphasizes the issue of HAIs in their respective health system and increases cognizance
of HAI issues across the organization.33 Frustration among respondents was due to a
perceived disconnect between reporting data to external stakeholders and tangible
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improvements in HAI-related outcomes. Specifically participants felt that public
reporting could not be linked to specific outcomes in their patients, therefore the added
burden of reporting was challenging to reconcile33 A larger study in California involving
many of the same researchers from the previous paper used a mixed-methods longitudinal
approach to evaluate the impact of new mandatory reporting law.31 Pre- and post-public
reporting surveys were conducted among hospital infection prevention leadership,
examining a wide range of issues from work processes to outcome measures. These
surveys were followed by in-depth interviews with six hospitals to gather further
information. Statistically significant changes were noted between pre/post reporting
mandates, specifically in reported adherence to evidence based protocols (use of barrier
precautions [p<.01], and chlorhexidine usage [P=.02]), as well as a reported decrease in
CLABSI rates (p<.01) and VAP rates (p=.02) .31 Themes of frustration with increased
workload, data validation concerns, but also a heightened awareness and prioritization of
infection prevention within organization were noted from qualitative interviews.31 In a
similar study with a larger multi-state scope, Stone and colleagues32interview key
stakeholders, including hospital and state administrators from states with and without
public reporting mandates. Results show that while public reporting is key to fostering
collaboration and increasing organizational awareness, significant concerns still existed.32
Yet interviewees noted that these public reporting laws are largely responsible for
highlighting the importance of HAIs within hospital settings and garnering support for
organizational initiatives to improve outcomes.32 An additional national study from the
University of Pennsylvania also queried infection control personnel in leadership roles, to
determine the impact of state mandated reporting on infection prevention processes.35
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Thirty-one states, 22 of which had mandated reporting requirements, were represented
across 110 hospitals. Contrary to findings in other studies, respondents in states with
mandatory reporting did not identify added process improvements or a perceived
decrease in incidence of HAIs when compared to those in states with no reporting
requirement31,35,43. Despite issues of small sample size, low external validity, and lack of
infection-related data, these findings do provide perspective on how mandated reporting
outcomes are perceived and reported by healthcare professionals. 35
A final study by McGuckin et al. (2013) described the opinions of hospital
epidemiologists with regards to mandatory reporting. Findings suggested that a majority
of hospital epidemiologists found public reports generated at the state level to be useful
(70%), and believed that they have a role in disseminating data (96%).30 An additional
finding from this study is that the majority of the epidemiologists surveyed believed that
consumers would likely have difficulty understanding HAI data and interpreting it for the
purposes of healthcare decision-making.30 This finding highlights the proposed role of
the consumer role in the HAI framework, particularly regarding the selection pathway,
and yet suggests that consumers may not be well-suited to use these outcome data for
decision-making. While clinical outcomes and organizational improvement data are key
to understanding the effects of public reporting on HAIs, a full picture of the impact of
public reporting HAI data must include a broader scope of how this available information
is used by consumers. Consumer involvement in this decision-making is a central tenet
to previously described frameworks20,21, however existing public reporting and HAI
literature reveals a diminished comprehension of these data by consumers.
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The Selection and Reputation Pathways: Data-driven, Consumer Decision-making
Understanding the utility of HAI data from the consumer perspective is essential
to determine the best methods for dissemination and support informed decision-making if
a goal of policy-makers is to empower consumers to use this data for healthcare decisionmaking.46 Four articles discussing consumer knowledge of publicly reported HAI data
and how those data affect healthcare choices were included in this review.
A study by McGuckin and colleagues described the results of a telephone survey
across the U.S. examining public awareness of HAI reporting and its use in selecting a
hospital for their care needs.44 28% of total respondents in states with HAI laws were
aware of the reporting laws and the presence of publicly available data. Only 14% of
respondents cited HAI data as a one of their top 2 considerations when choosing a
hospital, with most listing provider recommendation as their main driver for hospital
selection.44 More education (p<.0001), higher income levels(p=.0007), and previous
infection were noted in participants who appeared more engaged with and/or aware of the
HAI data reported in their state (p<.0001). 44
Two additional studies from researchers at the University of Massachusetts
examined the presentation and interpretation of HAI data and how these attributes might
affect healthcare decision-making in a local population.28,29 The first study was a crosssectional survey of residents from Worcester, Massachusetts, evaluating formatting and
structure of publicly available HAI data.29 Eight versions of the reports, each differing in
consistency of indicators, representation of the data, and the presence of confidence
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intervals were mailed to participants, followed by the questionnaire.29 From the 201
questionnaires returned and included in the study, researchers found that inconsistency in
metrics (i.e. one hospital with highest overall safety score, yet not the lowest HAI or
mortality rate) pushes consumers to select the aggregate score (safety score) as the
predominant means of decision-making.29 Similar to the findings from McGuckin et al44
higher levels of education were associated with higher understandability ratings,
suggestive of some influence of education on engagement and comprehension of publicly
reported data.29
An additional study by Mazor and colleagues28 used semi-structured, in-depth
interviews, to describe the views about publicly reported HAI data as experienced by
participants and generate new recommendations for publicly reporting HAI data. Data
was shown to participants in three forms: a standard report from the State of
Pennsylvania, a subsequent “improved” (p.414) report, using varying graphical
representations and a composite score, and web-based reports28. Findings from 59
interviews suggested many participants were unfamiliar with HAI-related terminology
but interested in the data and prevention strategies. However, confusion over
interpretation of data and results continued even after general explanations of HAI
concepts. Participants tended to prefer infection rates and mortality compared with other
measures.28 Similar to their previous study, Mazor and colleagues noted that while HAIs
were a concern for patients with regard to decision-making and hospital selection, other
factors predominated including: insurance status, family and friend recommendations,
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and prior experiences.28,29 Recommendations for improving data presentation included
stipulations on content and formatting.
A more recent study from Mansick and colleagues (2015) assessed the
interpretability of HAI data presented on the Hospital Compare website. Researchers
conducted a survey with questions designed to evaluate various domains covered on the
website including: written descriptions of the data with or without the SIR (Tasks 1 and
2), identical SIR descriptions with numerical SIRs (Task 3), and only numerical SIRs
(Task 4) .27 Corresponding tasks were used to gauge how well participants interpreted
these data in each domain. Overall, increased complexity of the data (written
descriptions vs. only numerical SIR data) was associated with lower mean correct
responses (Task 1: 72%, [95% CI, 66-79%] vs. Task 4: 38% [95% CI, 31%-45%])
meaning that as data becomes more complex, participants are less likely to interpret it
correctly.27 Similar to findings from Mazor28,29 and McGuckin44, those with higher
education levels had higher mean correct responses on more complex data
interpretation27.
A Revised Conceptual for HAIs and Public Reporting
Considering these findings, a revised conceptual framework for assessing the
impact of HAI public reporting policy is proposed (figure 3). This revised framework
incorporates existing pathways previously described, but proposes new relationships,
identifies the strength of existing evidence, and puts forward new frameworks for inquiry.
With respect to the larger framework, new pathways are designated by solid or dotted
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arrows indicating direct paths between variables of interested. Dotted arrows are
consistent with pathways that may be hypothesized but lack evidence or support in the
literature. Solid lines indicate conclusive or more mixed findings supporting that these
pathways do exist, but the mechanism and mediating factors may not be well understood.
Central to this new framework is the notion that patient outcomes are highlighted as a
primary target for public reporting mandates and are effected, although inconsistently, by
public reporting policy.35–38,40–43 However, the pathways by which these outcomes are
affected are not well described. The bi-directional nature of this reporting/outcomes
relationship is important since outcomes are fed back to organizations and consumers,
potentially stimulating the Change and Selection pathways. Yet the inconsistency in
previous findings suggest additional mediating variables and pathways that likely play a
role in impacting stakeholders.
Consumer choice operates within the more nebulous concept of the Selection
Pathway. It has been established that consumer education level has a remote effect on
their healthcare decision-making, but most have difficulty interpreting data specifically
for that purpose.28,29,44 However, one common theme present was reputation, specifically
how a hospital’s reputation was more likely to impact decision-making than HAI data
alone. Because HAI data may contribute to more global reputation and prior evidence
shows that hospitals are concerned with public reporting’s effects on reputation, it is
considered a potent mechanism by which data can affect consumer choice.21 This is
different from the prior stand-alone pathway, and couches the Reputation Pathway within
the larger concept of selection. There is a paucity in evidence that selection by providers
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(referrals) or payers (insurance companies) is affected by reported HAI data, however
this may be seen in other public reporting literature.8 Likewise, any change undertaken
by an organization to address its reputation resulting from publicly reported HAI data
may affect outcomes and, subsequently, consumer choice, but that relationship is not
well-understood. Improved outcomes or perceived positive changes within the
organization may stem from an organizational climate conducive to better HAI
performance and garner a higher reputation in the community possibly enhancing
selection. However, the circular relationship between the Selection Pathway and the
more intrinsic Change Pathway is not well explored in this group of studies.

2.7 Discussion
This review examines a diverse, but inclusive body of literature specific to public
reporting of HAI data and its impacts on specific stakeholder groups within the
healthcare system. The review encompassed the current state of HAI literature
evaluating the impact of public reporting mandates on various stakeholder groups, while
allowing for a wide range of methodologies and inquiry. However, these methodologic
variations, coupled with inconsistency in data sources, diversity of outcomes and
stakeholder groups, produce an incomplete picture of the public reporting’s effects on
outcomes, organizations and consumer choice. Yet, the range of findings from these
empirical investigations do help illuminate the public reporting pathways that drive
change within health systems and affect consumers’ healthcare decision-making.
This review shows similar findings to previous work regarding the conflicting
evidence that the public reporting of healthcare performance data has a significant impact
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on patient or clinical outcomes.8,15,47 The Change Pathway described by Berwick and
colleagues20, relies on this conceptualized relationship between performance monitoring,

Figure 2. 3 Revised Framework for Assessing the Impact of HAI Reporting Policy

This framework, adapted from Berwick et. al, 20 and Hibbard, et. al,21, addresses the complexities in relationships
between public reporting, outcomes, organizations and consumers. Dotted arrows represent limited or lacking
evidence for proposed directional pathways by which the larger encircled concepts may be affected by public
reporting. For example, public reporting has a notable impact on organizations, but the specific ways in which their
impacted and how they affect outcomes is still not well documented. Solid lines are indicative of more established
relationships in the literature (i.e. findings showed hospital reputation impacted consumer decision-making, but how
HAI data affects reputation is not well understood). Dotted lines are used to describe the impact of HAI data on
consumer choice, largely because consumers report an overall lack of awareness around publicly reported data.
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intrinsic change in organizations, and improving outcomes. However, while some studies
in this review showed significant HAI reduction associated with these laws, few could
delineate mediating pathways or processes that may explain these reductions.36,39–41
Sensitivity analysis conducted by Liu and colleagues41 showed a reduction in central line
days and increasing work-time by infection preventionists in the months leading up to
and well-after the laws were in place. Interestingly, anticipation of the law seemed to
influence outcomes as well, suggesting organizational change and preparation in
anticipation of these laws is a possible explanation for their impact.36,41 Although any
change in the organization would be pushed through to providers, when clinical decisionmaking was evaluated, no evidence of reporting policies’ impact was seen on antibiotic
use or blood culture rates suggesting the change pathway may be more complex that
previously described when applied to HAIs.20,38 Although some studies have found a
reduction in HAIs associated with these laws, the presumed effects of organizational
change that potentially mediates this pathway is not well understood. Essentially the
“why’s and how’s” of the Change Pathway, remain elusive.
These gaps in the literature are partially illuminated by the qualitative and mixedmethods studies examined in this review. Both Pegues34and Stone et. al31directly
describe the development and implementation of process improvements to improve HAIs
in response to public reporting mandates. Perhaps even more importantly, four studies
identify the improved awareness and heightened attention that public reporting brings to
HAIs within an organization.31–34 The study by Stone and colleagues31 in 2011 also
pointed to the importance of organizational climate-related concepts including teamwork,
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accountability and communication. These organizational climate findings were echoed in
work by Uchida et. al33, and described in detail by interview respondents. Findings
pointed to the importance of effective communication and sustained collaboration.33
While these studies may help to explain aspects of the Change Pathway, additional
research is needed to describe fully the effects of these laws on both organizations and
their outcomes. Mediating processes and organizational contexts may play an influential
role, and research examining these factors is essential. Where these studies fall short
however, is describing the proposed Selection Pathway with regard to provider and payor
selection. No effects of public reporting on provider or payor selection were identified in
the HAI literature included in this review. However, the Selection Pathway does appear
to play a role in consumers’ use of the data, albeit with the caveat that understanding and
utility of the data among consumers remains challenging.
Results from this review contend that while consumers do acknowledge publicly
reported data as a factor in hospital selection, interpretability of the data remains difficult
and other factors predominate in healthcare decision-making. 27–29,44 HAI outcomes
remain a lower priority for selecting a care provider or institution behind insurance status,
prior experience, recommendations of family or a provider, and location.28,29,44 While
HAI data do not appear to directly affect the Selection Pathway for consumers, the
Reputation Pathway may be an important mediator. Mazor, Dodd and Kunches29
qualitative work from 2011 found that a hospital’s reputation was second only to personal
experience when influencing consumers’ decision-making around hospital selection. The
larger concept of healthcare facility reputation may in fact be affected by publicly
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reported HAI data and could alter consumer choice when selecting a hospital. However
given the difficulty consumers have shown in interpreting HAI data, the concept of
reputation would likely be more global than nuanced, when using HAI data alone.27,29
Three studies also pointed to the recommendations of healthcare providers as an
important consideration for facility selection.28,29,44 Hospital reputation perceived by
healthcare providers may be more affected by publicly reported healthcare data and
contribute recommendation for one institution over the other. This presumption has not
been well-explored in the published HAI public reporting literature, and remains a
hypothesized pathway by which reputation affects selection. The available data suggests
varying ways that consumers may approach the HAI data and select the hospital where
they receive their care.
A potential theoretical foundation for empirical investigation of the relationship
between publicly reported HAI data and consumer choice is behavioral economics (BE)
research. BE examines the impact of multiple emotional, psychological and social factors
or constructs that can alter decision-making. With respect to healthcare, BE posits that
people do not make decisions based only solely on available knowledge that would signal
the highest quality hospital, but are greatly affected by a host of social contexts, and
attentional and cognitive restraints that cloud rational choice.48,49 Concepts of heuristics,
framing, limited time and/or capacity to assess all available knowledge (bounded
rationality) and loss aversion could provide testable pathways for exploring HAI data and
consumer decision-making.
Work from Mazor and colleagues29 discussed in this review, reports on the
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potential importance of framing HAI data as a means of invoking consumers’ desires to
avoid losses and seek gains.29 However, this concept remains largely unexplored in the
HAI public reporting literature. BE and its associated theories fit well within the revised
public reporting framework developed from this review. Decision-making can be guided
by data if presented in an effective manner and behavior change can be perpetuated by
thoughtful BE-focused initiatives.50 In future research that tests components of these
pathways, interventions supported by BE principles may prove useful and more
sustainable. As described previously, the Change Pathway remains somewhat undefined
in this body of HAI literature.
It is apparent that quantitative and qualitative methodologies are both needed to
elucidate the specific mechanisms that affect hospitals as a result of public reporting.
Organizational process improvements and climate characteristics are presented in this
revised framework as potentially lying on the causal pathway between HAI data and
outcomes. Organizational climate and its associated constructs (i.e. leadership strategy,
communication, and collaboration) serve this framework well as a structures for defining
relationship between data reporting and outcomes.51 While the impact of these HAIrelated changes is difficult to link to outcomes, a specific relationship between
implementation of public reporting and an improvement in outcomes was evidenced in
quantitative studies.36,39–41 Outside literature has also had difficulty linking
organizational climate components to outcomes, however some positive findings have
been noted in previous investigations.51 Presumably organizational climate, as impacted
by the presence or implementation of public reporting may be perpetuating outcomes
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oriented around HAI performance. More salient in this new framework is the knowledge
that reported data may stimulate some change toward better outcomes, yet the exact
mechanisms of how this happens and in what contexts these changes are implemented,
remain largely unknown.
A potentially valuable strategy for exploring the relationships between publicly
reported HAI data, organizations, and outcomes is the use of implementation science (IS)
research. IS investigates how evidence-based practices are systematically implemented
and sustained in practice and has been promoted as means of improving uptake of
infection prevention practices.52 While IS incorporates many concepts and constructs,
the goal of this research is to understand the challenges and successes specific to
implementation and sustainability. The discipline has embraced structured frameworks
to guide these inquiries while incorporating larger contextual factors, such as broad
policy mandates that contribute to organizational functioning. The Consolidated
Framework for Implementation Research (CFIR) proposed by Damschroder and
colleagues53 could help to guide inquiry around the unique pathways by which publicly
reported data stimulates and sustainable change within healthcare organizations. Two
constructs within the framework lend themselves particularly well to examining the effect
of public reporting. The Outer Setting is described as a set of factors that exert influence
on the healthcare organization and affect its ability to implement and/or sustain evidencebased practices.53 These factors may include relationships with the community or other
healthcare facilities (i.e. reputation and perception), peer pressure, and external incentives
or policies (i.e. public reporting mandates and benchmarking) .53 The Inner Setting
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construct involves the complex relationships and characteristics that enable or slow the
implementation of process improvements and evidence-based practices. Some of these
factors noted in the CFIR framework include communication structure and practices,
leadership engagement and feedback mechanisms. 53 These factors are similar to those
identified in this review as organizational factors that are often reported as being affected
by public reporting mandates. Since IS research accounts for these constructs as
facilitators or barriers to successful process improvements, the models and frameworks
within this emerging field are well-suited to examine the organizational effects of policy
mandates. However, public reporting remains distinct in that the mandate itself is not an
evidence-based intervention, but more so meant to stimulate improvement-oriented
changes within individual organizations. Still, IS may prove useful in unpacking the
intricate relationships between these laws and implementing sustainable improvement
processes in organizations.
This review is subject to limitations. First, the limited time-period for study
inclusion potentially missed other articles that fit within the sampling framework and
discussed HAI outcomes of public reporting. However, the bulk of HAI public reporting
policies were implemented during this time, and previous reviews showed little evidence
of HAI outcomes relative to public reporting laws in empirical research prior to 2006.8,9,15
Second, commentaries, HAI data validation studies, and theoretical papers were excluded
from this research, despite their contribution to the HAI public reporting body of
literature. While these studies impact the larger picture of public reporting controversy,
they do not target specific components of existing frameworks, nor do they empirically
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evaluate the impact on stakeholder groups. Additionally, over the past 4-5, years data
validity has improved across states and institutions with the use of NHSN for publicly
reporting HAI data. The primary aim of this paper was to integrate findings from these
studies to propose n revised conceptual framework that illuminates the pathways through
which public reporting may influence influences HAI outcomes and processes. Yet the
diverse methodologies, study designs, and outcomes made this body of literature less
conducive to a systematic review methodology. An integrative review methodology was
specifically chosen for the purposes of synthesizing diverse empirical sources and
conceptualizing a revised frame work for evaluating the relationships between HAI
public reporting, outcomes and stakeholder groups. However, this review and the
subsequent framework may have missed critical pathways because they have not yet been
empirically explored or published. This remains a proposed framework and will need
ongoing evaluation as new pathways emerge or existing pathways are tested.

2.8 Conclusion
The public reporting of HAI data impacts stakeholders through a multitude of
potential pathways and mechanisms. Prior to this work, no reviews had sought to
examine the Selection, Change and Reputation Pathways in the context of HAI data and
their impact on various healthcare system stakeholders and outcomes.20,21 This review
contends that these pathways are important, but much more complex than previously
assumed. A revised framework for understanding these complexities is presented; it
illustrates the directional components and key concepts that drive improvements and
determine choice using publicly reported HAI data. The framework also highlights BE
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and IS as new foundations and directions for investigation by which researchers can
examine causal pathways and conceptual relationships. Despite the expansiveness of
these laws, much is still unknown their effects on consumers, organizations and the larger
policy environment. More research is needed to determine how best to design,
implement, and evaluate these policies to ensure they are meeting their intended goals, to
improve patient outcomes and guide consumer choice.
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Abstract
Background: Healthcare-associated infections(HAIs) are a significant cause of morbidity
and mortality in U.S. hospitals. Blood stream infections (BSIs) with MethicillinResistant Staphylococcus aureus (MRSA) and gastrointestinal infections caused by
Clostridium difficile (C. difficile) are HAIs associated with increased risks for
complication, prolonged-hospitalization and death in acutely ill populations. As a result,
policy-makers have implemented state laws that mandate the reporting of these infections
to state officials, often for the purposes of publicly disseminating this information.
Purpose: The purpose of this study is to determine the impact of state HAI reporting
mandates on laboratory identified C. difficile infections and MRSA BSIs in U.S.
hospitals. Research Design: This is a quasi-experimental longitudinal secondary data
analysis was conducted using state public reporting law information and infection data
from a national sample of U.S. hospitals. Methods: Bivariate analysis was completed to
examine differences in characteristics of reporting hospitals and baseline infection data in
hospitals in reporting and non-reporting states. Poisson regression was used to model
temporal impacts of implementation of the law on hospital-wide, Hospital-onset C.
difficile and MRSA BSI laboratory-identified event rates as compared to hospitals in the
same month in non-reporting states. Results: Compared to pre-law implementation, no
statistically significant difference was seen in C. difficile infection rates in the time after
the law, when controlling for secular trends and hospital characteristics. Sensitivity
analyses revealed similar findings. Outcomes related to MRSA BSIs were unable to be
ascertained due to an inability of the model to converge. Conclusions: State mandates
for HAI reporting are present in most US states. Our investigation did not show a change
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in infection rates relative to implementation of these laws. More research is needed to
determine the impacts of these laws over time.
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3.1 Introduction
Healthcare-associated infections (HAIs) continue to be a significant source of
morbidity and mortality in the United States (U.S.). Device-associated infections
including central line-associated blood stream infections (CLABSIs), catheter-associated
urinary tract infections (CAUTIs), and ventilator-associated pneumonia (VAP) continue
to impose a significant burden to health systems and patients. Approximately 722, 000
HAIs occurred in 2011, resulting in some 75,000 deaths in the U.S.1, while healthcare
costs attributable to these infections can be upwards of 33 billion doallrs.2 Deviceassociated infections, including those previously mentioned, are often targets for
improvement within the healthcare system because they are often perceived as a
preventable source of extraneous health system expenditures and poor patient outcomes.3
However non-device associated HAIs including those caused by Clostridium
difficile (C. difficile) and Methicillin Resistant Staphylococcus aureus are also implicated
in poor patient outcomes and excess financial burdens for payers and systems.2,4–6
Recently the U.S. Department of Health and Human Services (HHS) has included MRSA
and C. difficile measures as part of the Value Based Purchasing program (VBP) to
provide incentive to hospitals that successfully decrease these infections.7 This is in
accordance with the HHS HAI Action Plan8 and subsequent updated targets for MRSA
and CLABSI reductions by 2020. While guidelines for the prevention of healthcareassociated MRSA9 and C. difficile infection10 are well established, policymakers have
used mandated reporting of HAI-related performance measures as means of attempting to
inform consumers and stimulate organizations to improve quality of care. As of 2013, 37
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states had some mandate for public reporting of HAI data including 20 states requiring
the reporting of MRSA bloodstream infections and 20 requiring C. difficile reporting.11,12
The aim of this study is to conduct a secondary longitudinal data analysis to
determine the impact of public reporting mandates on MRSA and C. difficile rates in
acute care hospitals across the U.S. No previous studies have examined the impact of
these laws on rates of these infections; this study will evaluate these effects and inform
the design of health policy interventions for the reduction of HAIs.

3.2 Healthcare-associated MRSA and C. difficile Infections
Both MRSA and C. difficile infections are prevalent HAIs within health systems
across the U.S. While disease course and pathogenesis differ, both bacterial infections
can lead to prolonged hospital stays and worsened clinical outcomes for patients.
MRSA BSIs are associated with an increased risk of death particularly in older
and critically-ill adults.13 Rates of MRSA-related disease rose in healthcare settings in
the early 2000s; soon reducing its incidence became a priority for both policymakers and
health systems.6,14 Invasive MRSA, particularly BSIs, declined starting in 200515 but
continued to be a prominent source of HAI-related morbidity and mortality. Kallen and
colleagues15 showed a total reduction in MRSA BSIs (-11.2% [95% CI, -15.9% to 6.3%]) from 2005 to 2008. A study examining rates from 2005-2011 showed a total
reduction in invasive MRSA of 54% during the study period yet noted a continued
presence of the HAI with 14,156 healthcare facility-onset MRSA infections occurring in
2011.16 Data from the U.S. Centers for Disease Control (CDC) notes that Hospital Onset
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(HO) MRSA BSIs, have decreased nationally by 13% from 2011 to 2014.1 However,
closer examination of the data yields some increases in certain states during the same
period. These variations indicate that some states have not seen the same HO-MRSA
BSI reductions as others.
Similar to MRSA BSI, C. difficile infections have also continued to pose a burden
to healthcare systems across the country. Recently, a study by Desai et. al (2016),
estimated 439,237 incident C. difficile infections occurred in 2014, with roughly twothirds originating in healthcare settings. Data from the CDC’s National Healthcare
Safety Network (NHSN) showed an 8% reduction in infections in 2014 when compared
to the 2011 baseline1. However, comparison of 2013 to 2014 data showed increases in
these infections despite the overall decreasing trend; C. difficile being only one of two
HAIs to see an increase during this time.
Despite some indication that these infections are decreasing within healthcare
institutions, their financial impact on the system continues to be burdensome. C. difficile
infection contributed an estimated an $1.5 billion USD in expenditures in 201117. A
review of the literature conducted by Scott in 20092, found attributable costs to
healthcare-associated C. difficile was between $5,042 and $7,179 USD per infection.
However, the author noted that the study reviewed did not include operative costs should
the patient have surgical complications from infections, potentially understating the true
costs of complex C. difficile cases2. A more recent modeling study from 2016 estimated
the total cost of C. difficile infections within the healthcare system, including long term
care facilities (LTCs) and long term acute care hospitals (LTACs), was $4.7 billion
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accounting for 87.6% of total C. difficile related healthcare expenditures in the U.S.18
Zimlichman and colleagues (2013) published a paper detailing the total burden of HAIs
on the U.S. health system and found that CLABSIs due to MRSA had some of the highest
costs at $58,614 USD ([95% CI, $16 760-$174 755]). A 2010 study comparing costs
associated with MRSA and Methicillin-Susceptible Staphylococcus aureus (MSSA)
infection showed unadjusted median costs to be more than twice as high in hospitalized
patients with MRSA versus MSSA infection (P <.001)19. The authors found that MRSA
infections were associated with higher costs across multiple strata including age,
infection site, severity of comorbid conditions (Charlson indices); those with MRSA and
a Charlson index of 4 or greater had mean adjusted costs roughly $25,000 higher than
those with MSSA19. Since these infections serve as a significant source of financial
burden and patient morbidity within the health systems, over that past decade
policymakers devised laws to mandate the reporting of these infections, often for public
dissemination to promote health system accountability, aid in consumer decision-making
and improve patient outcomes.

3.3 Public reporting of MRSA and C. difficile in Healthcare Settings
Laws mandating the public reporting of healthcare-associated MRSA and C.
difficile have been in place since 2005 and 2008, respectively11. As of 2013, 20 U.S.
states had laws mandating the reporting of these infections, although not all states report
all HAIs uniformly. A study by Herzig and colleagues11, showed that after initial laws
were passed for the public reporting of these infections, an accelerating trend in the
passage of these laws was noted. Nearly half of the laws pertaining to MRSA were
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passed during or after 2012, and those pertaining to C. difficile were passed in 2013. The
authors noted that this trend coincided with the implementation of Centers for Medicare
& Medicaid Services’ (CMS’) Hospital Inpatient Quality Reporting Program(IQR)11, a
program designed to provide hospital-related data to consumers and financially reward
hospitals for reporting their quality-related data. The Hospital IQR program began
requiring data submission for HO-MRSA BSI and HO-C. difficile infections in January
of 2013.20 Similar to these national reporting policies, the majority of state mandates for
HAI reporting include provisions for submission of data to an oversight entity (typically
state health departments or NHSN), the dissemination of that data to the public, and the
public reporting of facility identifiers that coincide with that data.21
While much has been written about C. difficile and MRSA BSIs in the healthcare
setting, little is known about the effect of mandated reporting laws on these infections. A
widely-referenced framework that describes the relationship between reporting healthcare
performance related data, indicate that the potential of these reporting laws to stimulate
change and improve care is related to various pathways by which these laws impact
behavior22. Berwick and colleagues22 relate the impetus of monitoring and reporting to
change behavior via a Change Pathway and Selection Pathway. These pathways are
reliant on intrinsic motivators within providers and organizations who want to improve
care and outcomes and the stimulus of external stakeholders (consumers, payors, etc) to
drive improvement by potentially effecting market-share and revenue.22 An additional
pathway proposed by Hibbard et al.,23 posits that hospital’s concern for market share and
reputation are actually stronger drivers of change than those pathways suggested in
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previous frameworks. This effect was most noted in hospitals which tended to perform
more poorly on key quality measures when compared to their peers.23
The current body of literature exploring the impact of mandatory reporting on
infection rates has yielded mixed findings. A recent systematic review and meta-analysis
exploring clinical outcomes, primarily mortality, found that implementing public
reporting was associated with a noted improvement in mortality across 10 studies (RR of
0.895 [95% CI 0.79-0.92]).24 However this review only included one study with an HAI
related outcome. More HAI-centric literature has attempted to evaluate the impact of
these laws, focusing primarily on CLABSIs. A recent study by Liu and colleagues25 used
longitudinal data to examine the impact of reporting mandates over multiple states. The
authors found a reduction in mean CLABSI rates both in anticipation of the laws and
long after the laws’ implementation. Similar findings were seen in a study by Black and
Kim.26 CLABSI data from Pennsylvania was examined longitudinally with data from 16
states with no reporting mandates used as a control. The researchers found a statistically
significant reduction in CLABSI rates, particularly in hospitals with higher baseline
rates.26 A subsequent study by Marstellar et al.27 found hospitals in states that had
pending or recent implementation of mandates had increased participation in a
performance improvement program designed to aid in CLABSI reduction. The authors
did show a trend toward greater reductions in CLABSI rates in states with reporting
mandates, but the differences were not statistically significant. Additional studies
examining the impact of these laws to reduce CLABSI rates have not shown an effect,
including in point-of-care practices such as antibiotic and blood culture utilization
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rates.28,29 To the authors’ knowledge, only one study has been published examining the
effects of public reporting on C. difficile rates.24 Studies specifically evaluating the
effects of mandatory reporting have shown some positive effects, but also more mixed
findings. While a host of studies have examined CLABSI rates and mandated reporting,
the only study to date has examined the relationship between public reporting and C.
difficile rates.
A study from Daneman and colleagues30 evaluated the impact of hospital public
reporting laws on C. difficile infections using longitudinal data from 2002 through 2010.
Public reporting in this cohort began in September 2008, and the authors used the
previous data to model age-specific predicted monthly C. difficile rates as if had no
public reporting occurred30. These 2008 modeled rates were then compared to 2008
observed rates to determine the impact of public reporting during the study period. The
authors found a significant reduction in observed C. difficile rates in the post-intervention
period compared to predicted rates (8.92 per 10,000 patient days compared to 12.16 per
10,000 patient days, P<0.001 [95% CI 11.35-13.04])30. The authors also noted a total
reduction of C. difficile cases of 26.7% (95% CI 11.35-13.04) over the first year of postpublic-reporting implementation.
While these findings show an effect of the Canadian public reporting laws,
additional study is needed to determine the effect of reporting mandates in U.S. states has
similar impacts on C. difficile. Additionally, no studies have evaluated the impact of
these laws on MRSA rates in U.S. hospitals. Further investigation is warranted to
understand if the impact of these laws seen in previous studies extends to MRSA BSIs,
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and coincides with previous findings regarding C. difficile. To address this need, our
study aims to investigate the impact of state reporting mandates on both C. difficile and
MRSA in U.S. hospitals.

3.4 Methods
This study used a quasi-experimental design to determine the effect of public
reporting mandates on Hospital Onset C. difficile (HO-C. difficile) and Hospital Onset
MRSA blood stream infections(HO-MRSA) in hospitals across the U.S. This design
allows for the examination of longitudinal trends in the pre-and-post policy intervention
period.31 A difference-in-difference design is often used to compare changes in outcomes
over a time period between two groups, one of which has experienced a particular
treatment or intervention.31 This study design involves a variant in the traditional
difference-in-difference in that varying implementation times by state are considered in
the analysis. Hospitals which submitted pre-and post-reporting mandate infection data
were included to model the effect of the law on infection rates relative to pre-reporting
infection rates in states with mandated reporting. This methodology allows for the
assessment not only of the impact of the law, but of how these effects may change in the
time prior to and after the laws implementation. This model was adapted from a study by
Liu and colleagues25 who examined the impact mandatory reporting on CLABSI rates in
ICUs, the results of which were discussed previously.
The study compared the rates of HO-C. difficile and HO-MRSA laboratoryidentified events (LabIDs) over time in hospitals in states without public reporting to
those in states that implemented mandatory reporting during the study period. Hospitals
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were selected as the unit of analysis rather than intensive care units (ICUs) because
hospitals reported facility-wide C. difficile and MRSA data with equal or greater
frequency than individual ICUs in this data set as is in keeping with NHSN reporting
structure.32 Additionally, this allowed the capture of infection data across the facility
including infections reported outside of the ICU setting. State-level public reporting
status was determined through a review of the published literature and legislative
documents. 11,12,33 This was set as the date of implementation for this analysis.
Sample
Infection and hospital level data used for this analysis comes from facilities
participating the Prevention of Nosocomial Infections and Cost Effectiveness Refined (PNICER) survey, completed in 2011 study (National Institutes of Health, RO1NR010107:
Stone, P.). Sampling methods and specifics of survey development are described
elsewhere.34 Briefly the P-NICER survey was conducted among infection prevention and
control leadership in hospitals that participated in the NHSN. Participation in NHSN at
the time of the survey was voluntary if hospitals were not mandated to report infection
data. All non-VA hospitals were eligible for inclusion. Researchers who developed and
implemented the survey decided against recruitment outside of the NHSN reporting
hospitals due to concerns around quality and validity of the data.34 Participation in
NSHN allows for infection event reporting based on specific surveillance criteria as well
as pre-defined outcome measures including guidance on determining infection rates,
prevalence and risk-adjusted standardized infection ratios (SIR) .32,35 The P-NICER
survey captured data on a variety of infection prevention related resources and practices
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as well as organizational climate, public reporting and process improvements.34

A

subset of participating hospitals joined the P-NICER NHSN research group and agreed to
provide NHSN reported infection data from the C. difficile/MDRO reporting module, as
well as data regarding CLABSIs.
A total of 975 hospitals were represented in the sample (29% response rate) .34
To determine the generalizability of survey results, the CDC compared characteristics
between responders and non-responders and did find some differences in facility
characteristics.34 Non-responders tended to be smaller facilities with fewer admissions
and patient days; additionally, differences were noted in geographical region. No
significant differences were noted when comparing CLABI rates in respondents and nonrespondents which supports generalizability of survey results despite a moderate response
rate.34
At the time of the survey (2011) approximately 73% of facilities were located in
states with mandated HAI public reporting.36 As part of the NHSN reporting program,
hospitals fill out a plan designating measures and frequency of data reporting. Hospitals
that chose to participate in the various surveillance modules must use the pre-designated
criterion for case definitions of HAIs and subsequent infection reporting.37 Both active
and passive surveillance techniques are encouraged for each appropriate reporting
module. Hospitals are also required to complete an annual survey which collects
information regarding certain facility characteristics, relevant annual denominator data,
infection control practices, and microbiology laboratory practices38. Surveillance-defined
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infection data are submitted regularly along with the appropriate denominator data
according to pre-specified reporting frequencies.32
Outcome Variable
The outcome variables of interest for this study were HO-C. difficile LabIDs and
HO-MRSA blood stream infection (BSIs) LabID events weighted by patient days as
defined in the MDRO and C. difficile reporting module in NHSN.32 HO-C. difficile
LabID rates werecalculated as the number of HO-C. difficile LabID events per 10,000
patient days whereas the number of HO-MRSA blood LabID rates are defined as events
per 1,000 patient days as defined in the most NHSN reporting module32. Rates per
patient days for each hospital were evaluated at monthly intervals, the smallest unit of
time at which data is aggregated and reported through the NHSN. Typically in federal
and state-based reporting, HO-C. difficile and HO-MRSA BSIs are reported as LabIDs,
but are also reported as surveillance-defined infections separate from the LabID event.32
These infection definitions are slightly different than the LabID event definition, relying
on additional patient level information, including symptomology to meet the infection
criteria. Because LabIDs for both HO-MRSA and HO-C. difficile rely on the presence of
positive diagnostics rather than symptoms or case definition, reporting these events was
meant to be less burdensome on the healthcare institution while providing an appropriate
proxy for the incidence of surveillance-defined infections.32 HO-MRSA BSI LabIDs are
reported for unique blood specimens that test positive for MRSA greater than 3 days after
admission. Similarly HO-C. difficile LabIDs are those positive test results (the presence
of C. difficile organism and or its associated toxin) in unformed stool specimens greater
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than 3 days after admission.32 The guidance from NSHN is clear that reporting for both
these LabID results should be on specimens sent for the purposes of diagnostic testing
only, to prevent inflated infection counts as a result of screening initiatives or other
screening protocols. The use of LabIDs as a proxy for infection surveillance-defined
cases of C. difficile and MRSA BSIs can lead to some discrepancy between metrics. An
evaluation of data submitted to the New York State Health Department in 2009 showed
the incident HO-LabID C. difficile rate to be 29% higher than that of surveillance-defined
hospital onset infections, but overall case-status match for all C. difficile infection of
81.3%.39 The authors also noted this effect was relatively consistent across hospitals
included in the study (Pearson Correlation Coefficient = 0.84) and proposed the reporting
of LabID events to be a sound and valid measure for the public reporting of C. difficile
events.39 A similar study examining MRSA blood LabID reporting to surveillance
defined MRSA BSIs showed larger discrepancies than in C. difficile, with concordance
ranging from 61%-76% in HO-MRSA BSIs.40 The authors suggested that a majority of
the discrepancy lies with the differences in onset definition; for surveillance defined HOMRSA BSIs any cases on or after day 3 are reported, whereas for HO-MRSA blood
LabIDs those specimens positive on or after day 4 are reported.40 To date, however, this
definition has not changed in NHSN reporting and remains a key component in state
reporting mandates.32 Additionally LabID events for both C. difficile and MRSA BSIs
remain the metric mandated by other reporting initiatives including CMS’ Hospital IQR
program and Value-Based Purchasing.
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Statistical analysis
Descriptive statistics of sample hospital characteristics were conducted. Testing
for differences between groups was completed t-tests and χ2 for hospitals in reporting
states and non-reporting states from 2008 to 2012. Unadjusted trends in HO-C. difficile
LabID rates and HO-MRSA blood LabID rates were calculated based on mean monthly
rates for all hospitals and compared between reporting and non-reporting states.
To model the effects of public reporting mandates on HO-C. difficile and HOMRSA BSI LabID rates a Poisson regression model was selected. This model is well
suited for modeling count data and has been used previously to examine the effects of
public reporting on incident HAIs25. The Poisson model assumes that the mean and
variance of the distribution from which observations are counted are equal and that the
count data has the possibility of zero counts. 41 Separate models were developed for both
C. difficle and MRSA count outcomes. As hospital characteristics reported in the NHSN
survey are largely independent of temporal trends (e.g. affiliation with an academic
medical center and profit status), a hospital (unit-level) fixed effect was used to control
for these potential covariates that might confound the relationship between reporting and
infection rates. A fixed-effect model was selected because it is robust to unobserved
variables, particularly those may differ across units, but are unchanging within units over
time. Additionally, admission prevalence rates for these infections were assessed and
noted to have an increasing trend over the study period and are likely not associated timeinvariant characteristics of the hospitals (figure 3). Therefore, this prevalence rate was
added as a covariate in the model. Consistent with NHSN rate calculations, monthly
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patient days as defined specifically for C. difficile and MRSA (exclusive of units
designated with a separate CMS designation as inpatient rehabilitation facilities or
inpatient psychiatric facilities and, for C. difficile only, infant-designated locations) for a
given hospital at a given month was included and will serve as the offset in the model.
The use of an offset allows the count data to be modeled as a rate and serves as the main
exposure for modeled events.
Indicators representative of the timing of implementation of the law in each
hospital’s state serves as an interaction term for the presence of the law and being in a
reporting state. A series of binary 3-month indicators will be used to account for time
differences relative to implementation of the laws during the study period and are
represented in the model for each given hospital at a given month. This will allow for the
determination of the policy effect with relevance to the timing of implementation of the
public reporting law, which vary from state to state. Implementation time (time when
data submission was first required) was determined by review of existing literature and
review of state HAI websites and/or published legislation.11,12 To account for trends in C.
difficile and MRSA BSIs over the study period, monthly indicators were used as a fixed
effect for calendar time. The independent variable of interest is Li,s(t) in the model below
where the term is defined as the time difference relative to the law in hospital i, in state s,
during month t. Dit serves as the offset and represents the log of patient days respective
to facility i in month t, while βadmprevit is the term representing admission prevalence rates.
The coefficient λ is the estimated mean difference in incident rates for the infection of
interest relative to non-reporting states in the same time-period. The proposed model is
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as follows, where Yit is the LabID counts for facilityi at montht) has a Poisson distribution
with a mean µit and βi and βm(t) are fixed effects for facilities and calendar time,
respectively:
Yit = βi + βm(t) + βadmprevit + γ log (Dit) + λLi,s(t)
Appropriateness of the Poisson distribution was assessed using the Chi-square
goodness of fit test. Robust standard errors were used to correct for overdisperssion in
the model, a common problem in Poisson regression often resulting from correlation
between responses as is possible here between repeated hospital unit measures over the
study period.41
The prevalence of zero values in the outcome data was assessed to determine the
impact of excess zero counts on the need for further measures to address this. Zeroinflated Poisson regression was used with the same terms and covariates as the original
model, but addressing the issue of excess zero counts, by assessing both the binary
probability model of zero as the outcome and the Poisson probability delineating the
outcome of infection (zero or a count) given an exposure (patient days). In our model,
we hypothesize the binary probability to stem from outside factors which may influence
hospitals ability to report on C. difficile infections during the study period. This may
include lack of infrastructure or ability to conduct surveillance and report infections.
This was assessed by examining data points to look for patterns which may indicate
difficulty with reporting that would predispose the data to excess zeros outside of the risk
for infection, particularly serial rates, infection counts, or exposures of zero in hospitals
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throughout the study period. The Voung test for the preference for the zero-inflated
model was conducted.
A random effects model incorporating time as a continuous variable and including
a hospital random effect was used as a sensitivity analysis. “Reporting” and “nonreporting” status was refined to include hospitals in states with reporting mandates now
defined as “non-reporting” if they were in the pre-law period. This allowed us to
evaluate baseline IRR between reporting and non-reporting groups as well as the
differences in slope, indicating change in infection rates over time between the two
“reporting status” groups. The random-effects estimator allows for modeling changes in
rates in while accounting for correlation within states.42
Coefficients generated from the Poisson model are reported as incidence rate
ratios (IRRs) for the relative time interval before or after implementation of the law and
are interpreted as change in the mean rates of HO-C. difficile and HO-MRSA BSI
LabIDs25,41. Statistically significant differences from the referent category will be
reported for those IRRs with a pre-determined p-value < .05. All analyses were
conducted using Stata statistical software version 14.2.43

3.5 Results
Early in model determination and testing, we discovered that the data for HOMRSA BSI LabIDs would not converge in our analysis. Subsequent testing and
evaluation hypothesized that the count data within the data set was unable to generate
findings given our proposed model, due to an abundance of zero counts and counts of 1
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(Figure 1). As a result it was decided that MRSA BSIs will be dropped from the analysis
for this study and primary analyses and interpretation of results would center on HOC.difficile events.
Over the study period, specifically from September 2008 to June 2012, 5,454
hospital-months of C.difficile-related data were provided by 242 hospitals across the U.S.
Of these, 219 hospitals with 4,328 hospital-month observations included complete data
relative to our proposed model. These complete cases were used as the final analytical
sample. Also during the study period, ten states had C.difficile reporting mandates with
eight states implementing data reporting during the study period (Figure 2).

Figure 3. 1 Frequency of MRSA HO-BSI LabIDs in the data set from 2008-2012.

MRSA, Methicillin-resistant Staphylococcus aureus; HO-BSI, hospital-onset blood stream infection; LabIDs, LaboratoryIdentified events.
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Figure 3.2 State Public Reporting Mandates and Implementation Dates
Year of Mandate
State*
Date Data Submission First Required
2008
OH
October 2009
2008
PA
January 2008
2009
CA
January 2009
2009
NY
July 2009
2010
TN
July 2010
2011
RI
January 2011
2012
IL
January 2012
2012
ME
January 2011
2012
NM
January 2012
2012
OR
January 2012
*Guide to state abbreviations in Appendix B. Dates of mandates and implementation/data submission
ascertained from existing literature and review of state legislation or HAI reports11,12

Distribution of facility characteristics of the overall sample were different
between hospital-month observations in reporting and non-reporting states (Table 1).
Proposed time-invariant characteristics including academic medical center affiliation,
ownership status, and bed size all differed significantly between reporting and nonreporting states (p<.001, p<.001, and p<.001 respectively). Event level data also differed
significantly between the two reporting groups with hospitals in states without mandates
reporting fewer C. difficile patient days than hospitals in states with reporting mandates
(3,840.57 vs. 5798.09, respectively [p<.001]). Hospitals in non-reporting states also
reported fewer counts of HO-C. difficile LabIDs than those in states with mandates (2.25
vs. 4.78 respectively, [p<.001]). Both community-onset rates and HO rates were lower in
hospitals with reporting mandates in this sample, with HO rates from hospitals under a
reporting mandate at nearly half the rate of those without mandates (7.23 vs. 13.48
respectively, [p<.001]).
Overall trends in HO-C. difficile LabID rates over the study period yielded
decreasing rates of events in states with and without reporting mandates and in the total
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sample (Figure 3). Analysis of rates was complicated by hospital-months with very few
patient days reported, causing significantly elevated rates, in some instances >1000
events per 10,000 patient days. To account for this, the analysis of rate trends was
conducted across all three groups (reporting, non-reporting, and total sample) after
removing observation months with patient days less than or equal to 25. Removing these
the observations diminished the rate extremes seen in the initial evaluations without
eliminating smaller hospitals (bed size <100) in the sample. Removing extremely high
rates made comparison in trends smoother, yet still allowed for a wide range of hospitals
size representation while still discerning differences in

Table 3.1 NHSN Survey Reported Facility Characteristics by C. difficile Reporting
Status, 2008-2012
NHSN Survey Characteristics

Non-Reporting

Reporting

Totals

Number of Hospital Months of Data
(mean, SD) §

616.02, ± 8.64

613.521, ± 9.31

Yes

439 (41. 53)

1,732 (46.53)

2,171 (45.43)

No

618 (58.47)

1,990 (53.47)

2,680 (54.57)

1,057

3,722

Total = 4,779

Non-profit

672 (63.58)

2,391 (63.39)

3,063 (63.43)

For profit

113 (10.69)

474 (12.57)

587 (12.16)

Government

23 (2.18)

167 (4.43)

190 (3.93)

Not-reported

249 (23.56)

719 (19.06)

968 (20.05)

0 (0.0)

21 (0.56)

21(0.43)

1,057

3,772

Total = 4,829

614.068, ± 9.22

p-value†
p<0.01

Affiliation with Academic Medical Center
(hospital months, %)

p<0.01

Ownership (hospital months, %)

p<.001

Physician Owned
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Table 3.1 NHSN Survey Reported Facility Characteristics by C. difficile Reporting
Status, 2008-2012 (continued)
NHSN Survey Characteristics

p-value†

Non-Reporting

Reporting

Totals

82 (7.76)

215 (5.70)

297 (6.15)

26-100

270 (25.54)

522 (13.84)

792 (16.40)

101-200

280 (26.49)

1,003 (26.59)

1,283 (26.57)

201-500

319 (30.18)

1,498 (39.71)

1,817 (37.63)

501-1000

106 (10.03)

527 (13.97)

633 (13.11)

0 (0.00)

34 (1.57)

34 (1.06)

0

7 (0.19)

7 (0.14)

1,057

3,806

Total = 4,829

3840.57, ± 4155.91

5798.90, ± 5067.12

5483.82, ± 4983.70

p<.001

Number of HO-C. difficle LabIDs (mean,
SD)

2.25, ± 3.74

4.78, ± 6.01

4.38, ± 5.78

p<.001

*Rates of HO-C. difficile LabIDs per
10,000 patient days (mean, SD)

13.48, ± 80.46

7.23, ± 6.47

8.19, ± 32.21

p<.001

C. difficile Community Onset Prevalence
Rate per 100 admissions (mean, SD)

2.85, ± 14.29

0.50, ± 1.71

0.86, ± 5.88

p<.001

Bed Size (hospital months, %)
<=25

p<.001

> 1000
Not reported

Number of C. difficile Patient Days
(mean, SD)

†

P-values in bold indicate statistical significant at α<.05. All continuous variables tested for normality using Shapiro-Wilk W test for
normality. All values p<.001. Differences in reporting/non-reporting continuous variables evaluating using Wilcoxon Rank Sum test.
Differences in categorical variables testing using Chi-square test. HO-C.difficile LabID rate adjusted for patient days ≥ 25 days.
NHSN, National Healthcare Safety Network; HAI, Healthcare-associated infection; C. difficile, Clostridium difficile; MRSA,
Methicillin-resistant Staphylococcus aureus; SD, standard deviation, HO, Hospital Onset. *Rates exclusive of facilities that reported
less than 50 (73 observations) C. difficile patient days as defined by NHSN.

trends. Additionally, trends were evaluated beginning with data from July 2009, as
observations prior to those were largely count values of zero and represented on 0.5% of
the total hospital-month sample. Overall larger declines were seen in non-reporting states
during the study period when compared to hospitals in reporting states and the overall
sample. A much more minimal trend was noted in reporting states with mean rate for
HO-C. difficile LabIDs lower in the third quarter of calendar year 2009 (6.70 events per
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10,000 patient days) compared to the second quarter of calendar year 2012 (5.41 events
per 10,000 patient days). Evaluation of community-onset prevalence rate yielded an
increasing rate over the entire sample during the study period (Figure 4).

Figure 3.3 Mean HO-C. difficiile LabID rates by Month

Effects of State HAI Mandatory Reporting Laws
Zero-inflated Poisson regression models with unit-level indicator variables for
hospital fixed effects were used to determine the change in mean rates relative to the
implementation of state reporting mandates.
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Figure 3. 4 Mean Community-Onset Prevalence Rate for C. difficile Infection

Community-Onset Prevalence defined as C. difficile LabID identified on hospital day 3, or earlier.

The Vuong test yielded a p-value of <.002, indicating a preference for a zero-inflated
model given this data set. IRRs were interpreted as change in mean rates in the modeled
time interval as compared to the reference group, 30-to-28 months prior to the law’s
implementation.
With the exception of 3-to-5 months after the law, all IRRs from postimplementation time-periods were less than 1.0, indicating a decreasing trend in HOC.difficile LabID rates when controlling for secular time trends and hospital
characteristics. However, in both the pre-and-post time periods, all but one of the rate
ratios were not statistically significant (Table 2). Similar trends were noted prior to the
law’s implementation, specifically at 18-to-16 months before the law (IRR 0.568, p =
0.034). This interval period is associated with a 43% lower mean rate in HO-C. difficile
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LabIDs compared with 30 to 28 months prior to the law’s implementation. An IRR of
0.452 was noted with in the farthest time distance interval from the law, 51-to-53 months
post-implementation although this was not statistically significant. Hospitals in nonreporting states had an average mean rate 3.6 times higher than those in reporting states
30 to 28 months prior to the law (IRR 3.578, p<0.001). This difference is also reflective
of the findings in the bivariate analysis presented in Figure 3.
Sensitivity Analysis
In addition to the zero-inflated Poisson regression a standard Poisson regression
with hospital and time fixed effects was modeled to ascertain the robustness of the zeroinflated Poisson model. Results of the panel data modeled with the standard Poisson
yielded similar results with overall trends to decreasing IRRs after the implementation of
the law, but none of them with statistically significant differences. The 18-to-16-month
time interval prior to the law did remain statistically significant with an IRR of 0.616
indicating a 39% lower mean rate in this time-period compared to 30-to-28 months
before the law.
An additional sensitivity analysis was conducted by fitting a random effects
model interacting hospital month, as a continuous variable, with reporting status.
Reporting status here was refined and modeled as all hospitals in non-reporting states and
hospitals in the pre-reporting period as “non-reporting” status. The model was used to
determine the difference between the rate of infection increase from month-to-month in
reporting compared to non-reporting groups. Results from the model indicate that over
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time the infection rate of the non-reporting status group changes at the same rate
compared to the non-reporting group, although these results were not statistically
significant (IRR 1.002, p = 0.304).

Table 3.2 Results of Zero-Inflated Poisson Regression: Effects of HAI Mandates in
Reporting States
Month Time Interval

IRR

Robust Std. Err.

P-value*

95% Confidence Interval

27 to 25 months prior

1.100

0.286

0.714

0.660, 1.832

24 to 22 months prior

0.885

0.233

0.642

0.529, 1.481

21 to 19 months prior

1.020

0.250

0.936

0.630, 1.650

18 to 16 months prior

0.568

0.152

0.034

0.337, 0.956

15 to 13 months prior

1.035

0.292

0.904

0.594, 1.799

12 to 19 months prior

0.993

0.263

0.978

0.590, 1.670

9 to 7 months prior

0.851

0.263

0.601

0.464, 1.560

6 to 4 months prior

0.942

0.267

0.834

0.541, 1.641

3 to 1 months prior

0.912

0.266

0.752

0.515, 1.614

0 to 2 months after

0.989

0.264

0.968

0.586, 1.670

3 to 5 months after

1.168

0.367

0.621

0.631, 2.164

6 to 8 months after

0.866

0.288

0.665

0.451, 1.661

9 to 11 months after

0.864

0.305

0.678

0.433, 1.724

12 to 14 months after

0.836

0.295

0.612

0.419, 1.668

15 to 17 months after

0.877

0.328

0.726

0.421, 1.827

18 to 20 months after

0.816

0.307

0.589

0.390, 1.706

12 to 23 months after

0.851

0.338

0.685

0.391, 1.854

24 to 26 months after

0.816

0.329

0.614

0.371, 1.798

27 to 29 months after

0.830

0.350

0.659

0.364, 1.896

30 to 32 months after

0.791

0.335

0.581

0.345, 1.816

Reference -30 to -28 Months
Prior to Law Implementation
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Table 3.2 Results of Zero-Inflated Poisson Regression: Effects of HAI Mandates in
Reporting States (Continued)
Month Time Interval

IRR

Robust Std. Err.

P-value*

95% Confidence Interval

33 to 25 months after

0.869

0.390

0.754

0.361, 2.093

36 to 38 months after

0.845

0.381

0.709

0.350, 2.044

39 to 41 months after

0.978

0.472

0.963

0.380, 2.517

42 to 44 months after

0.834

0.561

0.788

0.223, 3.119

45 to 47 months after

0.616

0.442

0.500

0.151, 2.517

48 to 50 months after

0.957

0.643

0.948

0.256, 3.573

51 to 53 months after

0.452

0.471

0.446

0.059, 3.487

non-reporting

3.578

0.768

0.000

2.350, 5.449

Zero-Inflated Poisson Regression was used. IRRs are exponentiated coefficients controlling for time and hospital fixed effects as well
as community onset prevalence rates (IRRs not shown). Depended variable modeled above is the count of HO-C.difficile LabIDs per
10,000 patient days as the exposure (offset) variable in the model. IRRs, Incident Rate Ratios; HO-Hospital Onset; C. difficile,
Clostridium difficile; Robust std. err, Robust Standard Errors. *p-values in bold are statistically significant at the α=.05 level.

3.6 Discussion
To our knowledge this is the first study that models the longitudinal effects of
public reporting laws on C. difficile infection events in U.S. hospitals. While the effects
of these laws on average rates, failed to reach statistical significance in the model,
important trends were noted in the findings. Additional methodological implications for
analyzing the impact of these laws were also apparent from study results.
Similar to previous work examining HAIs, lower average rates of HO-C.difficile
LabIDs were noted in the months after the laws’ implementation.25,26,30 Declining rates
of HO-C. difficile infection both during and after the study period have been observed in
other literature, as are the noted increasing trend in community-onset C. difficile
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infection, which in this sample, is noted on hospital admission or shortly after.1,44
Although not statistically significant, the general trends appreciated in the data may
reflect the effect of these laws, particularly as this model controlled for the secular time
trend in HO-C. difficile rates. The only lower rate that was statistically significant in
reporting institutions was noted in the time frame of 16-to-18 months prior to the laws’
implementation. Upon a more granular review of the data, it was noted that data which
reached this far back in time was from the same reporting state and institution as that
which populated the reference time interval (30-to-28) months prior to the law). This
effect is likely an incidental finding of a single institution being compared to its own
previously reported data, albeit possibly in anticipation of the law. While the model did
control for correlation between repeated hospital observations, its possible that in
addition to the impending law a time-variant extenuating factor or unobserved covariate
affecting that institution was implemented. These may include additional C. difficile
prevention programs including CDC supported state C. difficile collaborative groups or
other more local initiatives taken irrespective of the presence of state mandate.12
Interestingly, the IRR for HO-C. difficile LabIDs 50-to-53 months after implementation
of reporting mandates indicates a long-term reduction in these infections when compared
to mean pre-law rates. This may be an indicator that the strength of these laws is more in
their ability to impact hospitals over the long term, rather than stimulating immediate
change. Similar findings were noted in previous studies25,27 when examining CLABSI
rates in relation to state reporting mandates. Although the C. difficile study by Daneman
et. al, did not report findings beyond 20 months post-reporting, they too reported
prolonged reductions in observed cases compared to predicted cases as result of reporting
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mandates.30 Although our finding was not statistically significant, it may suggest that
these laws have long-standing impact which warrant further longitudinal investigation
Review of this data yielded many zeros counts, some across the same institution
for the entirety of the longitudinal observations. These zero values included both patient
days and outcomes, suggesting that hospitals may have had difficulty reporting infections
or reporting the proper metrics associated with NHSN surveillance. While support for
implementation of NHSN reporting exists, many hospitals may still have struggled with
or questioned surveillance definitions, data validation and implementation of reporting
infrastructure, causing incorrect reporting or missing. These struggles have been
described in other literature45,46 and may reflect a difficulty with implementation of
public reporting. These effects may represent one possibility for the over representation
of zeros in the data, justifying the need for the Zero-Inflated Poisson model.
There may be several reasons why little statistically significant effect was seen on
HO-C. difficile LabIDs resulting from state HAI reporting mandates. First these affects
may be attenuated by other additional policy interventions including federal policies.
During the study period, the CMS Hospital IQR was in effect and reporting of C. difficile
infections was slated to begin in January of 2013.12 These larger federal policy initiatives
may have stimulated additional process improvements during the study period that
contributed to declining rates of C. difficile in hospitals and made the effect of state
mandates difficult to isolate. Additionally, C. difficile infections may have been affected
by prior state reporting mandates for other HAIs. Before the enactment of reporting laws
specific to C. difficile, multiple states had mandatory reporting of CLABSIs which may
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have stimulated additional efforts at curbing HAI infection rates. Any novel process
improvements or programs that are put in place for the management of specific HAIs
may stimulate additional improvement in other HAI rates. Prior studies45–47 have shown
that any public reporting mandates tend to affect hospitals as a whole, rather than just
focusing on one particular outcome, and it may be that these effects are difficult to
separate from specific effects of a singular HAI reporting mandate.
Implications for Policy and Future Research
HAI reporting mandates have gained momentum over the past decade and have
been evaluated in the literature regarding their impact on health systems, process
improvements, and outcomes. However, many of the studies attempting to delineate an
impact on specific infection rates have yielded mixed results. Ours is the first study to
examine the effect of specific C. difficile reporting mandates in U.S hospitals, and does
illuminate specific policy implications.
While the findings in this study didn’t isolate a statistically significant effect on
C. difficile outcomes, it does show a potential trend toward reductions in these infections
Yet, it may still be difficult to ascertain how and why these effects occur. Some studies
have attempted to examine specific process improvements and organizational impacts
resulting from these mandates in hopes of better understanding the relationships between
reporting mandates and decreased infection rates. Many of these studies have also
yielded mixed findings noting that process measures may or may not be affected by these
policies.27,28 However, these impacts may not readily translate to changes in infection
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rates.48 While mediating factors were not a focus of this study, understanding the role of
process improvements and point-of-care changes may be an important component of how
these laws affect hospitals, and ultimately outcomes, and should be examined in future
research.
The methodological considerations of this study lend themselves well to future
mandated reporting policy research. Adapted from a model put forward by Liu and
colleagues48, our model aimed to isolate the effects of the law on C. difficile infections at
varying time distances before and after its implementation. This approach is valuable in
that it allows investigators to examine trends in the effects of the law, particularly if
reductions in infection rates persist, plateau or diminish over time. The importance of
these findings for policy makers lies in the understanding that broad policy initiatives,
such as state reporting mandates, may have stronger impacts in time points leading up to
or immediately after the law as has been seen in previous studies.25,27 This analysis may
also yield longer term policy impacts that may have sustained effects on outcomes over
many years. These considerations are key to crafting and evaluating broad policy
mandates. If its established that the effect of reporting mandates are likely to be strongest
in the months surround their implementation, then focused research on how, specifically,
health systems respond to those within that critical period is essential. If the converse is
true, indicating more long-term impacts from these state mandates, understanding
sustained patterns of change and how these laws have re-shaped hospitals would be
essential as well. In either case, defining the outcomes associated with these laws is as
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important as understanding what is likely a multifactorial response by hospitals to their
implementation.

3.7 Limitations
There are several limitations to this study. As previously discussed, the data set
likely did not have sufficient diversity in counts for its HO-MRSA BSI LabID for the
proposed model to converge, leading to the inability of the authors to model the laws’
effects on this outcome. While MRSA findings would have been complementary to the
findings related to C. difficile ultimately the difference in these two infections did not
represent a new or different process under investigation that was specific to MRSA. Our
sensitivity analyses confirmed the C. difficile results noted in the final model. However,
it is likely that data limitations were also applicable to the C. difficile analysis, primarily
in the lack of available pre-reporting data. Reporting of C. difficile to NHSN began in
March of 2009. This may have contributed to a lack of pre-data and inaccuracies in
reported data as hospitals scaled up reporting programs. While some pre-reporting data
was present, a larger panel of observations may have allowed us to detect a stronger
effect of these reporting mandates relative to their implementation time. Although this
was self-reported data and based on surveillance criteria it is possible that count and
denominator data was not accurate for every observation in this data set. This could
contribute to the underestimations in assessing the differences between pre-and-postimplementation rates. Some states do have data validation structures in place, but this
likely would have limited our analysis and, thus, we did not focus only on observations
from those states. Also, the data used in this analysis is from 2008 to 2012, representing
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a span of five years between data collection and this study. Ongoing changes in the
epidemiology C. difficile coupled with additional state reporting mandates and new
federal policy initiatives may diminish relevance to the current HAI policy environment.
However, the majority of C. difficile reporting mandates were implemented during the
study time-period or within one year of the final observation months.12 This allowed for
modeling of the effects of those laws during the critical time before, during and after
implementation. The number of hospitals included in this study is a subset of
participants in the P-NICER survey.34 While external validity is a potential limitation,
the original authors of the survey noted that comparison between respondents and nonrespondents yielded similar CLABSI rates between the two groups, despite difference in
other hospital characteristics.34 Finally, while our model controlled for secular trends in
infection rates and time-invariant hospital characteristics, additional process
improvements and programs implemented during the study period across differing
hospitals may have confounded effects of the state mandates on our outcome measure.

3.8 Conclusion
Most US states now have HAI reporting mandates in place. This study is the first
to examine the impact of these laws on C. difficile infections in US hospitals. Findings
may suggest a trend toward a reduction in rates, particularly after the law’s
implementation, although these changes were not statistically significant. Additional
research is needed to examine trends in infections associated with these laws and by what
mechanisms are these laws impacting hospitals to improve HAI related patient outcomes.
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Abstract
Background: Over the past decade, various policy initiatives have been implemented to
reduce the burden of healthcare-associated infections (HAIs). Mandating hospitals to
publicly report HAI performance data is a key legislative policy aimed at stimulating
improvement and reducing HAIs. Yet, little is known about how these state level
reporting mandates galvanize the organizational changes in hospitals needed to reduce
HAIs. The organizational climate of hospitals is the perception culture and specific
domains such as leadership, communication, and social norms. Purpose: The purpose of
this study is to examine the relationship between state HAI public reporting mandates and
specific domains of organizational climate. as they relate to infection prevention.
Research Design: This cross-sectional study uses organizational climate variables from
the Prevention of Nosocomial Infections and Cost-Effectiveness-Refined (P-NICER)
Survey. Infection Prevention organizational climate composite scores are developed
from the previously validated Leading a Culture of Quality for Infection Prevention
(LCQ-IP) instrument nested within the P-NICER survey. Methods: Bivariate analysis
was used to compare hospital characteristics in both reporting and non-reporting states.
Multiple linear regression is used to determine the effect of public reporting mandates on
organizational climate scores for the following climate-related concepts: Psychological
Safety, Prioritization of Quality, Supportive Work Environment, and Improvement
Orientation. These effects are examined while controlling for hospital level
characteristics. Results: There was no statistically significant difference in mean
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organizational climate composite scores between hospitals in states with and without
public reporting mandates. However, facility bed size and the presence of an infection
control director did have statistically significant associations with composite scores.
Additionally, hospitals in public reporting states reported a slightly higher sense of
urgency related to HAIs compared to those not in public reporting. Conclusion:
Although no statistically significant effect of public reporting was seen on organizational
climate composite scores, other key hospital and infection prevention program
characteristics did show an effect. Policy makers and researchers would benefit from
understanding more about how organizational climate domains are impacted by these
factors. New directions for empirical investigation are needed to better understand their
significance in improving HAI-related outcomes.
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4.1 Introduction
Healthcare-associated infections (HAIs) are a significant source of morbidity and
mortality in hospitalized patients in the United States. The U.S. Centers for Disease
Control and Prevention (CDC) estimates that approximately 722,000 HAIs occur
annually and contribute 75,000 deaths.1 Device-associated infections including central
line-associated blood stream infections (CLABSIs) and others often cause severe
complications in patient. Similarly, infections caused by Clostridium difficile (C.
difficile) and multidrug resistant organisms (MDROs) such as Methicillin-Resistant
Staphylococcus Aureus (MRSA) contribute to poor patient outcomes and prolonged
hospitalizations.2,3
Mandated public reporting of HAI-related outcomes has gained momentum as a
policy initiative over the past decade.4 These policies are directed at improving hospital
performance and empowering consumers to make informed choices about their care by
mandating hospitals to report HAI performance data to various state and federal
stakeholders. The evidence of their effectiveness in stimulating a reduction in HAIs
remains mixed. Policy makers and healthcare facilities understand that, along with public
reporting, additional factors intrinsic to an organization , such as organizational climate,
can play a role in changing behavior and improving performance around patient safety
and HAIs.5–7
Organizational climate, or shared perceptions of various features and attributes of
an organization and its functioning, has at times been associated with improved outcomes
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and processes for staff and patients.8 Yet, little is known about the relationship between
mandated public reporting of HAI performance data and specific domains of
organizational climate as they related to infection prevention (IP) within the hospital
setting. The aim of this study it to explore the relationship between state-mandated
public reporting of HAI-related data and IP organizational climate. Understanding these
relationships will guide future research to examine the pathways by which organizational
climate domains impact the outcomes of HAIs within the structure of public reporting
policy.

4.2 Background
HAIs in U.S. hospitals continue to be a significant source of morbidity and
mortality, as well as a prominent policy issue for various stakeholders concerned with
patient safety and quality of care.1,9 These infections are estimated to contribute to
75,000 deaths per year in this country and cost health systems in excess of $28.4 to $33
billion dollars annually.1,10 Over the past decade, growing patient safety and quality of
care concerns have led to HAI performance data being used in payment incentive
programs and reimbursement.9,11 These efforts center on infections associated with
medical devices including central venous catheters, indwelling urinary catheters and
ventilators, as well as surgical site infections and those caused by C. difficile and MRSA.
Evidence has shown that more than half of device-associated infections could be
prevented with the use of current evidence based guidelines, yet some organizations
continue to struggle with reducing infection rates despite efforts to implement prevention
initiatives.1,12 Infections such as those attributable to C. difficile and MRSA are not
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readily attributable to devices but are known to be transmitted within the healthcare
environment. Both infections can cause serious complications in the hospitalized patient
and contribute to excess financial burdens on institutions.
The past two decades have yielded growing concern over preventable HAIs.
These infections garner attention in the mainstream media and serve as drivers for
policymakers and administrators to address key issues around patient safety and quality
of care. HAIs play a central role in U.S. federal patient safety policy and have been a
national target for improvement since 2013, with a goal of total elimination by 2020.9
Federal and state-level lawmakers have used these infections as a means of monitoring
performance and driving improved performance among healthcare institutions.11
One policy intervention that has been widely used to promote the reduction of
HAIs has been public reporting of hospital and statewide HAI-related data. Beginning in
the mid-2000s, state-level policy began to mandate the public release of HAI data in a
variety of formats and for varying infections. Public reporting of healthcare and health
system performance measures has been a part of federal policy and guidelines since the
1980s.13 In a 2012 evidence report for the Agency for Healthcare Research and Quality
(AHRQ), Totten and colleagues13 describe public reporting as “data, publicly available or
available to a broad audience free of charge or at a nominal cost, about a health care
structure, process, or outcome at any provider level (individual clinician, group, or
organizations [e.g., hospitals, nursing facilities]) or at the health plan level” (p.3).
Public reporting of HAIs has gained momentum over the past decade. While
hospitals have tracked HAI-related data for many years, mandated reporting of data
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through state-level legislative initiatives has only gained traction over the past decade.14
This primarily involves requiring hospitals to report their HAI data to state government
bodies. Public reporting of HAI data can be mandatory or voluntary; most states in the
U.S. (37 states as of 2013) now have some type of state-level HAI-related public
reporting legislation, with a significant amount of that data reported at the federal level as
well.4 HAI data collection in the U.S. is facilitated by the National Healthcare Safety
Network (NHSN), a national HAI surveillance system managed by the CDC. NSHN
receives reported HAIs from healthcare institutions around the county who follow
specific surveillance criteria for the identification and reporting of certain these
infections. Aggregate data from this system is available to the public through federal
channels (i.e., Hospital Compare Website), and allows for uniform definitions for
infection surveillance as well as some risk-adjusted comparison.15,16 Centers for
Medicare and Medicaid Services (CMS) uses the same HAI-related data published on
their Hospital Compare Website in a variety of payment reduction plans, including the
HAC Reduction Program, the Hospital Inpatient Quality Reporting Program and
incentive programs such as Value Based Purchasing.11,17
These policies are directed at improving hospital performance and empowering
consumers to make informed choices about their care by mandating hospitals to report
performance data to various state and federal stakeholders. The evidence on their
effectiveness in stimulating a reduction in HAIs remains mixed. Studies evaluating the
impact of public reporting of HAI data have shown mostly mixed findings18–20, and most
of these studies focus only on a singular infection: CLABSIs. Some studies have shown
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a longitudinal reduction in CLABSI rates across various populations related to the
implementation of these laws.20–23 However other studies employing other
methodologies have shown no effect of these laws, particularly with regard to CLABSI as
well as point-of-care practices.18,19,24,25 This mix of findings is consistent with the larger
body of research examining the relationship between public reporting and patient
outcomes.26–28 The inconsistency in these findings suggest that larger systemic and
organizational factors impact their implementation and efficacy in promoting patient
safety and improvement.
Berwick et. al,7 contend that in order for the reporting of performance data to
improve organizational processes and quality of care, the environment within
organizations must be conducive to change. Some key characteristics of these
organizational environments include leadership, investment in time and change
management, communication, and ongoing evaluation.7 Similarly, Marshall, Romano,
and Davies29 describe the impact that public reporting can have on organizational culture
by empowering change-makers. The authors argue that strengthening the value of quality
improvement and improving accountability are key factors impacted by publicly
reporting data. Additionally, they discuss the impact of public reporting on guiding
quality of care social norms within healthcare organizations.29 They describe these
effects as potentially long-lasting, but only in the context of organizational factors that
promote behaviors that emphasize patient safety and improving patient.29 Few studies
have examined the effect of public reporting on these organizational-level processes and
characteristics. Thus policy makers and healthcare entities may fail to appreciate that
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both public reporting and key organizational factors can play a role in changing behavior
and improving patient safety and HAI performance.5–7 These key organizational factors
have been captured in measures of organizational climate. Organizational climate, or
shared perceptions of various features and attributes of an organization and its
functioning, has been found to be associated with improved outcomes and processes for
staff and patients.8 Yet, little is known about the relationship between mandated public
reporting of HAIs and organizational climate in hospitals.
In the Institute of Medicine’s 2000 report To Err is Human,30 the report’s authors
determined that organizations must understand why and how preventable errors or
adverse events happen within healthcare systems. Causes of adverse events were
multifactorial and were not solely attributable to individual healthcare providers.30 The
authors contend that specific conditions including the working environment, guidance
around acceptable performance, and proper communication all contribute to
improvements in quality of care and reduction of errors.30 In subsequent literature the
notion of organizational climate has been discussed as the perception of the culture
within an organization including characteristics such as leadership, communication, and
norms.8 It has been argued that since climate is a representation of perceptions of an
organization, it can be more easily measured and evaluated than that broader notion of
culture.8 Climate may be an effective way to capture various leadership and process
domains within an organization and assess their impact on the overall functioning or
outcomes within that organization. Stone and colleagues31 put forward an Integrative
Model of Organizational Climate (Figure 1) which incorporates structural and process
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domains and their relationship to outcomes in both healthcare workers and patients.
These domains comprise a host of interrelated concepts including leadership,
communication processes, work environment, innovation and collaboration.31 The effect
of these structural domains on outcomes is mediated by process domains that directly
impact worker related outcomes and patient outcomes. In 2007, MacDavitt8 and
colleagues published a systematic review evaluating the domains described in this model
and their impact on patient outcomes. Findings from the review suggested that some
organizational climate domains including work environment, collaboration, and the
availability of technology were associated with lower mortality, but these results were not
consistent across studies.8
Although the Integrative Model of Organizational Climate was not specifically
developed for infection prevention (IP), many of its domains are components of
comprehensive IP programs. The impact of public reporting mandates on organizational
climate domains related to IP programs has been explored, primarily in qualitative
studies. Stone and colleagues32 conducted interviews as part of a mixed-methods study to
evaluate these impacts on hospitals in California. They found an overall increase in
infection prevention awareness and priority within hospitals as a result of these
mandates.32
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Figure 4.1 The Integrative Model of Organizational Climate

This model provides a framework for how organizational climate, can impact patient care related outcomes by
associating core structural domains with potential mediating processes that affect measurable outcomes. Developed
by Stone et. al31

A study from Uchida and colleagues33 using the same data, but centering on quality
improvement factors, broadly describes the state of IP in California hospitals using
qualitative interviews of nurse leaders, hospital epidemiologists, infection prevention
directors, and other administrators across six hospitals. Results of the analysis
specifically identified the emergence of mandatory public reporting as a primary theme
among respondents, with a subtheme that indicated that public reporting had led to a
heightened awareness of infection prevention within the hospital. A separate, theme of
organizational climate emerged related to IP and highlighted the importance of increased
collaboration and teamwork for HAI prevention.33 Participants also reported additional
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IP climate components such as improved communication within the hospital and renewed
emphasis on quality of care.33 In a later qualitative study by Stone et. al,34 interviews
with multiple stakeholders across the country to examined the impact of federal and state
policy on health departments and hospitals specifically with regard to infection
prevention efforts. Participants included infection preventionists, state health department
officials, hospital administrators and epidemiologist. Findings were similar to previous
work regarding the impact of reporting mandates, but less so in differentiating between
state and broader federal mandates.34 Participants noted that these laws increased
collaboration between hospitals and health departments, and intensified the focus on
HAI reduction in hospitals.34
It’s clear from this prior work that these policy mandates strengthen the
importance of HAI prevention in healthcare organizations, but less is known about their
association with key organizational climate domains that relate to IP programs. It
remains unclear whether these laws impact patient outcomes by impacting key
organizational climate domains which then contribute to improved enhanced infection
prevention. While previous studies are valuable in their contribution to the public
reporting and HAI literature, they do not explore the specific relationship between public
reporting mandates and IP organizational climate domains. Given the number of states
that have implemented reporting mandates, understanding the association between public
reporting and the climate of organizations is crucial to exploring potential pathways by
which these laws improve outcomes. This study used survey data assessing IP
organizational climate domains to examine this issue. We proposed that higher
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organizational climate scores will be associated with the presence of public reporting
mandates. This study serves as a foundation for understanding the impact of public
reporting mandates on specific IP organizational climate concepts and build on previous
work that has explored this relationship in a more qualitative fashion.

4.3 Methodology
The data for this study came from the Prevention of Nosocomial Infections and
Cost-Effectiveness-Refined (P-NICER) survey (National Institutes of Health,
RO1NR010107: Stone, P.), a component of a mixed-methods study capturing the
complexities and structure of infection prevention programs in the U.S. and subsequently
informing the development of the survey tool.32,35,36 A subset of the P-NICER survey,
the Leading a Culture of Quality for Infection Prevention (LCQ-IP), was developed and
validated for the purposes of measuring organizational climate variables related to HAIs
and IP.37 The primary analysis in this study will examine the association of the validated
IP organizational climate domain composite scores and the presence of state public
reporting mandates.

4.4 Sample
All non-Veteran’s Administration hospitals who reported to NHSN during the
study period were eligible for participation in the P-NICER study. One infection
prevention director or leader from each participating institution was invited to participate
in the web-based survey in 2011. A modified Dillman technique was used for
recruitment as well as lottery-based incentives to promote participation.36 A total of 1064
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hospitals were represented in the survey (29% response rate) with 975 of hospitals
providing complete data on the organizational climate measures.37 Hospitals completing
the survey were invited to participate in the P-NICER NHSN research group.36 This
group agreed to provide researchers with access to device-associated infection data as
well as C. difficile and MRSA data reported to NHSN for the previous 6 years (20062011).36 Additionally, data from the NHSN survey detailing hospital demographic
characteristics was also made available through NHSN and hospital size, location, and
ownership status.

4.5 Independent and Control Variables
The primary independent variable was the presence of a state public reporting
mandate. The presence of a state reporting mandate at the time of survey participation
and data collection was ascertained by using published literature detailing the presence of
public reporting mandate by time of passage for any type of HAI.4 Any hospitals located
in a state with an HAI-related reporting mandate in effect in 2011 was counted as having
a mandate.
Control variables included hospital demographics and characteristics previously
known to impact HAI related outcomes19,36,38 and may be related to organizational
climate. These include location (Northeast, Midwest, South, West, other), ownership
status (for profit, not for profit/other), medical school affiliation (major, graduate, limited,
non-teaching), size (bed size ≤200, 201-500, 501-1000, >1000) and specific IP program
characteristics including the presence of an infection prevention director (yes/no),
presence of a hospital epidemiologist (yes/no) and number of infection preventionists on
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staff (continuous). Facility affiliation and facility ownership status were pulled from
additional NHSN survey data submitted by a subset of respondents.

4.6 Dependent Variables
The P-NICER survey captured a breadth of organizational level data including
information regarding processes and climate as it relates to the prevention of HAIs.
Imbedded within the P-NICER survey was the LCQ-IP survey. This was adapted from
the Leading a Culture of Quality (LCQ) instrument which was designed to assess quality
oriented climates by evaluating 9 quality related components.37 The subsequent LCQ-IP
was validated in a separate analysis that identified specific to organizational climate
domains as they relate to infection prevention. The organizational climate factors related
to infection prevention included 19 questions, grouped into 4 domains: Improvement
Orientation, Psychological Safety, Prioritization of Quality, and a Supportive Work
Environment (Figure 2). Psychometric nalysis determined the LCQ-IP instrument to be
psychometrically sound and a reliable measure of infection prevention organizational
climate among respondents (Chronbach α for 19-item instrument = .926).37
Infection prevention organizational climate composite scores from the LCQ-IP
are the dependent variables in this analysis. These composite scores are reflective of the
IP organizational climate domains and are summed from a groups of variables found to
be related and representative of the larger IP climate domains from the previous
psychometric validation study(Figure 2).37 Responses to the individual organizational
climate components within each domain were measured on a Likert scale (1=strongly
disagree, 2=disagree, 3=neutral, 4=agree, 5=strongly agree) and are coded so a higher
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score indicates a more positive organizational climate (Figure 2). Composite scores for
each domain are the sum of the individual components related to the climate domain
(Figure 2). Values for composite scores for larger climate-related domains are treated as
continuous variables for this analysis.

4.7 Statistical Analysis
Descriptive statistics were used to describe facility level demographics and
characteristics including geographic distribution, bed size, ownership status and medical
school affiliation. Differences in mean organizational climate composite scores for the
sample were analyzed between hospitals in public reporting and non-public reporting
state using the Wilcoxon rank-sum test to account for non-parametric data
Bivariate analysis was used to assess differences in demographics and
characteristics of hospitals with and without public reporting mandates. Additionally,
key structural components of IP programs including personnel and leadership, as well as
participation in HAI quality improvement initiatives were examined. Evaluation of
categorical variables (coded as either present or absent) was conducted using a Fisher’s
exact test, while Wilcoxon Rank-sum tests were used to evaluate the differences in the
means of continuous variables and mean composite scores. The null hypothesis of H0=0,
indicating no difference in these characteristics between institutions in reporting and nonreporting states, was rejected at a pre-determined alpha level ≤ 0.05.
A subset of the 975 hospitals with complete organizational climate data was used
to examine the relationship between public reporting laws and organizational composite
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scores. This subset (n = 662) is inclusive of all respondents who provided full data on all
organizational climate variables and covariates. Stepwise linear regression was used to
assess the association between public reporting mandates and IP organizational climate
composite scores while controlling for covariates. The association between public
reporting and composite score variables was modeled inclusive of control variables in a
stepwise fashion using backward elimination with covariates inclusion set at α < .05.
Coefficients for those states with reporting laws were evaluated as the change in
organizational climate score when reporting mandates are present. While these models
are inclusive of hospital characteristics selected a priori, they do not account for state
variation in HAI reporting law or timing of implementation, both of which may impact
organizational. Since the association between the presence of the law and the hospital
organizational was the primary outcome of interest, hospital characteristics were the
covariates of focus in the model. All statistical analyses were conducted using Stata
statistical software version 14.2.39

4.8 Results
In all, 1064 hospitals across 50 states and Puerto Rico participated in the survey.
Hospitals in the District of Columbia were not represented in the sample. At the time of
the survey, 34 states had HAI public reporting mandates while 17 did not (Table 1). The
majority of respondent hospitals in this sample (76%, n=811) were located in states that
had public reporting mandates in place in 2011 (Table 2). Respondents’ hospitals were
geographically distributed around the country, but were primarily in the South (36%) and
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Midwest (28%), and rather than the West (16%) and Northeast (19%). Most hospitals
identified as suburban or rural (74%) and smaller to mid-range in bed size (85%).

Figure 4.2. List of LCQ-IP Organizational Climate Composite Scores and Individual
Variables
Concept
Prioritization of Quality

Variable
Prioritization of Quality Composite Score
The health care-associated infection prevention goals and strategic and strategic plan of
our organization are clear and well-communicated
Results of our infection prevention efforts are measured and communicated regularly to
staff
There is good information flow among departments to provide high-quality patient safety
and care
People here feel a sense of urgency about preventing health care-associated infections

Psychological Safety

Supportive Work Environment

Employees are encouraged to become involved in infection prevention
Members of this organization are able to bring up problems and tough issues
Psychological Safety Composite Score
The climate in the organization promotes the free exchange of ideas.
Staff will freely speak up of they see something that may improve patient care or affect
patient safety.
I feel free to express my opinion without worrying about the outcome.
In general, people in our organization treat each other with respect.
If you make a mistake in this organization, it tends to be held against you.
People in this organization are comfortable checking with each other if they have
questions about the right way to do something.
The people in this organization value others’ unique skills and talents.
Members of this organization are able to bring up problems and tough issues.
Supportive Work Environment Composite Score
Senior leadership here has created an environment that enables changes to be made
Where I work, people are held accountable for the results of their work
The quality of work suffers because of the amount of work staff are expected to do

Improvement Orientation

Most people in this organization are so busy that they have very little time to devote to
infection prevention efforts (reverse coded)
Employees are encouraged to become involved in infection prevention.
Improvement Orientation Composite Score
I can think of examples when problems with patient infections have led to changes in our
procedures or equipment

I know of one or more health care-associated infection prevention initiatives going on
within our organization this year
I have a clear understanding of the organization’s mission, vision and values.
Responses to the individual organizational climate variables were measured on a Likert scale (1=strongly disagree, 2=disagree,
3=neutral, 4=agree, 5=strongly agree) and are coded to indicate a higher score consistent with a more positive organizational
climate.
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4.8 Results
In all, 1064 hospitals across 50 states and Puerto Rico participated in the survey.
Hospitals in the District of Columbia were not represented in the sample. At the time of
the survey, 34 states had HAI public reporting mandates while 17 did not (Table 1). The
majority of respondent hospitals in this sample (76%, n=811) were located in states that
had public reporting mandates in place in 2011 (Table 2). Respondents’ hospitals were
geographically distributed around the country, but were primarily in the South (36%) and
Midwest (28%), and rather than the West (16%) and Northeast (19%). Most hospitals
identified as suburban or rural (74%) and smaller to mid-range in bed size (85%).

Table 4.1. States with Public Reporting Mandates Enacted before or in 2011
Public Reporting
Mandate (2011, n=34)

AL, AR, CA, CO, CT, DE, FL, HI, IL, IN, MA, MD, ME, MN, MO, NC, NH, NJ, NV,
NY, OH, OK, OR, PA, PR, RI, SC, TN, TX, UT, VA, VT, WA, WV

No Public Reporting
Mandate (2011, n=17)

AK, AZ, GA, IA, ID, KS, KY, LA, MI, MS, MT, ND, NE, NM, SD, WI, WY

Data in the above table gathered from empirical evidence presented in Herzig, et. al in 2014.4 See
Appendix B for guidance on state abbreviations.

Bivariate analysis of respondent hospitals in reporting states versus non-reporting
states yielded significant findings regarding the hospitals’ participation in national IP
improvement initiatives and characteristics of individual hospital infection IP (Table 2).
Participation in an infection prevention improvement campaign outside of those
stipulated in the survey (On the CUSP Stop BSI Initiative and IHI 5 million Lives
Campaign) was noted to be different between hospitals in public reporting and non-public
reporting states (p = .05). Additionally, statistically significant differences were seen in
specific components of facility IP programs. The mean number of full-time hospital
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epidemiologists (physicians) was 0.41 in hospitals in reporting states compared to 0.31 in
non-reporting states (p = 0.04). While the mean number of infection preventionists (IPs)
in these hospitals did not differ between the two groups, IPs with specialty certification
appeared to be more prominent in hospitals with public reporting laws, however this
difference failed to reach statistical significance with mean in reporting hospitals vs nonreporting 1.01 and 0.83 respectively, (p = .06).

4.9 Organizational Climate Findings
Four composite scores were created from 19 variables previously
psychometrically validated to measure organizational climate specifically related to IP.37
When compared between hospitals in reporting and non-reporting states, mean composite
scores for all four organizational climate domains did not differ significantly between the
two groups (Table 3). Mean scores for both reporting and non-reporting hospitals were
well above the mid-range, indicating more positive IP organizational climates across the
all respondent hospitals. Analysis of individual components within each composite
score yielded similar findings except for the question asking respondents if people in
their hospital system feel a sense of urgency about HAIs. Overall hospitals in public
reporting states reported a slightly higher mean score than those without mandates, (3.7
vs. 3.5 out of 5, p = 0.03).
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Table 4.2. Demographics and Characteristics of Respondent Hospitals
Demographic/Characteristic

Public Reporting (% or
SD)
811 (76)

Non-public Reporting (% or
SD)
253 (24)

Total (%) [p-value]

Northeast
South
Midwest
West
Other (AK, PR, HI)
Total

197 (24)
288 (35)
189 (28)
129 (16)
8 (1)
811

0 (0)
99 (39)
106 (42)
44 (17)
4 (2)
253

197 (19)
387 (36)
295 (28)
173 (16)
12 (1)
1,064 [p < .0001]

Urban setting
Suburban
Rural
Total

224 (28)
278 (34)
304 (38)
806

52 (21)
63 (25)
136 (54)
251

276 (26)
341 (32)
440 (42)
1057 [p <.0001]

≤200 beds
201-500
501-1000
>1000 beds
Total

413 (53)
285 (36)
76 (8)
8 (1)
782

151 (61)
73 (29)
24 (10)
0 (0)
248

564 (55)
358 (35)
100 (9)
8 (1)
1030 [p = .06]

Total Hospitals

1,064

Location

Setting

Bed Size

Participation in IP Improvement Projects
Participation in the CUSP Initiative1
Yes
No
Total

267 (33)
544 (67)
811

96 (38)
157 (62)
253

363 (34)
701 (66)
1064 [p = 0.08]

Participation in IHI Five Million Lives
Campaign2
Yes
No
Total

272 (34)
539 (66)
811

81 (32)
172 (68)
253

353 (34)
711 (66)
1,064 [p = .356]

Participation in any other similar program
Yes
No
Total

199 (25)
612 (75)
811

78 (31)
175 (69)
253

277 (26)
787 (74)
1,064 [p = .03]

Infection Prevention Program Structure
Mean number of Full-time Hospital
0.41 (±0.734)
0.31 (±0.693)
0.38 (±0.729)
Epidemiologists -MD Only (SD)
[p = 0.04]
Mean number of Infection Preventionists
1.94 (±1.56)
1.79 (±1.23)
1.91 (±1.48)
(SD)
[P = 0.36]
Mean number of Infection Preventionists
1.01 (±1.22)
0.83(±0.99)
0.974 (±1.71)
Certified in Infection Control (SD)
[P = 0.06]
Hospital has an Infection Control Director
Yes
560 (69)
188 (74)
748 (70)
No
249 (31)
65 (26)
314 (30)
Total
809
253
1,062 (p = .07)
1Denotes participation in On the CUSP: Stop BSI Project, CUSP = Comprehensive Unit-based Safety Program. 2Denotes participation IHI
Five Million Lives Campaign, IHI = Institute for Healthcare Improvement. IP = Infection Prevention. All means compared using Wilcoxon
Rank-sum test. Normality assessed for continuous variables using Shapiro-Wilks test, all p<0.001. All other comparisons made using
Fisher’s exact test.
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Table 4.3. Mean LCQ-IP Composite Scores
LCQ-IP Composite Scores: Mean (N=975)
Public Reporting Hospitals

Non-Public Reporting Hospitals

Total
Composite
Mean

Mean Prioritization of Quality Composite
Score (range 7 – 30)

23.92 (±3.66)

23.66 (±3.50)

23.86 (±3.62)
[p = 0.26]

Mean Psychological Safety Composite
Score (range 8 – 40)

31.47 (±4.50)

31.11 (±4.86)

31.38 (±4.59)
[p = 0.60]

Mean Supportive Work Environment
Composite Score (range 5 – 25)

17.88 (±3.23)

17.86 (±3.29)

17.87 (±3.28)
[p = 0.97]

Mean Quality Improvement Orientation
Composite Score (range 3 – 15)

13.29 (±1.56)

13.23 (±1.52)

13.28 (±1.56)
[p = 0.62]

All scores tested for difference using Wilcoxon Rank-sum test. Normality assessed for continuous variables using Shapiro-Wilks test,
all p<0.001. LCQ-IP = Leading a Culture of Quality – Infection Prevention.

Four separate multiple linear regressions were conducted to determine the
relationship between HAI public reporting mandates and each IP organizational climate
composite score. Analyses of fully-specified models showed no statistically significant
impact of public reporting mandates on organizational composite scores, however other
hospital characteristics emerged as associated with organizational climate (Table 4). In
the Improvement Orientation composite score, an average decrease of more than 0.5
points in the mean score was noted in hospitals who reported being located a in rural
setting and those within the 500 - 1,000 bed range (p <0.001 and p=0.04, respectively).
Larger facility size was also associated with a decrease in mean Supportive Work
Environment composite scores, by an average of 1.20 (p = .001) and 4.38 (p=0.01)
points in hospitals with 500 – 1,000 beds, and more than 1,000 beds, respectively. A
similar association was seen in Prioritization of Quality composite scores in hospitals of
the same size. Conversely no association with size was seen on mean Psychological
Safety composite scores.
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Refined models determined by stepwise regression with backward elimination
showed that the structure and characteristics of the hospital’s IP program had statistically
significant associations with specific organizational climate composite scores (Table 5).
Many of the statistically significant covariates were held in the refined models. The
presence of an infection control director had a consistent finding across three composite
scores: Prioritization of Quality, Psychological Safety, and Supportive Work
Environment. Number of infection preventionist staff was also associated with an
average increase in the Supportive Work Environment composite score, suggesting a 0.37
average increase in the mean score for every one infection preventionist on staff. In
addition to the size of the facility, higher mean Improvement Orientation and
Prioritization of Quality composite scores were modestly associated with the number of
infection preventionists certified in their specialty.

4.10 Discussion
This study estimates the association between HAI public reporting mandates and
perceptions of infection prevention organizational climate in hospital settings. Overall no
statistically significant differences in organizational climate composite scores were noted
in the association between states with and without public reporting mandates. While no
effect of state-level mandates were seen, it is possible that some of the effects of these
specific laws were masked by federal reporting mandates and incentive programs
specifically targeting HAIs. Inpatient Hospital Quality Reporting, Value Based
Purchasing and the HACS Reduction Program are federal initiatives aimed at reducing
HAIs.
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Table 4.4. Multiple Regression Coefficients for LCQ-IP Composite Scores (Full Model)
Prioritization of Quality
(p-value, 95% CI)
Composite Range (SD)

Psychological Safety
(p-value, 95% CI)

Supportive Work Env
(p-value, 95% CI)

Improvement
Orientation
(p-value, 95% CI)

7-30 (±3.62)

8-40 (±4.59)

5-25 (±3.28)

3-15 (±1.56)

0.051
(0.883; [-.63, .73])

0.420
(0.35; [-0.45, 1.29])

-0.023
(0.942; [-0.64, 0.59])

-0.172
(0.246; [-0.46, 0.11])

-0.595
(0.145; [-1.40, 0.21])

-0.194
(0.709; [-1.21, 0.83])

0.050
(0.891; [-0.67, 0.77])

-0.249
(0.151; [-0.59,0.09])

-0.842
(0.071; [-1.76, 0.07])

-0.945
(0.112; [-2.11, 0.22])

-0.068
(0.871; [-0.89, 0.75])

-0.770*
(<0.001; [ -1.16, 0.38])

-0.095
(0.801; [-0.84, 0.65])

-0.165
(0.732; [-1.11, 0.78])

-0.419
(0.216; [-1.08, 0.25])

-0.001
(0.993; [-0.32, 0.31])

-1.379*
(0.048; [-2.74, -0.01])

-0.427
(0.630; [-2.17, 1.31])

-1.994*
(0.001; [-3.22, -0.77])

-0.609*
(0.040; [-1.19, 0.027])

-3.761*
(0.049; [-7.51, -0.01])

-2.934
(0.229; [-7.72, 1.85])

-4.377*
(0.011; [-7.74, -1.01])

-0.583
(0.473; [-2.18, 1.01])

Infection Control
Director (Yes)

0.883*
(0.005; [0.27, 1.49])

1.188*
(0.003; [0.41, 1.97])

1.058*
(<0.001; [0.05, 1.61])

0.176
(0.182; [-0.08, 0.43])

Number of Full-time
HE

0.225
(0.228; [-0.14, 0.59])

0.003
(0.991; [-0.46, 0.47])

-0.029
(0.863; [-0.36, 0.30])

0.078
(0.326; [-0.08, 0.23])

Number of IPs

0.326
(0.159; [-0.09; 0.57])

0.150
(0.482; [ -0.27, 0.57])

0.463*
(0.002; [0.168, 0.76])

-0.021
(0.771; [-0.16, 0.12])

Number of IPs with
CIC?

0.236
(0.080; [-0.04, 0.69])

0.113
(0.634; [-0.35, 0.58])

-0.027
(0.870; [-0.35, 0.30]

0.236*
(0.003; [0.08, 0.39])

IHI Campaign (Yes)

0.541
(0.08; [-0.06,1.14])

0 .294
(0.45; [-0.47, 1.06])

0.104
(0.70; [-0.43, 0 .64])

0.209
(0.114; [-0.05, 0.47])

On the CUSP Program
(Yes)

0.428
(0.16; [-0.175, 1.03])

-0.251
(0.53; [-1.03, 0 .52])

0.225
(0.47; [0.32, 0.76])

0.207
(0.115; [-0.05, 0.47)]

Other Similar Program
(Yes)

-.138
(0.66; [-.75, 0.48])

-0.002
(0.99; [-0.79, 0.78])

-0.097
(0.73; [-0.65, 0.45])

0.286*
(0.034; [0.02, 0.55])

Public Reporting
Mandate (Yes)
Setting
Urban (Ref)
Suburban
Rural

Bed Size§
≤200 beds (Ref)
201-500
501-1000

>1000 beds

IP Program
Characteristics

IP Improvement
Initiatives

*Regression coefficients significant at the p ≤ .05 level. Categorical variables not shown did not reach statistical
significance in the model. IP = infection prevention, CIC = Certification in Infection Control, HE = hospital
epidemiologist, CUSP = Comprehensive Unit-based Safety Program, IHI = Institute for Healthcare Improvement. Not
shown are coefficients for geographic location, medical school affiliation/type, facility ownership, all of which had no
statistically significant coefficients. §Wald Test conducted to determine significance of bed size as a group
(Prioritization of Quality Composite, F = 2.66, p =.047; Supportive Work Environment Composite, F=4.43, p = .0043)
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Table 4.5. Stepwise Multiple Regression Coefficients for LCQ-IP Composite Scores
(Final Model)

Composite Range (SD)
Public Reporting
Mandate (Yes)

Prioritization of
Quality
(p-value, 95% CI)
7-30 (±3.62)

Psychological
Safety
(p-value, 95% CI)
8-40 (±4.59)

Supportive Work
Env
(p-value, 95% CI)
5-25 (±3.28)

Improvement
Orientation
(p-value, 95% CI)
3-15 (±1.56)

0.051
(0.883; [-.63,
.73])

0.233
(0.574; [-0.57,
1.04])

-0.027
(0.942; [-0.60, 0.54])

-0.125
(0.370; [-0.39, 0.15])

-0.379*
(0.046; [-0.75, 0.01])

-0.521*
(0.012; [-0.96, 0.09])

-

-0.34*
(p<0.001; [-0.50, 0.18])

-

-

-0.637*
(0.008, [-1.11, 0.17])

-

0.940*
(0.002; [0.35,
1.53])

1.023*
(0.007; [0.27, 1.77])

0.981*
(<0.001; [-0.45,
1.51])

-

Number of Full-time
HE

-

-

-

-

Number of IPs

-

-

0.379*
(0.001; [0.17, 0.59)

-

0.314*
(0.015; [0.06,
0.57])

-

-

0.183*
(0.001; [0.08, 0.29])

Setting

Bed Size§

IP Program
Characteristics
Infection Control
Director (Yes)

Number of IPs with
CIC?

IP Improvement
Initiatives
IHI Campaign (Yes)
On the CUSP Program
(Yes)
Other Similar Program
0.301*
(Yes)
(0.024; [0.04, 0.56])
*Regression coefficients significant at the p ≤ .05 level. Model was refined using stepwise regression technique with
backward elimination and model re-fitting for variables meeting the predetermined α ≤ .05. Categorical variables not
shown did not reach statistical significance in the model. IP = infection prevention, CIC = Certification in Infection
Control, HE = hospital epidemiologist, CUSP = Comprehensive Unit-based Safety Program, IHI = Institute for
Healthcare Improvement.

This finding may also be explained in part by the sample of survey respondents.
This was primarily a survey of IP departments and leadership, who responded to
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organizational climate items from their unique perspective. Since organizational climate
is a perception of specific organizational features and domains, these IP professionals
may have more positive perceptions of measures specific to IP organizational climate.
This effect has been seen in other literature, specifically regarding infection prevention
staff’s increased favorable perception of senior management’s engagement in patient
safety compared to non-infection prevention quality improvement staff; an effect that was
higher in infection prevention directors versus non-directors.40 Overall, organizational
climate composite scores were noted to be high with no difference between reporting
groups. This could be reflective of respondents enhanced perception of their own
organizations’ IP infrastructure. Moreover, while the findings of regression analyses
presented here indicate no statistically significant association between overall composite
scores and reporting mandates, other hospital characteristics were noted to be associated
with organizational climate.
Size of the facilities was significantly associated with lower IP organizational
climate scores in three domains: Prioritization of Quality, Supportive Work Environment
and Improvement Orientation. The greatest effect sizes of coefficients were seen in the
Prioritization of Quality and Supportive Work Environment scores. These scores include
measures designed to assess the communication within organizations regarding quality
and strategic plan, as well as open dialogue concerning problems or concerns. The
Supportive Work Environment composite score is comprised specifically of measures
that address issues of accountability, amount of work tasked to staff and the ability of
leadership to promote an environment conducive to change. While it’s possible that
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larger hospitals may face more challenges surrounding the concepts addressed by these
measures (i.e. issues of distant leadership, stifled communication, obstructed chain of
command), more research is needed to determine reasons for these associations.
Leadership and communication have been noted as integral climate domains that
promote a high quality of care, particularly with regard to IP.41–43 The association of
hospital size with these IP organizational climate composite scores may indicate an
important consideration for leadership of larger institutions. Administrators in these
hospitals may benefit from taking additional steps to ensure that their organizational
climate promotes change, strong communication structures and accountability for
infection prevention efforts.
Infection prevention program characteristics, particularly the presence of an
infection control director, also impacted three composite scores in the final model. The
Psychological Safety score was associated with the largest statistically significant
increase (β=1.023, (p=0.007; [95%CI, 0.27, 1.77]) in institutions with a director present.
This composite score addresses personnel feeling safe to express concerns over patient
care, a climate that promotes open communication and a respect for persons within the
institution. It’s possible that the presence of an infection control director promotes more
open communication and facilitates the discussion of problems or issues related to IP
within the organization. While current literature contends that leadership plays an
important role in building an organization where infection prevention is supported and
promoted41; the specific role the infection control director plays in promoting a more
positive IP organizational climate has not been well-established in the IP literature. It is
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likely this role is critical to a well-functioning IP program and safe work environment,
yet more research is needed to determine the mechanisms behind how this role
contributes to these to an improvement IP organizational climate.
While all individual measures within each composite score were tested for
differences between hospitals in public reporting and non-public reporting states, only the
measure discussing a sense of urgency around HAIs was noted to be significantly
different between the two groups (3.7 vs. 3.5 respectively, p = 0.03). While this indicates
a somewhat higher agreement with a sense of urgency around HAIs in hospitals in public
reporting states, whether this difference is meaningful remains difficult to interpret.
However this finding is consistent with previous qualitative work examining the impact
of HAI public reporting mandates on organizations.32–34,44 These findings suggest that
perhaps a primary role of public reporting mandates is to highlight the importance of
HAIs and motivate organizations to begin examining methods to improve HAI-related
outcomes.
The IP organizational climate composite scores were inclusive of key domains
discussed in the Integrative Model of Organizational Climate including leadership,
communication processes, employee recognition and workload.31 Although the LCQ-IP
tool wasn’t built to test this model, it did explore specific domains that the Integrative
Model posits may contribute to clinical outcomes. Those scores that were most impacted
by hospital characteristics concerned measures related to leadership, communication and
accountability. These domains from the LCQ-IP are similar to those from the Integrative
Model suggesting that the impact of IP organizational climate may be tested using this
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framework. The Integrative Model of Organizational Climate does not account for
factors such as public reporting that are external to the health system, thus it may not be
useful in testing the role these policies play in impacting organizational climate. Despite
being helpful in delineating the pathways between larger climate domains and clinical
outcomes, an additional or separate framework may be needed to account for what, if
any, role public reporting may play in shaping IP organizational climate. While public
reporting was not associated with IP organizational climate in this study, it has been
shown to be associated with climate domains in previous work.32–34,44 Additionally it
has been noted that the impact of public reporting of healthcare performance data may
play stronger role in institutions where these domains have a stronger presence and can
potentiate a more constructive and collaborative environment.7,29,44

How these

pathways contribute to HAI outcomes in the setting of IP organizational climate domains
warrants further study.

4.11 Study Limitations
This study did have some limitations. The cross-sectional data does not allow for
causal inference; thus, it is not well suited to determine a causal effect of public reporting
on organizational climate. Also, this data is from 2011 and public reporting mandates
have changed considerably since that time, including the addition of more comprehensive
reporting policy, standardized reporting mechanisms, newer federal policy aimed at
improving HAI performance. Additional examination could be conducted to determine if
timing of the laws (recent implementation vs. less recent) has an impact on organizational
climate. While the sample size was considerable for the purposes of this study, the
162

original P-NICER survey had a response rate of 29%. The addition of NHSN related
covariates further limited the sample to only those respondents who provided NHSN
survey data in addition to the P-NICER survey data. As a result, a smaller subset of
respondents was used to for regression analysis, potentially impacting ability to see
statistically significant effect sizes. Also, it is likely that additional covariates exist that
were not included in the model potentially contributing to confounding. A sensitivity
analysis would be helpful in determining the impact of missing covariates particularly
with regard to the full sample and the analytical sample. Finally sampling bias and selfreport may be an issue with the P-NICER survey, given that IP professionals may be
more willing to respond if they are affiliated with specific types of institutions. The
authors who first reported on results of the P-NICER survey discussed a CDC
comparison of respondents to non-respondents.45 While no differences were noted in
intensive care unit (ICU) CLABSI rates there were significant differences noted in
hospital characteristics. Specifically, non-respondent hospitals tended to be smaller with
fewer patient days, fewer beds and admissions.45 While size of the facility was noted to
be associated with organizational climate in this study, smaller hospitals appeared to be
well-represented in our sample. Furthermore, organizational climate responses appeared
consistent across comparisons and participants appeared to be well distributed across
different geographic regions and facility characteristics so external validity appears
sound.
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4.12 Policy Considerations and Future Research
Although public reporting was not shown to be associated with IP organizational
climate in this study, findings did confirm that these policies stimulate a sense of urgency
around HAIs in hospital settings. While the intent of these policies is to improve care
and aid in consumer decision-making, they do not provide guidance as to how healthcare
systems should make the changes necessary to facilitate these outcomes. This allows for
flexibility within institutions to determine the best methods for improving care and
decreasing HAIs. It reasons then, that hospitals and other healthcare institutions may be
affected by these mandates in different ways. The results of this study are not meant to
suggest that public reporting laws are ineffectual in impacting hospitals’ organizational
climate; only that additional investigation is needed to address the complexity of their
impacts on health systems. Empirical study should continue to investigate how these
public policies drive change in organizational climate. If certain organizational climate
domains are identified as being related to public reporting policies, the relationship
between those domains and outcomes may be investigated.
Qualitative methodologies have been successful in illuminating these concepts in
previous literature32–34, and may be a beneficial strategy to investigate the large scope of
these laws and the intricate ways health systems respond to their implementation.
Organizational climate and its impact on patient outcomes has been studied in the
literature with mixed findings using quantitative methodologies, however few have
focused specifically in IP organizational climate.8 An innovative study from Gilmartin
and Sousa46 used structural equation modeling to determine the association between
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organizational climate, process improvements for CLABSI prevention and CLABSI
outcomes. Their findings indicated that organizational climate was associated with
CLABSI prevention activities, but not CLABSI outcomes, however the authors stress that
more research is needed.46 While quantitative methods may be helpful in illuminating the
relationship between climate and outcomes, mixed methodological studies may be
helpful in both understanding the effect of policy on climate and the subsequent effects of
climate on outcomes. Studies that examine how organizations change in response to these
laws as well as how these changes impact outcomes would help to paint a fuller picture of
the wide-ranging effects of these laws on health systems.
Additionally, understanding how different hospital personnel perceive IP climate
and their perceptions of publicly reported HAI data would shed important light on how
these laws are assimilated not only by IP staff, but by other stakeholders within hospitals.
Additional study of how physicians, nurses, and others view IP organizational climate
and HAI data may help policy makers understand the how these mandates perfuse
through healthcare systems and gauge their effect on key stakeholders. This knowledge
would highlight where these policies have their strongest effect in affecting decisionmaking and improving quality of care.
U.S. state and federal policy continues to promote public reporting of HAIs and
other healthcare quality measures; law makers must understand the full scope of how
these laws impact health systems. This knowledge may help drive new policy that
promotes or incentivizes hospitals to build programs that strengthen their IP
organizational climate in the hopes of achieving gains in patient outcomes related to
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HAIs. If the public reporting alone is not enough of a stimulus to propagate change and
improvement, policy-makers should consider other potential drivers that strengthen to
organizational climate domains. Policies that incentivize building a climate conducive to
HAI improvements may prove to be a powerful adjunct to public reporting policy, or may
prove more valuable to patients and organizations over the long term.

4.13 Conclusion
In this study, organizational climate as measured here, did not differ between
hospitals in states with and without mandatory HAI reporting. However important
findings were seen concerning the effects of specific hospital characteristics including
bed size and structure of IP programs that do have an impact on IP organizational
climate. Hospital size and IP program characteristics did show some association with IP
Organizational climate composite scores in the survey. However, more research is
needed to determine the exact mechanisms behind these relationships. Policy-makers
should consider the structure of IP programs and hospitals in addition to organizational
climate when formulating or implementing policy around HAIs and public reporting.
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5.1 Introduction

Healthcare-associated infections (HAIs) continue to be a significant source of
morbidity and mortality in the U.S. healthcare system. Infections contracted during
interactions with healthcare facilities or as a result of specific treatment interventions are
considered to be healthcare-associated and may arise from multiple etiologies.1 These
infections can cause serious complications and prolonged length-of-stay in inpatient
settings and can complicate treatments and cause additional morbidity in both inpatient
and outpatient settings. Recent estimates from the CDC suggested that as recently as
2011, 722,000 HAIs occurred annually and were responsible for approximately 75, 000
deaths in the United States.2 Financial estimates place the monetary burden of HAI
events as costing health systems anywhere from $24.8 to $33 billion dollars.2,3 Over the
past decade, attempts to curb rates of HAIs has centered on both the implementation of
evidence-based process improvements and promotion of broad policy initiatives and
patient safety programs. In many respects, these efforts may be considered successful, in
that recent data from the U.S. Centers for Disease Control (CDC) show a general
decreasing trend in HAIs in HAI incidence since 2008.4 However, a more granular view
of the data suggests these trends are not consistent across all states and all healthcare
systems.4 These fluctuations in trends indicate that there is still significant room for
progress and additional policies or interventions that may be aimed at improving HAI
outcomes. While it may be difficult to attribute specific gains to any particular policy or
evidence-based intervention, understanding the mechanisms behind larger HAI policy
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initiatives is the first step to evaluating how policy may impact organizations and,
ultimately outcomes.
One policy-level approach to addressing the issue of HAIs over the past decade
has been the wide-spread passage of legislation mandating healthcare facilities report
HAI-related data to specific state-level overseers, typically health departments.5
Although commonalities exist across most state-level reporting mandates, these laws do
vary from state-to-state particularly in terms of which specific HAIs must be reported,
whether the data is reported to the public, and whether the data is required to be
submitted with facility identifiers indicating which facilities are associated with specific
outcomes.6 Each of these provisions carries the propensity to affect how hospitals and
other healthcare entities respond to HAIs, particularly if they change their practices in
response the external pressure of reporting these metrics. Yet it is often contended that
the mandate to report HAI data for release to the general-public is what may play the
largest role in generating specific responses from hospitals aimed at improving HAI
outcomes.7–10
State HAI reporting mandates and their public reporting components have often
been met with controversy and skepticism. As of 2013, 37 states had legislative
mandates for reporting HAI-related performance data.5 Many of these laws, particularly
those mandating the report of device-associated infection data (central-line associated
blood stream infections [CLABSI] and catheter-associated urinary tract infections
[CAUTI]), were enacted in the mid or late 2000s5, even in the face of little evidence
supporting their ability to reduce infection rates or empower consumers to use to the data
for decision-making.11 Since that time additional studies have attempted to evaluate the
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impact of these laws on patient HAI-related outcomes, organizational process
improvements, and consumer decision-making. The empirical evidence from these
studies has yielded mixed results concerning the potential impacts of these mandates and
HAIs continue to negatively impact patient outcomes, despite the persistence of these
laws.
The aim of this dissertation is to illuminate the impacts of state HAI reporting
mandates by examining their relationships to organizations and infection rates.
Specifically, this dissertation was written as three papers, each contributing a new
understanding and evaluating hypothesized relationships between these mandates and
hospitals or infection-related outcomes. The first paper proposes a revised conceptual
framework that builds on findings from existing literature to discern the various pathways
by which reporting mandates may stimulate change in provider or system behavior,
process improvements, outcomes and consumer decision-making. The second paper is a
quasi-experimental longitudinal data analysis that examines the impacts of state public
reporting mandates on Clostridium. difficile (C. difficile) infections over time. The third
paper is an exploratory data analysis that examines organizational climate and its
relationship to state reporting mandates using cross-sectional survey data from the
Prevention of Nosocomial Infections and Cost-Effectiveness-Refined (P-NICER)
survey12. Each of these papers approaches the phenomenon of mandated reporting from a
varying perspective: the impact on outcomes, the impact on organizations and the
conceptual pathways which may guide those impacts.
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5.2 Key Findings
Findings from each component of this dissertation contribute to the larger body of
knowledge surround HAI public and mandatory reporting. These papers represent a
different aspect of reporting that has larger implications for healthcare systems, patients
and policy.
The first paper in this dissertation proposed a revised conceptual framework to
describe the relational pathways by which the reporting of HAI data impacts health
systems, consumers and infection-related outcomes. Prior pathways describing the
impacts monitoring performance data7 and public reporting8 were used to guide the
analysis and served as a foundation on which to build the revised framework. The
intricate relationships between these laws, key stakeholders and outcomes is illuminated
by current evidence in the literature and analyzed using an integrative review
methodology to develop and propose a revised conceptual framework. The 19 studies
reviewed, spanned a breadth of HAI reporting mandates and their associated impacts on
healthcare organizations, consumers, and infection related outcomes. Studies with
diverse methodologies including qualitative, quantitative, mixed-methods and one
systematic review were included in the analysis. Key components of existing conceptual
frameworks were used to organize the analysis and present findings. Building from
existing frameworks 3 key stakeholder groups were the focus of the literature review.
Studies centering on HAI reporting impacts on consumers, healthcare organizations and
providers were analyzed. Findings were synthesized and compared to existing
conceptual frameworks. The author then determined whether empirical evidence exists
179

to support these existing relationships and if needed proposed new directional pathways
that describe the hypothesized impacts of reporting based on the findings of the review.
The Change pathway, first described by Berwick and colleagues7, centers on the
intrinsic ability of organizations to respond to their own performance data and implement
change to improve outcomes. In this pathway, motivational drivers of change include
desire-to-achieve and caring, yet are still subject to the environments in which these
changes are slated to occur. Studies examining the change pathway delineated mixed
findings regarding patient outcomes and process improvements as a result of public
reporting.13–22 With regard to infection related outcomes, multiple studies do show an
effect of public reporting in reducing infection rates14,16,17,23, particularly related to
CLABSIs. Yet while these studies showed reductions in infection rates or events, the
mechanism by which these laws generate these changes remained unclear. A study by
Marsteller and colleagues14 was able to link participation in process improvements to
pending or recent reporting mandates, which in turn, was associated with decreased
CLABSI rates. A paper from Liu et. al23, also hypothesized on the potential impacts of
public reporting on healthcare systems, finding that reducing central line days and
strengthening surveillance programs may be an effect of these laws that contribute
diminished CLABSI rates. However additional studies were unable to find similar results
with regards to both point-of-care processes, including antibiotic utilization, or infection
rates.18,24 Qualitative studies showed more specific impacts of HAI reporting mandates,
particularly their effects on organizational climate, infection prevention infrastructure and
process improvements. Studies examining California hospitals showed that after the
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implementation of reporting laws, increased adherence to various infection prevention
measures were noted as well as a general sense of increased infection prevention
visibility and importance within the system.21,25 However, study participants also noted
frustration with HAI laws due to variability in reporting requirements between state and
federal agencies and increased workload. Improved processes were described as a direct
response to both federal and state reporting requirements in two other California
hospitals, noting specifically that while challenges remain, reporting mandates had
stimulated improvements in infection prevention infrastructure and implementation of
evidence-based prevention practices.19 In addition to process improvements,
organizational climate factors such as leadership, accountability, communication, and
support also emerged.20 These factors were noted by respondents as being key
components of broader responses to mandatory reporting within healthcare organizations.
Two additional pathways, the Selection Pathway and the Reputation Pathway,
have also been proposed as drivers of change as a result of public reporting.7,8 These
pathways acknowledge the potential impact of reporting mandates and publicly reported
data on consumers. However studies examining these potential pathways largely showed
that publicly reported HAI data is not a prominent factor when consumers make decisions
about their healthcare often outweighed by provider recommendations, geographic
location or insurance status.22,26–28 Additionally most consumer respondents across all
studies had difficulty interpreting HAI data, particularly in the face of numerical or
statistical complexity and variable outcome metrics. These findings suggest that while
consumer selection may be a proposed pathway for public reporting mandates, additional
181

evidence is needed to examine the mechanism by which it affects consumer decisionmaking. Interestingly consumers often ranked provider and family recommendation as a
contributing factor to their healthcare decision-making.
Findings from this review showed largely mixed support for the current pathways
proposed by Berwick et. al7, and Hibbard8. A revised conceptual framework was
proposed that used evidence from the literature to support existing pathways and propose
new pathways and relationships between public reporting and various stakeholders within
the healthcare system. In the revised framework, publicly reported data does have a
direct impact on patient outcomes related to HAIs. Studies presented in this review have
shown this relationship both for clinical outcomes and process improvements.14–17,23 Yet
the exact nature of the relationship between reporting and outcomes remains somewhat
undefined. Improvement processes and organizational climate were noted in these
studies to be key factors related to HAI reporting laws, yet evidence for how these
components impact outcomes is not readily appreciable across findings. Thus, the
framework describes a direct association of reporting mandates on HAI outcomes, but
also a potential mediating impact through organizational processes and climate.
While consumer choice had less supportive data describing potential relationships
within the Selection Pathway, evidence from this review suggests that the Reputation
Pathway may play a greater role in selection than previously discussed. Findings from
consumer-focused studies showed that consumers more often rely on recommendations
from family and care providers for healthcare decision-making than publicly reported
HAI performance data.22,26–28 In this regard the Reputation Pathway may mediate the
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Selection Pathway, if reported HAI data does in fact affect the reputations of healthcare
organizations.
Despite these new hypothesized relationships further study is needed to determine
how and to what magnitude these pathways impact outcomes, organizations and
consumer decision-making. Understanding these relationships is crucial not only in the
broader context of discerning public policy impacts on patient outcomes, but to ensure
these policies are being implemented effectively and rationally to improve patient care.
To contribute to the body of literature and further discern the impacts of HAI
reporting mandates on clinical outcomes and organizations, two additional studies were
undertaken in this dissertation. Both studies explored the impacts of HAI reporting
mandates at the state level, the first reporting on C. difficile events in hospitals and the
second addressing impacts on organizational climate indicators.
The second paper in this dissertation examined the association between state HAI
reporting laws and C. difficile and Methicillin-resistant Staphylococcus aureus blood
stream (MRSA-BSI) events across a longitudinal sample of hospitals from varying states.
Building from an analysis previously conducted by Liu and colleagues23, this paper used
a quasi-experimental design to determine the effects of reporting mandates on hospitalonset (HO) C. difficile and MRSA-BSI Laboratory-Identified (LabID) events as defined
by the CDC’s National Healthcare Safety Network(NHSN).29 These LabID events are
the common metric used in both state and federal reporting mandates.4,5,30,31 Data from
the P-NICER survey was used for the primary analysis and included a final sample of
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219 hospitals was included in the analysis, yielding 4,328 hospital-months of complete
data. Outcome events were modeled with respect to effects of mandatory reporting laws
at varying time distances before and after the laws’ implementation. This design allows
for the identification of time trends in infection rates as they related to implementation of
the law.23
Early in the analysis phase of this study it was determined that the proposed
model for MRSA-BSI LabID events would not converge, likely due to a high frequency
of zero or one event counts in the panel data. MRSA outcomes were thus not included in
the final analysis. Zero-inflated Poisson regression models for C. difficile showed no
statistically significant effect of public reporting mandates either before or after
implementation of these laws. One statistically significant incident rate ratio (IRR) at 18
to 16 months before the law was significant (p = 0.034) but likely represented a decline in
a single hospital during that period. Overall trends in IRRs indicated decreased rates in
C.-difficile LabID events after implementation of the laws, when compared to 28-to-30
months prior. Although these IRRs did not reach statistical significance, findings may
suggest some impact of mandatory reporting laws. Sensitivity analyses confirmed that the
rate of change over time in both reporting and non-reporting groups was statistically not
different, however, and further study is needed to determine the significance of these
findings.
To approach the concept of mandated HAI public reporting from a different
perspective, the third paper in this dissertation aimed to conduct an exploratory data
analysis and examine the relationship between organizational climate variables and
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public reporting. Organizational climate refers to the perception of culture within an
organization inclusive of specific factors such as leadership, communication and social
norms. Data on organizational climate was collected as part of the P-NICER survey and
reported in a specific subsection of the Leading a Culture of Quality for Infection
Prevention (LCQ-IP) survey.32 Organizational climate factors included in this survey
spanned multiple domains and assessed concepts specific to infection prevention.32 Four
domains emerged from grouping of individual factors related to infection prevention
organizational climate. These domains included Improvement Orientation, Psychological
Safety, Prioritization of Quality and Supportive Work Environment. Survey questions
measured factors associated with each domain on a Likert Scale and were coded so
higher scores indicated more positive organizational climates. These individual factor
scores were then summed to generate composite scores for each domain. These scores
were then compared across reporting and non-reporting states and linear regression was
used to determine the impact of reporting laws and various facility-level characteristics
on organizational climate domains.
Across all four climate domains, no statistically significant differences were noted
in composite scores between hospitals in states with HAI public reporting and those
without. Additionally, results of multiple linear regression found that the presence of
public reporting laws had no statistically significant association with organizational
climate composite scores. However, in the final models, some key hospital
characteristics remained significant indicating associations with individual composite
scores. The presence of an infection control director was shown to be associated with
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higher mean composite scores in the Supportive Work Environment, Psychological
Safety, and Prioritization of Quality composite scores (p < 0.01). Similarly, the number
of infection preventionists certified in infection control was also associated with a higher
Improvement Orientation score and Prioritization of Quality score (p<0.01, p = 0.02,
respectively). While not directly related to public reporting in this study, these findings
do contribute to the larger body of knowledge regarding organizational climate and
infection prevention. Future research will be needed to assess additional relationships
and potential impacts among public reporting hospitals.
Together these three papers contribute a well-rounded perspective on HAI public
reporting and its impacts on organizations and outcomes. They provide findings from
empirical investigations and a revised framework gleaned from a substantive review of
existing literature. The integration of these findings yields new knowledge regarding
HAI public reporting mandates and proposes new directions for policy research.

5.3 Discussion
The mandated reporting of HAI performance data is a widely used policy
intervention that attempts to promote consumer decision-making and healthcare system
accountability.10,33 Current reporting mandates in the United States span a breadth of
states, include a variety of HAI reporting requirements, and a promote a diverse
methodology for data dissemination.5 Most reporting mandates include three key
legislative or administrative components: the mandate to report HAI data, the mandate to
report that data to the public, and the inclusion of facility identifiers that link performance
data to specific healthcare facilities. In much of the previously discussed literature the
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publicizing of facility-linked performance data is often thought of the primary motivator
behind consumer decision-making and changing practices to improve patient care.7,8,10
Subsequently the primary body of knowledge surrounding HAI public reporting has
attempted to describe or quantify the effect of these reporting mandates, often with
diverse and innovative methodologies. The findings from each of the papers in this
dissertation contribute significant findings to this body of knowledge. Yet, as a whole,
they provide a new direction for future research and innovation needed to understand
how and why these laws impact healthcare consumers and organizations.
The revised conceptual framework this dissertation presents is the first updated
framework to specifically propose pathways between publicly reported HAI data, patient
outcomes, organizations and consumers. While it does build from previously proposed
frameworks7,8, these frameworks were not specific to HAI data. The importance of an
HAI-specific framework lies in the need to address the pathways for the process
improvements, epidemiologic considerations, evidence-based interventions and patientrelated considerations that are unique to HAIs. Unlike other publicly reported healthcare
performance data, HAIs are somewhat set apart both because of their implications for
transmission to other patients within a health system and the medical and environmental
conditions that put patients at risk for infection.1 Additionally these infections can pose a
threat to the larger community including patient families, healthcare workers and
others.34 These distinctive characteristics of HAIs pose a unique challenge to health
systems attempting to curb their transmission, and often sets them apart from other
metrics and prevention programs within healthcare settings. As federal and state policy
makers have moved public reporting mandates forward, research into how these laws
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impact these infections and the organizations trying to prevent them, is integral. The
revised framework in this dissertation allows investigators to test direct pathways
between laws and outcomes, or examine specific mediating variables that are evidenced
in the literature as potentially being impacted by these laws and related to decreased HAI
rates. Additionally, the idea that HAI performance data is driving consumer decisionmaking is perhaps an intuitive one, but the current available literature suggests that
consumers are either not aware of the existence of this data22 or have difficulty
interpreting this data, particularly when metrics are varied or highly statistical and when
consumers have less eduction.26–28 The framework presented in this dissertation provides
researchers and policy makers with new pathways for empirical testing and investigation
of relationships between HAI reporting mandates, outcomes and organizational
processes. In addition, it integrates the iterative role consumers play in influencing
healthcare organizations, while keeping the unique pathways that may prove specific to
consumers.
The two empirical studies in this dissertation tested specific components of this
revised framework. The quasi-experimental longitudinal C. difficile and MRSA study
evaluated the direct association between state reporting mandates and outcomes. The
organizational climate study centered on examining the association between these laws
and specific domains of organizational climate as they relate to infection prevention.
Although different in aim, methods, and outcomes, these two studies contribute equally
valuable findings, regarding the broader effects of reporting mandates.
Understanding the direct impacts of HAI reporting mandates and potential
mediating factors of these effects is an important component in understanding how these
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laws impact outcomes. The revised framework presented in the first paper proposes that
a directed pathway exists between reporting of HAI data and an improvement in
outcomes, which is often a reduction in infections. The evidence from previous studies
has been mixed regarding this pathway and this dissertation was unable to find a
statistically significant association. Although one other study had noted a decrease in C.
difficile in Canada after implementation of reporting laws16, this paper was the first to
examine these associations in the United States. While this does not confirm or
strengthen the evidence underlying this pathway, further research will be needed to
determine how this pathway differs with other types of HAIs, in other policy settings, and
potentially in other types of care settings.
This direct pathway, likely has significant mediating organizational influences
that may contribute to infection outcomes. These relationships have been explored in
previous literature, again with mixed findings.14,15,23 However qualitative exploration of
organizational responses to HAI reporting mandates have shown significant impacts of
these laws on infection prevention personnel and organizational climate factors.20,21,25
The exploratory analysis presented in this dissertation is the first to examine
organizational climate variables specific to infection prevention and attempt to quantify a
relationship between these variables and public reporting. While not specifically testing
for mediation, this paper explores the first pathway from mandated reporting to potential
impacts on organizations. Knowledge of this relationship can guide additional inquiry to
understand how organizations may be impacted by these reporting laws. If these
relationships are established, further analyses may show they are a mediating factor for
decreasing HAIs in response to public reporting. Organizational climate is an integral
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component to this pathway as it may not only contribute to better patient outcomes35, but
it may help policy makers and healthcare administrators understand in what type of
facilities, these laws may have the biggest impact.
The findings from this dissertation yield that much remains unknown regarding
how these reporting mandates impact outcomes and organizations. Additional study is
needed to explore these complex relationships presented in these studies and previous
work. Examination of theses interrelationships open the door for a significant amount of
new research and innovative policy directions.

5.4 New Directions for Nursing Research and Policy
This dissertation provides a comprehensive groundwork for additional nursing
research and new considerations for policy-makers. In a dynamic policy environment
both researchers and policy-makers will need to respond to the demand for new inquiry
and thoughtful policy recommendation and implementation.
Nursing researchers have been at the forefront of investigating the effects of HAI
reporting mandates. The larger implications for healthcare organizations and personnel
cannot be understated. Nurse are often directly involved in the care for those at risk for,
or affected by HAIs and some HAIs may be nursing sensitive to nursing processes and
behaviors.36 Although much has been examined regarding HAIs and reporting mandates,
large gaps in knowledge persist. One significant paucity in the research is how
healthcare workers and administrators outside infection control interpret and use publicly
reported HAI data. Administrators and front-line staff play significant roles within
healthcare systems and are often responsible for key decision making, implementing
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process improvements and conducting patient education. HAI data is an important tool
and consideration for many of these staff, yet little is known about if or how publicly
reported HAI data impacts their roles or their decision-making. None of the studies
reviewed investigate the knowledge base or attitudes of nursing or physician personnel,
outside of infection control departments, regarding publicly reported HAI data and
whether they can interpret or use the data to effectively. Additional study is needed
concerning the impact public reporting continues to have on infection prevention
personnel and as well as those healthcare workers not directly responsible for data
submission or surveillance.
Nursing research can also play a key role in revealing what specific factors
contribute to patients understanding of publicly reported HAI data. Some evidence has
shown a relationship between educational level, prior healthcare experience and higher
income levels.22,27,28 Yet many of these studies were conducted on small populations and
are difficult to extrapolate outside of the study setting. These findings should be further
examined in other geographic regions with differing populations to establish and test
hypotheses about how social determinants of health impact a consumer’s ability to
interpret data that may guide their decision-making.
Finally, there is ample opportunity for nursing researchers to develop novel
interventions that aim to guide patients through the interpretation of HAI data and
empower them to use that data to promote safer care environments. While not every
consumer has the ability to choose from multiple healthcare institutions, they may still
benefit from understanding their own hospital’s HAI performance and become advocated
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for their own high-quality care or that of their family members. Nurses are uniquely
qualified to not only educate consumers about this data, but also to advise policy-makers
and administrators about the best way to organize and disseminate this data to make it
relevant and applicable across varying sociodemographic and socioeconomic groups.
In addition to nursing research, the implications of these findings on health policy
is significant. Many of current federal policy initiatives centered on improving care
include a component of mandated and/or public reporting. The Hospital Inpatient
Quality Reporting Program (IQR), Healthcare-acquired Conditions Reduction Program
(HACRP) and Value-Based Purchasing (VBP) are legislative mandates implemented by
the Centers for Medicare and Medicaid Services (CMS), and require the submission of
HAI data for various payment incentives and penalties at the healthcare facility
level.30,31,37 This data is then reported publicly on the Hospital Compare website. These
data are received through the NHSN, a primary component of most state-based reporting
mandates. Many state mandates require the public dissemination of reported data,
sometimes in varying formats. A key consideration for policy-makers is the
understanding of whether or not the impetus behind these laws’ ability to instigate change
in healthcare settings is the public reporting component of these mandates. This is likely
a consideration for both policy-makers and researchers. While some studies attempt to
evaluate the impacts of these public reporting mandate, few delve into what, if any,
motivators are specific to public reporting. If the public dissemination of HAI facilityspecific is a stronger motivator than internal reporting, examining the specific
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mechanisms (i.e. social norms or intrinsic drivers) may be beneficial when applying
similar policy interventions to other areas of society.
An additional policy consideration is the propensity to report outcomes rather
than process indicators or process measures for HAI improvements. While some
hospitals do report certain process measures, including Central Line Insertion Practices
(CLIPs), most of the metrics required by public reporting mandates are outcome
measures. The decision to mandate the implementation of process measures rather than
outcomes reporting may be based on the feasibility of wide-spread process measure
implementation. With the varying sizes, geographical regions, and financial resources
across hospital settings, broad implementation of targeted process improvements may be
challenging. However, the recent passage of mandated antimicrobial stewardship
programs in California hospitals may serve as a model for future policy initiatives that
target implementation of interventions rather than simply reporting outcomes.38
Although some evidence exists that these public reporting mandates have a direct impact
on infection-related outcomes, the association between process improvements and
evidence-based prevention programs is more readily understood. It may prove
worthwhile for policy makers to develop or promote structured interventions or provide
funding for participation in broad process improvement initiatives as a means of
improving HAI-related outcomes.
Finally, policy makers should would do well consider both the ethical components
of these mandates and how to best use data to empower consumers across all measures of
diversity and social determinants of health. Transparency in both the implementation and
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evaluation of these laws’ utility among consumers is essential to understanding and
improving methods for effective and fair dissemination. Understanding the goals of these
mandates and their effectiveness may guide needed changes in how data is reported and
shared among multiple stakeholders. If a critical goal of reporting these data is to help
consumers make decisions about their care, policy-makers should consider strengthening
dissemination efforts to make reported data more meaningful. Data should be publicized
in a way that acknowledges and is sensitive to the social determinants of health,
differences in health literacy levels, and health disparities.

5.5 Conclusion
Mandated reporting of HAIs has been a prominent policy initiative in the United
States for over a decade. This dissertation aimed to examine associations between these
policy mandates, HAI outcomes and impacts on organizational climate in acute care
hospitals. These studies provide critical foundations for ongoing inquiry regarding the
effects of these mandates on patient outcomes, organizational characteristics and
processes and consumer decision-making. More research is needed to examine the
important implications of these HAI reporting mandates and determine the mechanisms
by which they motivate change and improvement in healthcare systems.
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Appendix A. Integrative Review Matrix/Table of Evidence
Author(s),
Year

Purpose of the
study

Stakeholder
Group/
Pathway

Conceptual
Framework

Sample

Data Analysis
Methods

Attrition and
Results

Significance of
Findings

Limitations

Mansick et.al,
2015

To assess the
interpretability of
HAI data as
presented on the
hospital compare
website.

Consumers/
Selection

None
Specified

110
hospitalized
patients at the
University of
Maryland
Medical
Center
selected from
a list of
admissions in
prior 24 hours.

Cross-sectional
survey design. The
mean correct score
for each task is
reported as
percentage.
Response to 4
domains was
evaluated: Written
description of data,
written description
plus SIR,
IDENTICAL SIR
descriptions with
numbers, and only
numbers.

First quantitative study
evaluating data
interpretation specific to
HAI data. Outside of
the experimental
environment real data is
likely more difficult to
interpret.

No critically ill
patients, or
members of the
non-hospitalized
population were
used which
excludes those
who had the
ability to use the
data for decision
making
purposes.

McGuckin, et.
al 2014

To assess
consumer
awareness,
engagement, and
intention to seek
information on
HAI rates.

Consumers/
Selection

None
Specified

Random
telephone
sample of
3000
consumers
from the U.S.
All 18 y.o.
and older.

Descriptive
statistics and
Pearson Chi-sq tests
for differences in
participants from
public reporting vs.
non-public
reporting states.

Performance of
hospitals with
regards to HAIs was
correctly assessed
72% of the time
when plain language
description of HAI
rates/SIRs was used.
Mean percent correct
decreased as
complexity
increased. Similar
decreasing trend seen
among college
graduates, those who
were more likely to
get question 1
correct, and
healthcare
workers/caregivers of
frequently
hospitalized persons
3031 respondents
took the survey, 1895
lived in states with an
HAI reporting law
and at least 1 HAI
PR. In states with PR
28% knew this. Only
14% of respondents
stated HAI data as
one of the top 2
factors in decision

While some respondents
were aware of HAI
reporting, few listed it as
a top motivator for
healthcare decisionmaking.

Researchers
don't analyze
correlation with
demographic
variables
(race/ethnicity)
as predictors or
correlates of
responses.
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Author(s),
Year

Mazor &
Dodd, 2009

Purpose of the
study

To evaluate
different
approaches for
reporting hospitallevel comparative
data on HAIs and
the extent to which
such data might
influence hospital
choice.

Stakeholder
Group/
Pathway

Consumers/
Selection/
Reputation

Conceptual
Framework

Berwick and
Hibbard

Sample

Data Analysis
Methods

Random
sample of
residents from
Worcester
MA selected
from city
clerk's office
for mailing.
201
respondents
included in the
final sample.

204

Descriptive
statistics for
respondent
characteristics, ttests and Chi-2 to
compare
respondents to nonrespondents. IV's
impact on
understandability
were tested with ttests and
multivariate linear
regression.

Attrition and
Results

making regarding
hospital choice with
recommendation
from HCW and
reputation being the
2 most common
criteria.
Reponses rate of
34% (201 total
respondents of those
able to respond),
25% of total
solicited. Education
was associated with
correctly choosing
the best and worst
hospitals (65% of
those with HS or less
selecting the best
hospital compared
with 83% at least
some college or
higher p=.003).
Understandability
ratings were also
associated with
correct selection.
Prior experience,
hospital reputation,
MD
recommendation,
insurance all ranked
above infection data,
practice score in
terms of factors
affecting hospital
choice

Significance of
Findings

Limitations

Data on HAIs and safety
ranked lower in
hierarchy of factors
affecting hospital choice,
however reputation was
the second most
important factor.
Overall
understandability of
these reports was high
however there was
sufficient evidence to
suggest that education
plays a role in
understanding these
reports. Numerical data
were noted to be the
least comprehensible.
Aggregate scores were
most impactful.

Low response
rate. The
respondents
were more
educated than
the general
community, so
generalizability
may be difficult,
particularly if
the goal is to
evaluate or
recommend how
state reporting
should be rolled
out.

Author(s),
Year

Purpose of the
study

Stakeholder
Group/
Pathway

Conceptual
Framework

Sample

Data Analysis
Methods

Attrition and
Results

Significance of
Findings

Limitations

Mazor et. al,
2009

To explore
consumers'
responses to a
variety of HAI
public reporting
formats and
content and to use
the data to develop
reporting and
formatting
recommendations.

Consumers/S
election

None
Specified

Random
sample of
residents from
Worcester
MA selected
from city
clerk's office
for mailing.
59 consumers
included in the
final sample

Describe a range of
opinions using
qualitative
descriptive
techniques from
data collected
through interviews.
Two themes were
developed as well
as subthemes.

Significant
recommendations were
generated including
recommendations on
format and content.
Most indicated other
factors as paramount for
selection of hospitals
including insurance, past
experience sand
recommendations.
Discrepant scores from
the same institution
posed a challenge for
participants

Little diversity
in race/ethnicity.

McGuckin et.
al, 2013

To explore the
hospital
epidemiologist
opinions regarding
HAI public reports
and their use of
reports in their
work with
consumers and
HCWs.

Providers/Ch
ange and
Consumers/S
election

None
Specified

59 healthcare
epidemiologist
s frim SHEA
Research
Network
across 40
states and 30
of the 32 with
public
reporting.

Descriptive
statistics of
responses to survey
items and open
ended questions
(categorized by
theme)

59 interviews were
completed and 2
major themes were
identified: (1)
responses and
reactions to reporting
with 4 subthemes:
responses to HAIs in
general, responses to
specific indicators,
reactions to different
modes of reporting,
and anticipated
impact of reporting
on hospital choice.
(2) recommendations
with 3 subthemes:
recommendations
related to report
content, recs related
to report format, and
recs related to
dissemination.
36% response rate
(N=59), 90% were
from states with
mandatory reporting.
93% reported seeing
the state report, and
70% used reports
with administrators
and HCWs.
Respondents marked
consumer awareness
, understanding, and
use of data as low
and 21% suggested

Supports the notion that
this public ally reported
data is used by hospital
epidemiologists for work
with administrators and
other HCWs. However
suggests they do not find
it useful for general
consumer purposes.

Small sample
size of
epidemiologists.
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Author(s),
Year

Purpose of the
study

Stakeholder
Group/
Pathway

Conceptual
Framework

Sample

Data Analysis
Methods

Attrition and
Results

Significance of
Findings

Limitations

No difference in 2
groups of hospitals were
noted in any outcome
variable. No
demographic differences
noted.

Cross-sectional
design with a
small and
homogenous
sample although
representative of
the academic
medical center
population.

Rich qualitative data that
discusses the impact of
public reporting and
regulation on IP
practices and
organizations. These
laws, while frustrating
can also help to improve
the profile and
importance of IP within
an organization. They

One state only
included in the
sample, this state
had early
adoption of
mandatory
reporting which
limits external
validity.

that more explanation
of data for consumers
is needed.

Larkin et. al,
2013

To evaluate the
association
between statemandated public
reporting of HAIs
and perceptions of
infection control
process and
outcome measures
at their hospitals.

Outcomes/
Change

None
Specified

137 infection
professionals,
representing
hospitals in 35
states from
SHEA
Research
Network.

Descriptive
statistics of sample.
Chi-sq and t-tests
for differences in
reporting groups.

Uchida et. al,
2011

To conduct indepth semi
structured
interviews to gain
insights about the
experience of the
infection
prevention practice
in California

Outcomes/
Change

Donabedian
Framework of
Healthcare
Quality

25 participants
from
California
hospitals
participating
in CHAIPI,
representing a
range of
personnel.

Open coding and
content analysis.
Initial set of codes
developed by two
coders. Secondary
coding completed to
contextualize the
phenomena and
suggest
meanings/themes
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110 respondents, 91
hospitals in reporting
states. No outcomes
were found to be
associated with
public reporting.
Most respondents
stated no increase in
infection control
resources and
perceived risk of
HAI was slightly
decreased in the past
3 years. No perceived
improved process
measures or lower
infection rates
between two groups
of hospitals.
23 interviews (22
1:1, 1 with multiple
personnel) 4 themes
found (1) mandatory
reporting/ (2) impact
of technology for
surveillance (3) IP
role expansion (4)
organizational
climate. Mandatory
reporting yielding an

Author(s),
Year

Pegues, 2014

Purpose of the
study

To describe the
impact of HAI
Action Plans on an
academic health
system in
California, in
planning and
implementing HAI
prevention
activities and
reduce HAI rates

Stakeholder
Group/
Pathway

Outcomes/
Change

Conceptual
Framework

Context-inputProcessProduct
Model (CIPP)

Sample

Two acute
care teaching
hospitals
within the
UCLA Health
System, both
with dedicated
infection
control
programs

207

Data Analysis
Methods

Attrition and
Results

Significance of
Findings

can stimulate a more
positive organizational
climate for IP

Description of the
implementation of
the HAI action
within the CIPP
model.

increased awareness
in infection control,
however fair
comparison is
lacking, laws do not
always address HAI
of concern,
significant increased
workload. With
regard to
organizational
climate subthemes of
communication,
organizational values
and environment
emerged.
Context- at the time
of HAI action plan
multiple processes
already in place for
HAI reduction, yet
substantial
organizational
barriers as well.
Inputs - Voluntary
reporting in place to
NHSN, yet the
impact of state public
reporting drove
process
implementation to
improve HAI rates
across the system
(implementation of
CVC bundle, policy
development, data
collection and

Implementation of
evidence-based practices
for HAI prevention can
be stimulated by
increased awareness
from public policy
initiatives. However,
each setting must tailor
practices to their own
systems and allocate
needed resources and
organizational support.

Limitations

Small sample
size for
description of
implementation,
and not
generalizable in
experiences.
However,
lessons learned
may be
generalizable to
wider audiences.

Author(s),
Year

Stone et. al,
2015

Purpose of the
study

To explore the
impact of federal
and state HAI
policy on state
health
departments,
hospital
stakeholders in the
USA and to
explore
perceptions across
varying states.

Stakeholder
Group/
Pathway

Organization
s/Change

Conceptual
Framework

Donabedian
Framework of
Healthcare
Quality

Sample

Data Analysis
Methods

Purposive
sample to
ensure equal
number of
states with and
without HAI
laws. 5-10
participants
were recruited
after snowball
sampling. 12
states were
selected 6
with laws, and
6 without.
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Open coding and
content analysis.
Initial set of codes
developed by two
coders. Coded data
were reviewed to
develop necessary
themes and evaluate
differences based on
the presence of
public reporting

Attrition and
Results

Significance of
Findings

Limitations

reporting structure.
Difficulty with
implementation,
given time frame.
External data
validation proved to
be a challenge, but
spurred collaboration
internally.
Reporting lead to
increases in
awareness and focus
in HAI reduction.
Implementation
practices for
evidence-based
interventions need to
be tailored to practice
settings and
embedded into
existing processes of
care
90 interviews
conducted with state
officials, regulatory
officials, legal
counsel, clinicians
and IP professionals,
and community
partners. Four themes
were identified: 1)
Increased
collaboration, 2)
using public reported
data for
benchmarking and
prioritization, 3)

Findings suggest that
laws aimed at mandating
public reporting of HAIs
fosters and heightens
collaboration and
awareness within the
acute care setting to
improve HAI prevention
efforts. The
collaboratives include
surveillance,
implementation of
prevention measures and
data feedback. There
was surprisingly little

Qualitative
interviews
yielded selfreported
narrative data.
The researchers
report there is a
potential for bias
due to social
desirability.
Despite efforts
for a
representative
sample, only 12
states were

Author(s),
Year

Purpose of the
study

Stakeholder
Group/
Pathway

Conceptual
Framework

Sample

Data Analysis
Methods
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Attrition and
Results

Significance of
Findings

Limitations

concerns related to
public reported data
and 4) resource
needs. Public
reporting was key in
focusing importance
on HAIs within
hospital settings and
garnering support for
initiatives (reported
by hospital staff).
This was due to
reputation and
accountability of the
institution. Data
validation continued
to be a concern.
Resource needs are
significant
particularly at the
hospital level for IP
staff, but also at the
state level for
providing guidance.
Data validation
remains a concern.

variation between
groups of states. This
may be due to larger
federal mandates where
data is reported.

included, thus
generalizability
may be
hampered.

Author(s),
Year

Purpose of the
study

Stakeholder
Group/
Pathway

Conceptual
Framework

Sample

Data Analysis
Methods

Attrition and
Results

Significance of
Findings

Limitations

Stone et. al,
2011

To examine the
impact of federal
and state HAI
policy on
California hospital

Organization
/ Outcomes/
Change

None
Specified

331 hospitals
in CA with
adult ICUs
were eligible
to participate.
One staff
member from
each hospital's
infection
prevention
and control
department
was asked to
complete the
web-based
survey.

Descriptive
statistics were
presented. Survey
results pre/post
were computed
using t-tests and
chi-squares. Linear
and logistic
multivariate
regression were
used to examine
changes over time
while controlling
for hospital
characteristics.
Qualitative data was
coded and content
analysis preformed.

207 Hospitals
completed presurveys and 203
completed post. At
time 2, IPs reported
more time spent on
surveillance, in
offices rather than
other locations, and
increased data
mining. Increase in
CLABSI and CAUTI
policies increased at
time 2 as well as SSI
and VAP-related
policies. Increased
adherence noted at
time 2 to CHG use
for CVC insertion
and barrier
precautions.
Decreased ICUspecific rates of
CLABSI and CAUTI
were also noted.
Subthemes gathered
from mandatory
reporting included
increased workload
and associated
frustration, variation
in reporting
requirements
between state and
federal policy,
increased awakened
and priority of IP and

This finding confirms
previous qualitative
studies that show similar
themes with regards to
mandatory reporting.
Sample size was large to
evaluate the state
hospitals with good
response rates (>50%).
Quantitative data capture
was expansive and
collected a wide-range
of data on structure,
processes and outcomes
from policy
implementation.

Pre-and postmeasures are
useful, but
ultimately selfreported by
survey
respondents.
Regression
methods may
show association
with public
reporting and
outcomes, but
not clear from
the models how
the trends were
isolated from
pre-to post
implementation.
This data was
collected from a
sample of
hospitals from
one state and
may not be
generalizable to
experiences of
other states in
the U.S.
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Author(s),
Year

Purpose of the
study

Stakeholder
Group/
Pathway

Conceptual
Framework

Sample

Data Analysis
Methods

Attrition and
Results

Significance of
Findings

Limitations

Compliance with HAI
prevention practices in
NICUs appears to be
associated with reporting
mandates, yet the impact
of this on outcomes
remains unclear. An
associated increase in
compliance was seen
with increased urgency
of the mandates.

Cross-sectional
design does not
allow for causal
inference and it
may be hard to
isolate the effect
of the public
reporting
mandate. Small
sample size may
hamper
generalizability.

increase use of
technology and
associated efficiency.

Zacharia et.
al, 2014

To determine the
association
between state legal
mandates for data
submission of
central lineassociated blood
stream infections

Organization
/ Outcomes/
Change

None
Specified

190 NICUs
included in the
study (107
located in
states with
mandates)
from a
national
sample of
NHSN
participating
hospitals and
associated
NICU (level
II/III and level
III).
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Bivariate analysis
were used to
compare
characteristics of
NICUs, ANOV and
Chi-sq were used to
compare process
measures and
outcome measures.
Multivariable
logistic regression
were used to test the
association between
mandates and
process/outcome
measures.

190 NICUs were
included in this study
(21.8%) of total
NHSN NICUs. Over
half were in states
with reporting
mandates. More
NICUs in mandatory
reporting states
reported >95%
compliance with all
prevention practices
compared to those in
states with no
requirement (36.4%
vs. 16.8%, p=.002).
No difference in
NICU CLABSI rates
overall. No
statistically
significant difference
in SIR between the

Author(s),
Year

Flett et. al,
2015

Purpose of the
study

To determine
whether blood
culture and
antibiotic
utilization changed
after mandatory
public reporting of
CLABSIs

Stakeholder
Group/
Pathway

Clinical
Processes
and
Outcomes/C
hange

Conceptual
Framework

None
Specified

Sample

Data Analysis
Methods

Children's
hospitals that
report to the
Pediatric
Health
Information
System
database
including 17
hospitals in 9
states with
implemented
mandated
reporting and
4 hospitals in
4 states
without.

212

Interrupted time
series using
generalized linear
mixed-effects
models were used to
look at outcomes as
adjusted rate
rations. Covariates
were selected for
inclusion in the
model after pre/post
2-sided t-tests
revealed significant
differences (p<.2)
between before and
after reporting
implementation.

Attrition and
Results

two reporting groups.
(Mean SIR 1.6 vs.
2.7, p = .02).
Greater than 95%
compliance with
prevention practices
was associated with
more recent
mandates which
compared to states
with more than 3
years of mandates.
CLABSI rates in low
BW <750g infants
were significantly
lower in in states
with reporting
mandates.
Blood culture
utilization: No
significant changes in
rates. PICU Adjusted
Annual rate ratio
1.01 [95% CI, 0.901.13], NICU 0.98
[95% CI, 0.88-1.09].
No difference found
in Antibiotic days
aARR 1.03 [95% CI,
0.94-1.13] for PICU
and aARR 0.98 [95%
CI, 0.88-1.10] for
NICU. In hospitals
without mandatory
public reporting rates
of monthly blood
culture dropped in

Significance of
Findings

Limitations

Longitudinal analysis of
outcomes measures
overtime. These
outcomes were focused
more on point of care
decision-making rather
than broader process
improvements. This
could potentially
illuminate a new
pathway for examining
how these laws work or
don't work within
organizations.

Administrative
data can be
subject to
reporting and
validity
weaknesses.
There may have
been
institutional
differences
among facilities
that contributed
to stable
prescribing and
culturing
practices.

Author(s),
Year

Purpose of the
study

Stakeholder
Group/
Pathway

Conceptual
Framework

Sample

Data Analysis
Methods

Attrition and
Results

Significance of
Findings

Limitations

This was a national
sample covering 34
states and examining the
impact in the differences
in mandates as well as
the presence of those
mandates . Well
controlled for case mix,
academic setting and
acuity of patients

Cross sectional
design makes
causal
relationships
difficult to
analyze. The
sample only
included
academic
medical centers
and may not
have been
powered enough
to detect an
association. The
cross sectional
nature of the
data and analysis
did not allow for
temporal trends,
thus it is
unknown if rates

both PICU (p<.0001)
and NICU (p<.0001).
Antibiotic utilization
dropped in the PICU
but the change was
not statistically
significant. Yet was
significant in the
NICU, aARR 0.95,
[95% CI, 0.93-1.01].

Pakyz &
Edmond,
2013

To evaluate the
impact of state
laws on reporting
of HAIs on
CLABSI rates

Outcomes/
Change

None
Specified

Administrativ
e data from
the University
Health System
Consortium
hospitals from
calendar year
2011. 159
hospitals were
included in the
study. 34 in
states with no
mandate, 92 in
states with all
3 legal
requirements,
33 in states
that did not
meet the 3
legal
requirements.
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Ordered probit
regression model
used to test
associations
between legislation
and CLABSI rates.
Secondary analysis
of state-level SIRs
and their
association with
CLABSI reporting
legislation using the
Tukey Kramer HSD
test.

Results of regression
models showed no
effect of the presence
of legislation
category on hospital
SIRs. No difference
in State-level SIRs
was noted between
the three legal
mandate statutes.

Author(s),
Year

Purpose of the
study

Stakeholder
Group/
Pathway

Conceptual
Framework

Sample

Data Analysis
Methods

Attrition and
Results

Significance of
Findings

Limitations

are similar due
to a natural trend
in declining
CLABSIs.

Daneman et.
al, 2012

To determine
whether mandatory
reporting is
associated with a
reduction in
hospital rates of C.
difficile infection

Outcomes/
Change

None
Specified

All admitted
patients in the
study period
were
identified with
broad
inclusion
criteria.
Excluded
patients were
those admitted
to psych,
rehab/complex
continuing
care and nonacute areas.
Administrativ
e data from
the registered
persons
database, the
Ontario
Health

214

Primary analysis
consisted of
modeling temporal
patterns of C. diff
infection using
generalized
estimating
equations, with the
unit of analysis as
the hospital , month,
and age-group.
Exponentiated postmonth coefficient
was the relative
difference between
the observed postmonth and the
predicted postmonth.

Results from the
primary analysis
indicated a 26.7 %
reduction in c. diff
cases comparing the
predicted to the
observed outcomes.
This translates to
5,417 cases observed
compared to 7, 327
predicted, or
8.9/10,00 patient
days vs.
12.16/10,000 patient
days. (p<.001).
This trend was seen
across multiple
hospital settings.

This is a well-designed
longitudinal cohort study
with significant power
and high-fidelity models
to detect the effect of
mandatory reporting on
C. diff. To date this is
the only study to look as
C. diff rates as an
outcome of mandatory
reporting. Sensitivity
analyses were used to
confirm robustness of
primary findings.

All C.difficile
cases were used
in this study
without attention
to those that may
have been
transmitted
outside of the
acute care
setting. Coding
data can
sometimes pose
challenges
although the
authors did
validate their
data with public
reporting
statistics.
Temporal
confounders
remain a
challenge in this

Author(s),
Year

Purpose of the
study

Stakeholder
Group/
Pathway

Conceptual
Framework

Sample

Data Analysis
Methods

Attrition and
Results

Significance of
Findings

Insurance Plan
database, the
Canadian
Institute for
Health
Information
Discharge
Abstract
Database and
the Ontario
Drug Benefit
database.

Marsteller et.
al, 2014

To examine the
mandatory
reporting impact
on participation
and performance in
reducing CLABSIs
in a national
patient safety
collaborative.

Organization
s and
Outcomes/C
hange

None
Specified

Sample from
the On the
CUSP: Stop
BSI program,
organized in
cohorts of
state-level
ICUs. 6
cohorts from
5/2009 to
3/2011.
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Limitations

study design,
and it is difficult
to isolate the
primary effect of
reporting
mandates.

Hospital
participation for
each group tested
whether unit
participation rates
were different
among each group
using chi-square.
Covariates were
tested using Fisher's
exact tests.
Difference-indifference design
was used to
evaluate the effect
of each reporting
group on CLABSI

56% of hospitals
joined the national
program in those
states where
mandatory reporting
started within the
program period. For
those where mandate
was in effect for <1
year, participation
was 50%. For those
hospitals with no
reporting mandate or
a mandate that was
>1 year after the
project, participation
was low (22% and

Longitudinal design
showed some potential
effect of reporting
mandates, when
mandates are newer or
on the horizon as
signified by increased
participation in On the
CUSP in these states.
These mandates may
influence participating
and improvement
initiatives within
hospitals. Hospitals may
already see lower
CLABSI rates states
with long term reporting.

No nonparticipating
ICUs were used
to compare
impacts of
public reporting,
which may be
different than
the sample
provided. Also
CMS
reimbursement
policy in 2008
may have been a
factor in
changes, yet this
would have

Author(s),
Year

Purpose of the
study

Stakeholder
Group/
Pathway

Conceptual
Framework

Sample
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Data Analysis
Methods

Attrition and
Results

Significance of
Findings

Limitations

rates.

23%). Results of the
regression showed
voluntary reporting
(G3)or longer
duration of
mandatory reporting
(G2) had higher
baseline CLABSI
rates (G3 IRR = 1.48,
95% CI, 1.16-1.89;
G2 IRR = 1.14, 95%
CI, 1.01-1.29), but
greater reductions in
CLABSI rates during
the first 6 months of
the On the CUSP
program. Toward the
end of the program
period, hospitals in
states with
mandatory reporting
showed a trend
toward a larger
reduction in CLABSI
than those hospitals
in states without
reporting (not
statistically
significant).

The presence of a
mandate is not
predicative of how well
these initiatives may be
implemented however.

impacted all
ICUs.

Author(s),
Year

Purpose of the
study

Stakeholder
Group/
Pathway

Conceptual
Framework

Sample

Data Analysis
Methods

Attrition and
Results

Significance of
Findings

Limitations

Rinke, M et.
al, 2015

To test the impact
of pediatricspecific public
CLABSI reporting
on rates of
CLABSI as
defined by the
AHRQ PQI 12.

Organization
/ Outcomes/
Change

None
Specified

Discharges
identified in
the Kids'
Inpatient
Database
(KID). States
were
identified as
public
reporters if
states had
facility
identification
as part of its
mandate.

Patient and hospital
characteristics
where compared
using chi-squared
statistics and F-test
for means of
continuous
variables.
Multivariable
logistic regression
was used to
estimate the odds of
PDI12 during each
three-year period
for EACH reporting
group. Random
intercept was
included to account
for correlation
within hospitals
over time.
Covariates included
patient age, sex,
payer, number of
diagnosis, hospital
bed size, location
(urban/rural), and
teaching status.
Odds ratios
estimated change in
the PDI12 rates
over time by
comparing rates in
time groups 2006
and 2009 to the
2003 baseline.
Relative OR were

There 7 states and
1006 hospitals in the
2009 reporting
group, 2 states in 135
hospitals in the 2006
reporting group and
18 states and 2066
hospitals in the never
reporting group
totaling 4,705, 857
observations. States
that began reporting
in 2006 outcome
rates dropped by
46% [95% CI, 31%68%](2006) and by
90% [ 95% CI, 83%94%], (2009)
compared to
baseline. Those who
began reporting in
2009, PDI12 rates
began decreased by
35% [95% CI, 30%39%] in 2006, 74%
[95% CI, 72%-76%]
in 2009. The never
reporting group had
similar decreases
including a greater
decrease in PDI12 in
later reporting
periods when
compared to
reporting begun in
2009 group (OR .12
for never reporters,

This is the first study to
evaluate pediatric
CLABSI outcome in the
advent of public
reporting. The results
indicate that CLABSI
rates as defined by the
study decreased across
all 3 groups, mirroring a
national trend in
CLABSI
prevention/patient safety
and improvement in
quality.

There is some
potential for bias
by the data
indicated in the
PDI12 database,
from the way
that data is
coded. Potential
for
misclassification
exists. The
public reporting
in 2006 group
only had 2 states
and a subsequent
low number of
hospitals.

217

Author(s),
Year

Purpose of the
study

Stakeholder
Group/
Pathway

Conceptual
Framework

Sample

218

Data Analysis
Methods

Attrition and
Results

used to compare
these to the never
reporting group.

and OR 0.26 for
2009 reporters,
relative OR:2.1
p<0.001).

Significance of
Findings

Limitations

Author(s),
Year

Purpose of the
study

Stakeholder
Group/
Pathway

Conceptual
Framework

Sample

Data Analysis
Methods

Attrition and
Results

Significance of
Findings

Limitations

Black and
Kim, 2014

To provide a
narrative and case
study description
of the challenges
of studying the
effect of public
reporting and
HAIs.

Outcomes/
Change

None
Specified

A difference-indifference design
was used to
determine the
impact of state
mandated public
reporting policy on
CLABSI rates, for
reported rates and
inpatient rates.

High rate hospitals
find that reporting
decreases inpatient
data, yet gaming
(time-inconsistent
reporting) exists.
Facilities with higher
rates experience
more significant
drops.

These findings use a
quasi-experimental
design to show a strong
association between
public reporting
implementation and
decreases in CLABSI
rates. Differences in
reported findings also
include changes in
reported data vs.
discharge data,
suggestive of gaming.

While a strong
study design is
used, only one
experimental
group is
evaluated
against the
control.

Liu et. al,
2016

To determine the
impact of
mandatory
reporting laws on
CLABSI rates in a
national sample of
intensive care
units.

Outcomes/
Change

Berwick and
Hibbard

Data is
sampled from
the PA Health
Care Cost
Containment
Council and
PA Inpatient
Discharge
dataset, and
National
Inpatient
Sample. 16
additional
states no
reporting
laws.
A total of 244
hospitals, with
1,902 ICU
years.
Hospitals
reporting to
NHSN
between 2006
and 2012. All
non-VA acute
care hospitals
enrolled in
NHSN were
eligible to
participate.

Variant of a
difference-indifference design,
using a fixed effects
Poisson regression
model of CLABSI
counts for each ICU
month at a given
time interval.
Sensitivity analysis
with CLABSIs by
central line days
and time spent by
infection
preventionists
(#hours per 100
hospitals beds per
week) on
surveillance.

When compared to
25 months or more
prior to the law’s
implementation,
notable decreases in
CLABSIs are seen
both in anticipation
of the law (IRR =
0.66 , p<.001) and
long after the laws
went into effect
(IRR=0.343, p=.009)

These findings use a
quasi-experimental and
multi-state longitudinal
analysis to show an
impact of public
reporting on CLABSI
outcomes. This is the
first study to use
surveillance data from
NSHN to examine
CLABSI in adult ICU
across the country.
Findings also show
longitudinal and
sustained impacts of
these laws on CLABSI
rates.

There is a
potential for
selection bias as
well as changes
in the CLABSI
definition,
however this
would have
affected all
hospitals within
the sample.
Process
improvements
and point of care
decision-making
were not
evaluated.
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Author(s),
Year

Purpose of the
study

Stakeholder
Group/
Pathway

Conceptual
Framework

Sample

Data Analysis
Methods

Attrition and
Results

Significance of
Findings

Limitations

McKibben et.
al, 2006

To conduct a
systematic review
of the available
literature to
determine the
ability of public
reporting laws to
improve care.

Outcomes/
Change

None
Specified

Of the 450
papers
selected for
review with
inclusion/excl
usion criteria.
10 papers in
the final
analysis.

Systematic review
of empirical
evidence presented
in the papers.

No significant
empirical evidence
was found supporting
the recommendation
that public reporting
may improve HAI
outcomes or improve
care.

First systematic review
to focus on HAI related
empirical evidence for
the purposes of policy
recommendations.

Potential for
publication bias
as with any
systematic
review.
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Appendix B. List of State Abbreviations
Appendix B. U.S. State Abbreviations
AL

Alabama

MI

Michigan

UT

Utah

AK

Alaska

MN

Minnesota

VA

Virginia

AR

Arkansas

MO

Missouri

VT

Vermont

AZ

Arizona

MS

Mississippi

WA

Washington

CA

California

MT

Montana

WI

Wisconsin

CO

Colorado

NC

North Carolina

WV

West Virginia

CT

Connecticut

ND

North Dakota

WY

Wyoming

DC

District of Columbia

NE

Nebraska

UT

Utah

DE

Delaware

NH

New Hampshire

VA

Virginia

FL

Florida

NJ

New Jersey

GA

Georgia

NM

New Mexico

HA

Hawaii

NV

Nevada

IA

Iowa

NY

New York

ID

Idaho

OH

Ohio

IL

Illinois

OK

Oklahoma

IN

Indiana

OR

Oregon

KS

Kansas

PA

Pennsylvania

KY

Kentucky

PR

Puerto Rico

LA

Louisiana

RI

Rhode Island

MA

Massachusetts

SC

South Carolina

MD

Maryland

SD

South Dakota

ME

Maine

TN

Tennessee

MI

Michigan

TX

Texas
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